Scientific - myESR.org

IMAGING 2.0 

Philips Imaging 2.0 is more than an evolution in imaging, it’s a revolution. It’s about collaboration. A multi-modality 

approach. Providing advanced solutions allowing you to focus on better 

patient care. Join the conversation at www.philips.com/imaging2.0 and see 

how our revolutionary innovations bring greater simplicity to healthcare.

www.myesr.org | EUROPEAN CONGRESS OF RADIOLOGY 2011 

Table of Contents 

General Information 

4 Welcome by the ECR 2011 Congress President 

8 Le chef vous recommande 

11 Your Timeline to ECR 2011 

12 Timetable 

92 ESR Dignitaries 

100 ESR Executive Council 

101 ECR 2011 Committees 

105 ECR 2011 Topic Coordinators 

Scientific Highlights 

20 SA 2: New advances ensure imaging 

plays pivotal role in ovarian cancer 

24 SF 14: CT’s unrivalled success poses 

dilemmas in thoracic emergencies 

26 SF 15a: Molecular imaging for radiologists 

32 PC 10: New bridges could help improve 

cancer patient management 

36 CC 18: Common clinical cases in a click 

42 MC 25: Europe and USA combine expertise 

in oncologic imaging 

Scientific Programme 

14 ESR meets France, Brazil, 

Iran & Gastroenterologists 

19 New Horizons Sessions 

22 State of the Art Symposia 

28 Special Focus Sessions 

34 Professional Challenges Sessions 

Coordination: 

ESR Office, Neutorgasse 9, 1010 Vienna, Austria 

Phone: (+ 43 1) 533 40 64-0 

Fax: (+ 43 1) 533 40 64-441 

E-mail: communications@myESR.org 

www.myESR.org 

Managing Editor: Julia Patuzzi 

Art Direction: Peter Baierl / Robert Punz 

Layout/Satz: Tine Ulbing 

Printed by Holzhausen Druck, 2010 

All data as per date of printing: November 2010 

Photo Credits: 

Unless otherwise indicated all pictures 

© ESR – European Society of Radiology. 

08 © photocase.de/3quarks 

23 © Julius Silver (Belvedere) 

30 © Julius Silver (Gasometer) 

35 © Julius Silver (Oper) 

44 © Julius Silver (Stephansdom) 

48 © Julius Silver (Gloriette) 

58 © Julius Silver (Fiaker) 

73 © Julius Silver (Karlskirche) 

89 © Julius Silver (Hofburg) 

90 Tonkünstler im Musikverein © Werner Kmetitsch 

92 Akademietheater auditorium © Reinhard Werner, 

Burgtheater Wien 

Scientific Programme 

Categorical Courses: 

38 KISS (Keep It Simple and Straightforward): 

Musculoskeletal MRI 

39 Radiology in Abdominal Emergencies 

40 CLICK (Clinical Lessons for Imaging Core Knowledge): 

Common Clinical Cases 

Mini Courses: 

44 Organs from A to Z: Pancreas 

45 The Beauty of Basic Knowledge: 

Interpretation of the Chest Radiograph 

46 Functional Imaging of Tumours: How to Do It 

47 Essentials in Oncologic Imaging: 

What Radiologists Need to Know 

Refresher Courses/Scientific Sessions 

48 Abdominal and Gastrointestinal 

50 Breast 

51 Cardiac 

52 Chest 

54 Computer Applications 

55 Molecular Imaging and Contrast Media 

56 Genitourinary 

57 Head and Neck 

58 Interventional Radiology 

60 Musculoskeletal 

63 Neuro 

65 Paediatric 

66 Physics in Radiology 

67 Radiographers 

68 Vascular 

69 EFOMP Workshop 

E 3 – European Excellence in Education: 

70 Foundation Course: Paediatric Radiology 

71 Interactive Teaching Sessions 

74 1 st ESR/EANM Joint Pre-Congress Workshop on PET/CT 

76 4 th Post Processing Face-Off Session 

76 ESOR Session 

76 Radiology Trainees Forum: RTF Highlighted Lectures 

76 EIBIR presents: IMAGINE Workshop 

77 Standards and Audit 

77 Image Interpretation Quiz 

77 Hospital Management Symposium 

79 ENCITE Session 

79 EuroAIM Session 

79 Junior Image Interpretation Quiz 

Update Your Skills (Practical Courses): 

81 Image-Guided Breast Biopsy: How to do it 

83 Musculoskeletal US: Shoulder and Elbow 

85 Satellite Symposia 

91 Industry Hands-On Workshops 

3

EUROPEAN CONGRESS OF RADIOLOGY 2011 | www.myesr.org 

Dear Colleagues, 

The ECR is really something special! 

Of course, this is the place where attendees learn radiology 

in all types of sessions from foundation courses to advanced 

presentations. Obviously, it is where renowned experts, 

extending their teaching skills every year, share their knowledge 

and experience with us. There is no doubt that it is a unique 

opportunity for researchers to present their scientific work and 

discuss it with other scientists. Unequivocally, it is where the 

industry proudly presents its many technical advances. 

Yes, the ECR is an important scientific meeting. Yes, the ECR is 

a landmark in our professional lives. Yes, ECR 2011, for its 23 rd 

edition, will be a scientific and educational success. 

However, the ECR is much more! Let me reveal some facts and 

thoughts. Since its re-foundation in 1991, when it was decided 

that the meeting would be organised every year instead of being 

biennial, the number of attendees has continuously increased. 

More importantly, the delegates come from more and more 

different countries, within Europe and outside Europe, even 

from the antipodes! Analysing the statistics for attendance, 

we are always surprised that so many sessions are packed with 

participants, including scientific sessions, which are sometimes 

more intimate at other meetings. The percentage of attendees 

who are really present in the sessions is one of the highest 

among large meetings. 

Ingredient #1 

is evaluation. 

Every year, the delegates are asked to complete evaluation 

forms. Far from being only a formal procedure for 

accreditation, the feedback from the attendees is carefully 

scrutinised. Quantitative and qualitative data are all taken 

into account. Comparisons are made year after year, 

watching for increasing or declining activities. Evaluation 

provides green, red and orange lights. No red light is 

ignored. Usually, an activity that is poorly rated is stopped 

or profoundly remodelled. Orange lights are also important. 

This information is of utmost importance to the speakers, who 

know that they have to work on their presentation to make it 

more appealing to the organisers, who understand that such 

a situation should not remain unchanged. Even the green 

lights are important, not only because they encourage those 

who promoted these activities, but also because this is a very 

strong message from the delegates to the organisers, pointing 

out their expectations. In 2011, I strongly encourage you to 

participate in the continuous improvement of the meeting 

by filling in forms as completely and objectively as possible. 

Truly, innovation is the mother of success. 

Is there a secret ECR recipe for achieving such a success Of 

course, there is! Today, I am in a position to disclose some of 

the ingredients: 

4


Ingredient #2 

is innovation. 

Which is the sentence you agree with: “never change a winning 

team”, or conversely “always change a winning team” Should 

I say that both are true The winning team provided success 

and this should not be denied. Reasons for the success should 

be fully understood. This is the role of evaluation. However, 

continuation without reinvention and changes would be a 

complete guarantee of future failure. This is why year after year 

the ECR has introduced new concepts, new sessions, and new 

formulas. The ECR is constantly remodelling the concept of 

attendance, moving away from the initial passive accumulation 

of knowledge, and aiming at personalised interaction. In the 

era of electronics, there are so many tools that we should take 

the best advantage from each. Since 2003, the ECR has been 

the leader in electronic presentation. Later, the ECR initiated 

interactivity within sessions between the teacher and the 

attendees. A lot is still to be done, but 2011 will be another 

landmark for interactivity and you will certainly discover the 

future of teaching during these days. For all these reasons, 

innovation is the daughter of evaluation. 

Ingredient #3 

is regenerating continuity. 

Being inherently international, the ECR has to take into account 

the reality. Because there are so many nationalities, the ECR 

has to promote an organising group that reflects its ‘customers’. 

Accordingly, each country needs to be represented within the 

committees, and the voice of everyone should be heard. This 

could be a drawback or an advantage. The drawback is the socalled 

geopolitical balance, which might be regarded as a melting 

pot where origin and nationality would be more important 

than scientific and educational skills! However, the result is 

just the opposite. Because we need to change the members of 

the committees every year and introduce people from different 

horizons, this is a fantastic opportunity to welcome new 

refreshing ideas and new ways of looking at radiology, and also 

to enrich the ECR story with different experience. There is a 

little secret: most of the people who join the committees have 

had the opportunity to participate in previous meetings in 

different positions, and then reinforced their knowledge of the 

organisation. Not a single chairperson of an important committee 

will come to this position without having been included in a 

previous programme. On top of that, the continuous overlap 

in the organisation of several sequential meetings improves the 

continuity and in particular the Presidents of those meetings 

work together to promote both flexibility and continuity. I would 

like to express my sincere thanks to Prof. Borut Marincek (ECR 

2009), Prof. Małgorzata Szczerbo-Trojanowska (ECR 2010), 

Prof. Lorenzo Bonomo (ECR 2012) and Prof. Dr. José Ignacio 

Bilbao (ECR 2013) for their valuable input and participation in 

the making of ECR 2011. 

Continued on page 6. 

5


Continued from page 5. 

Ingredient #4 is expertise. 

How can we learn anything if the teacher is not good How can 

we implement new knowledge into our daily practice if it is 

only esoteric How can we envisage our future if no visionaries 

are pointing out the new horizons How can we enjoy our 

science if speakers are not enthusiastic For all these reasons, 

the expertise of the speakers is mandatory, whether they are 

well-established, renowned experts or rising stars. 

Ingredients are not all. We need also some ‘savoir-faire’! I 

will come back to that later. As an example, you will, while 

navigating through the programme of ECR 2011, find many 

sessions that are adapted to your expectations, whatever 

the desired level, beginner or expert, clinician or researcher, 

subspecialist or general radiologist. The future will come to 

you, with the prediction of what breast radiology will be like in 

2025, with new developments in CT (the 5 th dimension!) and 

MRI (quantum leaps). The future is always much closer than 

we think! I would like to take this opportunity to welcome the 

increasing number of medical students attending the ECR. 

We will hold a special session for them, and I am sure that all 

delegates will be more than happy to celebrate the cheerful 

presence of our future among us! 

Multidisciplinarity will improve. 

There is a good reason for this: our daily lives are nothing if 

not multidisciplinary. Discussion with our clinical colleagues 

always reinforces the strength of our diagnosis. Following on 

from 2010’s multidisciplinary sessions on oncologic imaging, 

2011 will offer a Categorical Course (‘CLICK’) dedicated to 

interactive clinical situations, describing very precisely the role 

of the radiologist in real life, the patient with a symptom, and not 

the patient with a diagnosis. The patient who comes to you says 

that he has a headache, not an aneurism … Multidisciplinary 

discussions will also be enhanced in many Refresher Courses 

and Special Focus Sessions. I am very glad to also welcome 

the gastroenterologists, represented by The United European 

Gastroenterology Federation (UEGF), for a very attractive 

session entitled ‘ESR meets Gastroenterologists’, which will 

decide whether optical colonoscopy and CT colonography are 

friends or enemies. Whatever the conclusion will be, I can say 

that gastroenterologists are definitely our friends! 

Interactivity is a priority. 

E 3 interactive sessions have been a tremendous success over the 

past few years. Rooms were packed and many attendees had 

absolutely no chance to get in. This year, the sessions will be 

installed in rooms B and C, providing more than 100 additional 

seats, and still with electronic interactivity. However, even if 

electronic voting will be extended to other sessions like the 

CLICK course, it is not the only way to experience the ECR’s 

interactivity. In many sessions, the moderator has been asked 

to organise, together with the speakers, a practical discussion, 

with a significant amount of time allocated. The questions and 

the topic are already written in the programme. The discussion, 

led by the chairperson, may be organised according to prepared 

questions, or even to clinical cases. Be prepared to participate! 

The aim is to build bridges between the potentially theoretical 

message of the lecture, and the practical application in daily 

routine. 

Overall, the role of the 

moderator has been enhanced. 

Because they are the intermediaries between the speakers and 

the audience, they are very important people. The success of 

the session lies in part on their shoulders, not only due to time 

allocation, but also because they are the natural ‘translators’. 

I would like to thank in advance all those who accepted the 

invitation to play this role, and I have no doubt that this will 

be the standard format of future sessions at most meetings. 

6


I said that having the main 

ingredients does not always 

lead to a delicious dish. 

You also need some spices. 

One is commitment, which means showing loyalty, duty and 

allegiance to the ECR. After months of preparation for the 

meeting, this is exactly what I can say when I see the amount 

of work that has been produced by the organising group. Most 

of them, despite a busy professional life, have made themselves 

available to work together in Vienna or from home in order 

to propose, evaluate, discuss, and finally build the ECR 2011 

programme. This appreciation goes to all the professionals, 

radiologists, physicists and radiographers, but also to the 

members of the ESR Office, who have once again demonstrated 

knowledge and efficient support in all aspects of preparation 

for the ECR, from logistics to scientific programme building. 

I encourage you to consult the gallery of the ECR 2011 

Programme Team on the ESR website. It is a real dream team! 

Two more are respect and friendship. The ECR is a European 

initiative, but heartily welcomes colleagues from the five 

continents. There is no doubt that this worldwide participation 

greatly enhances the quality of the meeting. I am thankful for 

that. We will make every effort to make anybody feel at home in 

this European house. This year, I am extremely happy to offer a 

special welcome to our colleagues from Iran and Brazil, as well 

as my home country France, all of whom will participate in the 

‘ESR meets’ programme. These three countries have prepared 

very interesting sessions, with an attractive combination of 

useful science and local flavour! 

I am very much looking forward 

to seeing you in Vienna and to 

meeting you personally during 

the many scientific or social 

events. 

Being French, I hope that you will enjoy our ‘cuisine’. Eating is a 

necessity, but gastronomy is a benefit for the whole individual, 

and not only for the mouth and stomach! So is radiology. Yes, 

this is our profession, and the ECR can help us once more to 

make it a total pleasure! 

Yves Menu 

ECR 2011 Congress President 

7

Le chef vous 

recommande … 

An original recipe by Yves Menu 

Do you want to treat four people to a good meal 

Then try my recipe for sauté au miel. 

Take two beautiful yellow onions and 750g of pork, veal 

or poultry meat. Do not use frozen meat as it will contain 

too much water, which will dilute the flavour of the sauce. I 

personally prefer the filet mignon but gladly take the advice of 

my butcher. You also need liquid honey, but be careful; only a 

small quantity. No more than two not-very-full tablespoons. 

One often adds too much honey, but sugar impairs the flavour 

whereas it should just add a discrete smoothness, which 

combines wonderfully with pan-browned onions. 

We also need 6cl of balsamic vinegar of Modena. This is about 

two full tablespoons, but it depends on your taste. 

In addition we need two exotic ingredients to make the 

flavour of this dish more rich and complex. Soy sauce raises 

the flavour while remaining discrete. Two full teaspoons are 

enough. Ginger powder adds an original flavour, but only in 

the background. Pour two teaspoons, no more, or else you 

might disturb the harmony. 

Finally, we need crushed tomatoes. If you do not feel like 

making this purée yourself, you can buy small ready-made 

cartons (300 to 400g), which are more than suitable! I 

personally prefer the ones prepared with basil, otherwise I add 

a fresh, finely chopped leaf myself. Be especially careful not to 

cut big pieces, which might disturb your palate. 

There, we are now ready to cook. It takes very little time to 

prepare (20 minutes), and a bit longer to cook (30 to 50 minutes). 

One only needs a frying pan or a stewing pan. As for me, and 

as a reference to soy and ginger, I like to use a wok, which really 

facilitates smooth stewing. What better way to emphasise even 

further the various flavours contained in this dish 

Let us start by thinly slicing the onions on a chopping board. 

They must be thin enough to almost melt in a compote but 

thick enough to be recognised in the velvet of the sauce. 

Let us put our onions in the wok with a few drops of olive oil. 

My favourite oil comes from Lake Garda in Italy, in memory 

of Antonio Chiesa, who, upon learning my passion for cuisine, 

had a tasting arranged for me. Ever since that day, I have 

remained faithful to it, maybe as a tribute to this gentleman of 

radiology. Let us not be rushed, the onions must brown slowly, 

without burning. 

While the onions are singing sweetly, we again use the board to 

chop the meat into small cubes of about one centimetre each. 

As soon as this is done, these pieces will join the onions in the 

wok. Raise the fire a little as the meat should be browned on 

each side in 3 to 4 minutes, without cooking the middle. Once 

this is done, make room for the ginger powder! Mix everything 

right away so that this spice diffuses itself well. Beware of lumps! 

Everything is taking shape! Now make room for the culinary 

odd couple, namely honey and vinegar. Add them to the dish 

alternately, while slowly mixing so that everything is evenly 

combined; the chef ’s nose is starting to be enchanted. I first 

put one full spoon of honey, then one of vinegar and I mix well. 

And I start again. My tip concerning honey: I prefer acacia 

honey or flower honey, but above all you need liquid honey, as 

one of the secrets of this dish is to intimately and rapidly mix all 

the ingredients. Too thick a honey would take too long to mix, 

and would cause a damaging heterogeneity. Your palate would 

go from sweet to salty, whereas this recipe is the praise of the 

intimate mix, not simple cohabitation. 

Let us add a bit of salt (three to four turns of a Guérande salt 

mill) and black pepper (three turns of a Vietnam pepper mill), 

and mix some more. 

Did I mention everything has to be cooked at a low heat yet 

Yes, of course I did, but I must emphasise it once more. After 

the onions and the meat turned brown, we had lowered the 

heat a little, as if to gently welcome all these ingredients.

It is now time to add the crushed tomatoes. Little by little, well 

integrated with a wooden spoon, each portion has to be totally 

mixed before you add some more. 

There, the preparation is over. Now it’s time for cooking. To 

harmonise the mix of savours, raise the heat for 10 minutes 

without covering, to let the excess water evaporate. Turn the 

sauce in the wok two to three times so that it cooks evenly. 

Then place a lid over the pan, preferably a glass one (not that 

it’s better but just for the pleasure of watching), lower the heat 

and let it stew for 20 to 30 minutes. 

The only thing left to think about is how to accompany your 

dish. As for me, and depending on the day, I prepare either 

fresh pasta or cooked Thai rice. 

Then simply wait for your guests. If they are late, no problem. 

Once cooked, you can lower the heat while the cover is still on, 

to keep it warm. It will be just as delicious an hour later! 

When your guests savour the dish, 

start playing with them by asking 

them to identify every ingredient. 

If you’ve prepared everything smoothly, they will not recognise 

all of them. But once you will have listed them, they will answer 

it was obvious. Only this way will you be able to assess your 

culinary success! 

Choosing the wine is not easy for a dish of such complex 

flavour. You need one with personality but which knows how 

to remain humble. I would advise you a Givry first regional red 

wine, a Chalonnais wine that never lets you down. 

By the way, did you have anything in mind for starters What 

would you say to some noix de Saint-Jacques with Normandy 

cream You will also serve that with a Givry, but white this time.

Share your scientific 

work with the 

radiological world. 

New and unique – submit your work, all year long! 

EPOS Abstract Submission is open all year! 

If you want your poster to be shown at ECR 2011, 

submit your abstract by December 31, 2010. 

Abstract submission for EPOS (Electronic Presentation Online System) 

has been re-structured to include the following new features: 

All-year-round submission & poster upload 

Quicker review process 

Your publication citable and available online throughout the year 

Find more information at 

myESR.org/epos_all_year


Your Timeline 

to ECR 2011 

from September 1: 

from October 1: 

November 12: 

November: 

December 31: 

January 31: 

March 3–7: 

Online Registration Open 

Middle Fee from November 12 to December 30, 2010 

Late Fee from December 31, 2010 onwards 

Travel & Accommodation Service Open 

Participate from Home Registration Open 

Notification of Paper Abstract Acceptance (Oral Presentations) 

Final Deadline for ECR 2011 Poster Abstracts 

Deadline to Upload Accepted Posters to EPOS TM 

ECR 2011: Thursday to Monday 

Congress Venue 

Austria Center Vienna 

Bruno Kreisky Platz 1 

1220 Vienna, Austria 

Congress Language 

English 

CME Accreditation 

Each ECR delegate receives confirmation of all activities 

attended (CME confirmation – Record of attendance). 

The approximate maximum number of hours of scientific 

activity attendance is 40 (please note that this number differs 

from the maximum number of UEMS/EACCME credits). 

ECR 2011 is expected to be designated for a maximum of 27 

hours of European external CME credits. 

Facts & Figures 

19,000 Participants 

100 Countries 

270 Scientific and Educational Sessions 

4,300 Accepted Proffered Papers and Exhibits 

Fully Electronic Scientific Exhibition 

Industrial Exhibition 

approx. 285 exhibitors 

26,000 m² 

Scientific and Educational Programme 

3 Honorary Lectures 

1 Opening Lecture 

1 Guest Lecture 

4 ESR meets Sessions 

2 Image Interpretation Quizzes 

3 New Horizons Sessions 

3 State of the Art Symposia 

14 Special Focus Sessions 

4 Professional Challenges Sessions 

3 Categorical Courses (18 Sessions) 

4 Mini Courses (15 Sessions) 

74 Refresher Courses 

1 Foundation Course: 

Paediatric Radiology (6 Sessions) 

14 Interactive Teaching Sessions 

1 e-Learning Centre with Self Assessment Tests 

1 RTF – Radiology Trainees Forum: 

Highlighted Lectures Session 

2 Update Your Skills (Practical Courses) 

1 EFOMP Workshop 

1 ESOR Session 

1 Standards and Audit 

1 Hospital Management Symposium 

1 Post Processing Face-Off Session 

Satellite Symposia & Industry Hands-on Workshops 

11


Timetable 

08:30 09:00 09:30 10:00 10:30 11:00 11:30 12:00 

12:15 13:00 13:30 14:00 

Siemens Symposium 

Friday, March 4 

Thursday, March 3 

New Horizons Session 

NH 3 

State of the Art Symposium 

SA 3 

Special Focus Sessions 

SF 3a, SF 3b, SF 3c, SF 3d 

Categorical Course 

CC 316 

Mini Course 

MC 322 

Refresher Courses 

E³ Sessions 

Update Your Skills (introductory lecture) 

Update Your Skills (practical course) 

(300) 

ESR meets France 

E³ Session 

Scientific Sessions 

Update Your Skills (practical courses) 

(400) 

Josef Lissner 

Honorary Lecture 

Scientific Sessions for 

Medical Students 

Post Processing Face-Off Session 

GE Healthcare Symposium 

Bayer Schering Pharma Symposium 

SuperSonic Imagine Symposium 

Saturday, March 5 

Special Focus Session 

SF 7 

Professional Challenges Session 

PC 7 

Categorical Courses 

CC 716, CC 718 

Mini Course 

MC 719 


E³ Session 


(700) 

EFOMP Workshop 

7 

3 4 

ESR meets Brazil 

E³ Session 



(800) 

EFOMP Workshop 

Standards and Audit Session 

8 

Bracco Symposium 

Pierre et Marie Curie 


Guest Lecture 

Mini Course – MC 21C 

E³ FC Self Assessment Test 

Scientific Sessions for Medical Students 

ESR EU Affairs Session 

Siemens and Bayer Schering Pharma Symposium 


Guerbet Symposium 

Hitachi Symposium 

Philips Healthcare Symposia 


Sunday, March 6 


SF 11 


CC 1117, CC 1118 

Mini Courses 

MC 1119, MC 1125 


E³ Session 


(1100) 

ENCITE Session 

ESR meets Iran 

Mini Course 

MC 1225 

E³ Session 



(1200) 

Wilhelm Conrad Röntgen 


Junior Image Interpretation Quiz 

Mini Course 

MC 21D 

Scientific Session for 

Medical Students 


Philips Healthcare Symposium 



Monday, March 7 


E³ Session 

(1500) 

15 

11 12 

EIBIR Session 


SF 15a, SF 15b 


PC 15 


CC 1516, CC 1517, CC 1518 

E³ Session 


(1600) 

16 

Mini Course 

MC 21E 

12


Timetable 

14:00 14:30 15:00 15:30 16:00 16:30 17:00 17:30 17:45 18:00 18:30 19:15 

Mini Course 

MC 21A 

E³ Session 

Update Your Skills (Introductory lecture) 


(100) 

Mini Course 

MC 21B 

E³ Session 



(500) 

ESOR Session 

Image Interpretation Quiz 

1 2 

5 


Hospital Management Symposium 

Hologic Symposium 



Sectra Symposium 


SF 13 


CC 1316, CC 1318 

Mini Course 

MC 1325 


E³ Session 

Update Your Skills 

13 

(practical course) 

(1300) 

E³ Sessions 


(1700) 

State of the Art Symposium 

SA 2 


SF 2 


PC 2 

Categorical Course 

CC 216 

Mini Course 

MC 222 


E³ Sessions 

(200) 

ESR meets Gastroenterologists 

New Horizons Session – NH 6 

State of the Art Symposium – SA 6 

Special Focus Session – SF 6 

Categorical Course – CC 616 

Mini Course – MC 622 


E³ Sessions 

Update Your Skills (practical 6course) 

(600) 

RTF Highlightes Lectures 

EIBIR - PEDDOSE.NET Workshop 

New Horizons Session – NH 10 

Professional Challenges Session – PC 10 


CC 1016, CC 1017, CC 1018 

Mini Course 

MC 1019 


E³ Session 


(1000) 

EIBIR Network Member Event 


9 10 


SF 14 


CC 1416, CC 1417, CC 1418 

Mini Course 

MC 1425 



(1400) 


SF 18a, SF 18b 


E³ Session 

(1800) 

14 

17 18 

Opening Ceremony 

Presentation of Honorary 

Members and Gold Medallists 

Opening Lecture 


Thursday, March 3 Friday, March 4 Saturday, March 5 Sunday, March 6 Monday, March 7 

13


ESR meets … 

Portraits of the ECR 2011 guest countries 


The Brazilian College of Radiology and Diagnostic Imaging 

(Colégio Brasileiro de Radiologia e Diagnóstico por 

Imagem – CBR) was founded on October 15, 1948, in São 

Paulo, and is the legitimate representative body of Brazilian 

radiologists. It brings together about 9,000 members and 

has regional affiliates in 25 Brazilian states. 

Over its 62 years, the CBR has become an important 

tool for updating and evaluating the 

training of radiologists. It also aims to be 

a regulator and to standardise radiological 

techniques, as well as the quality 

of imaging exams. The 

society carries out 

projects aimed at 

better understanding 

the market 

reality in radiology. 

With these data, the 

actions and decisions 

of the CBR may have a 

greater connection with 

the reality of radiological 

services in the country. 

Since 1955, the CBR, in conjunction 

with the Brazilian Medical Association, 

has been providing specialists in radiology 

and diagnostic imaging, nuclear medicine 

and radiotherapy. Besides ensuring the 

educational and professional improvement of 

radiologists, the CBR strives to improve public 

health in Brazil through diagnostic imaging, 

with early and accurate tests. 

The society promotes refresher courses, conferences, 

seminars and meetings on various radiological methods 

and provides informative bulletins and scientific journals, 

including the Bulletin of the CBR and the Brazilian Journal 

of Radiology. 

The CBR organises two major events considered the largest 

in Latin America: one of them is the Brazilian Congress of 

Radiology, attended by approximately 4,000 delegates, and 

the other is the Jornada Paulista de Radiologia, held by our 

affiliates every year in Sao Paulo, with more than 12,000 

participants . 

The question of the use of teleradiology is a concern because 

Brazil is a country of continental dimensions; when practised 

well and according to the law it can help many people, 

but we must emphasise that the matter should be treated 

with caution so that the clinics always obtain the best diagnosis, 

performed by a specialist from the CBR. 

Other key activities include the responsibility for regulating 

and controlling the imaging examinations in the country 

(governed by the National Agency for Sanitary Surveillance 

and the National Commission for Nuclear Energy – CNEN) 

and participation in training and control of radiology residencies. 

It is also the institution responsible for interfacing 

with government agencies like the Ministry of Health, Education, 

Finance, and with entities outside of radiology. 

Last but not least, the society constantly struggles on behalf 

of CBR specialists for the best possible working conditions 

and remuneration in exchange for their services. 

Dr. Sebastião Cezar Mendes Tramontin 

President, Brazilian College of Radiology and Diagnostic 

Imaging 

14


The French Society of Radiology (Société Française de 

Radiologie – SFR), founded in 1909, is one of the oldest 

radiological societies in Europe. The origins of the SFR can 

be traced back to a first meeting held on January 12, 1909, 

including Antoine Béclère and some enlightened pioneers. A 

unique characteristic of the SFR among other French medical 

societies is in that it has academic, hospital-based, and privately 

practising radiologists as members. 

Overall membership of the SFR has tripled over the past 

14 years and the SFR now has more than 7,700 members 

worldwide. The mission of the SFR is to promote the study and 

dissemination of scientific knowledge regarding all aspects of 

radiology and related sciences, to maintain and extend to the 

public advantage the usefulness of the work of the radiologist, 

and to promote study and research by setting professional 

standards of practice. The SFR has nine subspecialties within 

radiology and more than 30 professional working groups and 

links with other branches of medicine and allied healthcare 

professionals. 

If radiology is to remain as a medical specialty and not be 

‘bought up’ by other specialties, then the education of future 

generations of radiologists remains an important issue for the 

SFR. The educational programmes are mainly accomplished 

during the Journées Françaises de Radiologie (JFR), which 

take place in Paris every October together with monthly 

regional meetings organised by the subspecialties sections 

throughout the year. The last JFRs were very well attended 

and attracted a large number of participants not only from 

Europe but also from many far away countries. In order to 

promote innovation and quality of healthcare, more than 

540 electronic posters in all subspecialties and 300 hours of 

Continuing Medical Education (CME) were proposed. To 

extend CME beyond the period of the congress, the SFR is 

continually expanding its online offerings: the e-learning 

section of our website includes electronic posters, as well as 

courses recorded during the JFR. Moreover, SFR publishes 

educational materials such as syllabi, CD-ROMs and books 

on imaging. 

The peer-reviewed journal Le Journal de Radiologie, created 

in 1914, is published monthly, with six focused Continuing 

Medical Education textbooks published in a run of 8,000 copies. 

Le Journal de Radiologie upholds history and tradition, 

but looks ahead to developing and adopting new trends in 

modern scholarly publishing. Collaboration with other radiological 

societies is another important undertaking of our 

society. The SFR is deeply involved in providing educational 

programmes and teaching materials in French-speaking 

countries, with which the SFR has developed close cooperation 

over many years. 

In the name of promoting the development of good practices 

and standards, official documents, such as books of guidelines 

on the clinical use of medical imaging and optimal procedures 

of imaging technique have been available via a continuously 

updated website since 2006. In order to increase the scientific 

level and the internationalisation of French radiology, the SFR 

aims to focus its efforts on some major topics: 

• Coordination of research projects and research 

cooperation between institutions of radiology 

• Help to build a network between the communities 

in Europe to support and train our radiologists 

• Organisation of courses on scientific methods 

for radiological research. 

The SFR, in association with private and public French radiological 

unions, along with the College of Academic Radiologists, 

has contributed to the founding of a professional 

organisation, the Professional Council of French Radiology. 

The aims of this cooperation are to harmonise strategies in 

defence of radiology and medical imaging in France as well 

as to present common positions in negotiations with national 

institutions and other health organisations. For further information 

regarding the SFR and its various activities, please see 

our website at www.sfrnet.org 

Jean-Pierre Pruvo 

Secretary General, French Society of Radiology (SFR) 

15


ESR meets … 


The Iranian Society of Radiology (ISR), established in 1968 

by the late Dr. Rooholamini, has the role of both a professional 

association and a scientific society focused on science 

and the practice of radiology in Iran. It currently has more 

than 2,000 members with eight provincial/regional branches 

in large cities like Shiraz, Isfahan and Tabriz. It has many 

subspecialty committees consisting of outstanding university 

professors and experienced practitioners who conduct 

training and subspecialty consultations whenever required 

for decision making. 

The scientific activities of the ISR consist of holding annual 

meetings, the most important of which is the Iranian Congress 

of Radiology, the largest gathering of Iranian radiologists 

and related scientists, as well as the annual imaging 

informatics conference, along with numerous refresher 

courses throughout the country. The next ICR, to be held 

on May 17–20, 2011, will have the honour of hosting delegations 

from around the world. The industrial exhibition at the 

ICR features a number of local and well-known international 

vendors showing state-of-the-art high-end equipment. 

The Iranian Journal of Radiology is the only Iranian radiology 

journal published in English by the ISR, in collaboration 

with Tehran University of Medical Sciences. The ISR holds 

the authority of setting the country’s radiology-related regulations 

and making national policies and decisions in collaboration 

with the Ministry of Health and the Iran Medical 

Council, and so defining the boundaries of the radiology 

profession at a national level. The ISR is also a member of a 

coalition of professional medical associations. 

A current major project proposal of the ISR is the ‘Iranian 

School of Radiology’ following the general idea of the European 

School of Radiology (ESOR), with the aim of boosting 

the ability of practicing radiologists and those in training to 

improve the role of this profession in healthcare. 

The ISR highly appreciates becoming a corresponding member 

of the ESR. 

Dr. Abdul Rasool Sedaghat 

President, Iranian Society of Radiology


ESR meets 

Sessions 

Friday, March 4, 10:30–12:00, 

Room A 


EM 1 From neurosciences to 

clinical practice 

Presiding: 

Y. Menu; Paris/FR 

J.-P. Pruvo; Lille/FR 

• Introduction 

J.-P. Pruvo; Lille/FR 

• White is white: 

a simple guide to demyelinating diseases 

V. Dousset; Bordeaux/FR 

• Interlude 

• Functional imaging: useful tool for the radiologist or 

crystal ball for the psychiatrist 

A. Krainik; Grenoble/FR 

• Interlude 

• Stroke around the clock: 

will the challenger (CT perfusion) 

beat the champion (diffusion MRI) 

X. Leclerc; Lille/FR 

• Panel discussion 

Friday, March 4, 16:00–17:30, 

Room C 

ESR meets Gastroenterologists 

EM 2 Optical and virtual 

colonography: friends or enemies 

Presiding: 

R. Hultcrantz; Stockholm/SE 


• Chairmen’s Introduction 

R. Hultcrantz; Stockholm/SE 


• Facts from the statistician (true for once): incidence, 

prevalence, rationale for screening, standard results of 

optical colonoscopy 

U. Haug; Heidelberg/DE 

• Facts from the statistician (true for once): 

how accurate is CT colonography 

A. Laghi; Latina/IT 

• When optical beats virtual 

J.F. Riemann; Ludwigshafen/DE 

• When virtual beats optical 

S.A. Taylor; London/UK 

• Panel discussion: Integrated strategy 

What about the outsiders (capsule, DNA, PET, ...) 

Saturday, March 5, 10:30–12:00, 

Room B 


EM 3 Thoracic imaging: 

a Brazilian approach 

Presiding: 

M.A. Gomes da Silva; Sᾶo Paulo/BR 



M.A. Gomes da Silva; Sᾶo Paulo/BR 

• Granulomatous interstitial lung disease: 

HRCT path correlation 

C.I.S. Silva; Salvador/BR 

• Interlude: Brazilian masterminds 

• Granulomatous pulmonary infections 

A.S. Souza Jr.; São José do Rio Preto/BR 

• Interlude: The world is in love with Brazil 

• Congenital lung disease in children: 

state-of-the-art imaging 

P.A. Daltro; Rio de Janeiro/BR 


Sunday, March 6, 10:30–12:00, 

Room B 


EM 4 Interventional radiology: 

from scratch to innovation 

Presiding: 


A. Sedaghat; Tehran/IR 

• Welcome and introduction 

A. Sedaghat; Tehran/IR 

• How to start interventional radiology 

H. Ghanaati; Tehran/IR 

• Uterine artery embolisation for 

treatment of symptomatic fibroids 

K. Firouznia; Tehran/IR 

• Interlude: Persian physicians contribution 

to the evolution of medicine 

K. Vessal; Shiraz/IR 

• Interventional procedures in liver transplantation 

A. Rasekhi; Shiraz/IR 

• Interlude: Persian physicians contribution 

to the evolution of medicine 

K. Vessal; Shiraz/IR 

• Radiochemoembolisation of hepatic metastases 

M. Fatehi; Tehran/IR 


17

18 

EUROPEAN CONGRESS OF RADIOLOGY 2011 | www.myesr.org


New Horizons 

Sessions 

Friday, March 4, 08:30–10:00, Room G/H 

NH 3 Quantum leaps in MRI: 

teslas, pulses, tracers 

 

 

• Chairman’s introduction 

O. Clément; Paris/FR 

• What will be the standard machine and 

field of the future 

L. Darrasse; Orsay/FR 

• Will new technologies allow a jump in 

sensitivity 

J. Hennig; Freiburg/DE 

• Will new MR contrast probes compete 

with PET 

S. Aime; Turin/IT 

• Panel discussion: 

What is ready for our next machine 

Friday, March 4, 16:00–17:30, Room A 

NH 6 Not just Hounsfield numbers: 

CT aimed at the fifth dimension 

 

 


J.M. Boone; Sacramento, CA/US 

• Basic principles of dual energy CT 

W.A. Kalender; Erlangen/DE 

• Clinical examples of dual energy CT 

L. Guimaraes; Viseu/PT 

• CT contrast perfusion 

V.J. Goh; Northwood/UK 


Will CT surprise us again 

Saturday, March 5, 16:00–17:30, Room F1 

NH 10 Breast imaging in 2025 


T.H. Helbich; Vienna/AT 

• Is mammography still an accepted modality 

for breast cancer imaging in 2025 

M.J. Yaffe; Toronto, ON/CA 

• Breast cancer screening with MR imaging 

and nothing else 

C.K. Kuhl; Aachen/DE 

• The evolving role of the radiologist 

P. Brader; Vienna/AT 


Breast imaging 2025: blood test or still 

imaging 

19


New advances ensure 

imaging plays pivotal 

role in ovarian cancer 

By Edna Astbury-Ward 

Thursday, March 3, 

16:00–17:30 

SA 2 

Ovarian cancer: 

update and what’s next 

The role of radiologists is growing rapidly in the investigation and monitoring of suspected 

ovarian cancer. New diagnostic and interventional techniques, together with changes in clinical 

management and the validation of emerging areas such as MRI of adnexal mass and imageguided 

peritoneal core biopsy, offer new challenges and opportunities. 

Ovarian cancer is the leading cause of death from genitourinary cancer in women. Due to its nonspecific 

clinical features, it may present to any radiologist involved in abdomino-pelvic imaging. 

Attendees at ECR’s state of the art session on ovarian cancer will learn more about the trend 

towards individualised patient treatment with high-quality imaging and detailed pathologic 

analysis based on information provided by an image-guided biopsy. In the future, the timing and 

extent of surgery may be specific for each patient and the chemotherapy regimen may be selected 

for the different pathologic types of ovarian cancer. 

Dr. John Spencer, consultant radiologist at St. James University Hospital in Leeds, U.K., stressed 

that although ovarian cancer screening remains experimental, the trend towards cross-sectional 

imaging for evaluation of common gastrointestinal and genitourinary tract problems has a 

significant rate of discovery of incidental findings of adnexal masses and other gynaecological 

abnormalities. He added that some findings, such as peritoneal carcinomatosis, are clearly 

relevant. After further clarification, most adnexal masses that are discovered as incidental 

findings turn out to be ‘nuisance’ lesions, but he remarked that this results in significant costs 

and increased patient anxiety. Spencer suggested that MRI can benefit patient care because of its 

ability to make specific non-invasive diagnoses and define masses as benign or malignant. 

PET/CT can improve the accuracy of staging in patients with ovarian cancer, especially by 

detecting metastases in normal-size lymph nodes and unsuspected extra-abdominal nodal sites 

of disease. Experts are also excited about the potential of diffusion-weighted MRI (DW-MRI) 

as a diagnostic tool for improved accuracy of ovarian cancer detection with peritoneal spread. 

“Radiology will play an increasingly crucial role in staging of ovarian cancer,” said Dr. Evis Sala, 

university lecturer and honorary consultant radiologist at Addenbrooke’s Hospital, Cambridge, 

U.K. “Furthermore, we are likely to see an increase in the use of PET/CT and potentially MRI 

(with added DW-MRI sequences) for primary staging of ovarian cancer. However, well-designed 

studies with histopathology as standard of reference are required to evaluate and compare the 

accuracy of PET/CT and DWI in staging of ovarian cancer.” 

Although imaging already plays a vital role in staging and treatment planning in ovarian 

cancer by assuring an appropriate selection of patients for primary surgery versus neo-adjuvant 

chemotherapy, other benefits can result, particularly for the surgeon. Sala indicated that imaging 

provides the surgeon with a map of distribution of the disease prior to either primary or interval 

debulking surgery. Additionally, it is routinely used to monitor the response to chemotherapy and 

detect tumour recurrence. 

20

A 

B 

Contrast-enhanced CT remains the gold standard for staging of ovarian cancer because it is easier to 

interpret (due to less intra-observer variability), and it is also more widely available and cheaper than 

MRI and PET/CT. A combination of clinical examinations, together with serum CA 125 measurement 

and imaging features, may be useful, but ultimately a diagnosis is made by histopathologic evaluation 

of tumour tissue obtained from surgery, laparoscopy, or image-guided core biopsy. 

Because of the unique properties of peritoneal spread in ovarian cancer (large surface development 

at a relatively small depth), the potential use of intraoperative or laparoscopic imaging is an 

important development. This technique exploits the refraction of light or emission of fluorescence 

in order to image sub-surface tissue at a depth of approximately 2mm. Preliminary data have 

confirmed the promise of the technique for improved detection of peritoneal seeding. 

Dr. Isabelle Thomassin-Naggara, from the department of radiology at Hôpital Tenon in Paris, 

emphasised the potential value of combining ultrasound with MRI, including perfusion and 

diffusion sequences. She suggested that because of the high diagnostic performance of these 

techniques (up to 96% for characterising complex adnexal masses), this is likely to be the way 

forward. She agreed with Sala regarding the benefits to the surgeon of using these techniques, 

which should help influence a surgical decision and treatment. “Because the most important 

prognostic factor for ovarian cancer is the absence of residual tissue after the first surgery, 

all imaging modalities have the potential to assist surgeons when deciding on best treatment 

options,” she noted. 

Figure: 

Axial fused 18FDG PET-CT 

images of a patient with advanced 

ovarian cancer demonstrate 

increased tracer uptake in the left 

internal mammary and subcarinal 

lymph nodes (arrows in A) and 

in the peritoneal deposits in the 

serosa of the descending colon 

(arrows in B). PET/CT may 

improve the accuracy of staging 

in patients with ovarian cancer 

by better delineating peritoneal 

disease and detecting unsuspected 

extra-abdominal nodal sites of 

disease. 

(Provided by Dr. Evis Sala) 

She identified ultrasound as the gold standard for detection of adnexal masses, MRI for 

characterisation of complex adnexal masses, and spiral CT for ovarian cancer extension. In the 

future, high-field MR may improve the feasibility and the accuracy of MR spectroscopy for the 

characterisation of adnexal masses. She suggested considering ultrasound in the first instance for 

exploring adnexal masses. 

Dr. Rosemarie Forstner, from the department of radiology at Paracelsus Private Medical 

University, Salzburg, Austria, agreed that where adnexal masses are indeterminate following 

ultrasound, a complementary MR examination may be warranted because it may contribute to 

improved patient management by influencing specialist referral, surgical approach, and other 

therapeutic options. She added that in patients with an unequivocal malignant mass with 

or without peritoneal spread, preoperative staging by CT helps optimise therapy planning, 

and radiology reports should provide detailed information about findings that are crucial for 

treatment planning, including the primary tumour and its dissemination. Radiologists should 

also include details about tumour sites that may be difficult to assess intraoperatively, as well signs 

that are indicative of suboptimal debulking in extensive tumour load. 

To determine appropriate chemotherapy, evaluation of tumour extent using multidetector CT 

and image-guided biopsy looks set to ensure imaging remains the mainstay of assessment of 

treatment response. Therefore, working in a multidisciplinary team in gynaecological cancer will 

give radiologists a central patient management role. 

21


State of the Art 

Symposia 

Thursday, March 3, 16:00–17:30, Room E2 

SA 2 Ovarian cancer: 

update and what’s next 


SA 6 Brain tumour: 

imaging and response 

 

 

 

 


R. Forstner; Salzburg/AT 

• Ovarian cancer: 

update and role of radiology 

J.A. Spencer; Leeds/UK 

• Imaging of adnexal masses: 

is it feasible to diagnose ovarian cancer 

I. Thomassin-Naggara; Paris/FR 

• Staging ovarian cancer: 

what technique is the best 

E. Sala; Cambridge/UK 


The illustrated role of the radiologist in 

multidisciplinary consensus conferences 


SA 3 The 3 P’s of CT colonography: 

polyps, protocols and politics 

 


S. Halligan; London/UK 

• CT colonography in 2011: 

how far has it come 

P. Lefere; Roeselare/BE 

 

 

 

• Current status of reimbursement 


• Quality, training and accreditation 

D. Burling; London/UK 

• CAD: friend or foe 



In 2011, should CTC now be the primary 

method of colorectal investigation in my 

hospital 

 

 

 

 

 


M. Stajgis; Poznan/PL 

• Advanced brain tumour imaging: 

complete imaging protocol 

M. Law; Los Angeles, CA/US 

• Monitoring and prediction of 

treatment response 

P.C. Maly Sundgren; Lund/SE 

• Radiation necrosis and 

pseudo-progression vs recurrent tumour 

M. Essig; Heidelberg/DE 


Try to understand the clinical question 

and you will know which imaging is 

appropriate 

22


State of the Art 

Symposia 

23


CT’s unrivalled 

success poses 

dilemmas in 

thoracic emergencies 

By Philip Ward 

Sunday, March 6, 

16:00–17:30 

SF 14 

Thoracic emergencies: 

triage with MDCT 

Should you insist that every request for an emergency CT scan is screened for its 

appropriateness Should you refuse to perform CT scans without a proper indication, 

risking the anger of your referring colleagues And how can you manage appropriateness 

effectively 

There are no easy answers to these three urgent questions facing radiologists, but those 

who attend the special focus session on thoracic emergencies at ECR 2011 will no doubt 

be much better informed about the issues. 

In many countries, imaging in the emergency department is not solely based on 

appropriateness but also on defensive medicine, finances, and politics, according to session 

moderator Dr. Digna R. Kool, from the department of diagnostic imaging, University 

Medical Centre Nijmegen, The Netherlands, who will moderate the session. Because of fear 

of missing a significant diagnosis, some clinicians request an imaging examination even 

when it is in conflict with accepted clinical decision rules and evidence in the literature. 

Furthermore, if CT is reimbursed fully under an insurance-based healthcare system, it will 

be in the interests of the hospital – and of private practice radiologists – to perform CT. 

“In many countries, politics rule, and it could be a great PR message for administrators 

to stress the fact that they offer the best method to exclude potentially life-threatening 

diseases, although we do not have enough evidence in this field yet,” she said. 

Kool thinks all radiologists should brush up on their knowledge of acute chest pain 

because the number of requests for imaging in these patients is rising fast and it is often 

encountered during on-call work. Part of the increase in requests for multidetector 

CT (MDCT) in acute chest pain is appropriate because technical advances have led to 

significant increases in diagnostic opportunities, resulting in faster and more accurate 

diagnoses and more effective clinical decision-making. 

Clinicians use MDCT to decide if patients need treatment and whether they should be 

admitted to hospital or can be discharged from the emergency department. Early discharge 

can decrease hospital costs significantly, she stressed. However, MDCT has important 

drawbacks, including costs and radiation, and with the increasing use of MDCT, the yield 

in positive results is decreasing. 

24

A B C D 

E F G H I 

Any discussion of how to manage appropriateness in the emergency department should 

consider patient selection protocols, such as clinical decision rules and research that 

has been, or should be, done, Kool pointed out. Alternative diagnostic strategies, like 

ventilation/perfusion lung (V/Q) scans for pulmonary embolism in young women, should 

also be investigated. 

MDCT is already the diagnostic reference standard for chest trauma, and allows the correct 

definition of life-threatening lesions, the triage of patients, and the decision about whether 

to adopt a ‘watch and wait’ approach or perform percutaneous or surgical interventions, 

explained Dr. Filippo Cademartiri, a radiologist from the University of Parma in Italy. The 

main drawback, however, is related to the skill of the operator in both defining the correct 

technical strategy and in the interpretation of the findings. 

“Patients with chest trauma are usually difficult to image because they are fairly 

uncooperative, they suffer from chest pain, and their breath-hold can be hard to control,” 

he commented. “Also, their heart rate, which is very important for a good MDCT 

examination, is more difficult to manage in chest trauma. The latest technologies are 

more robust, and they can cope with high heart rate, especially dual source CT equipment 

because of its higher temporal resolution.” 

To minimise radiation exposure to both patients and staff, it is necessary to consider several 

factors, including the body mass index of the patient, the patient’s ability to manage breathhold 

and heart rate, and the presence and amount of coronary calcifications. Radiation 

dose can be reduced the most when all conditions are favourable, stated Cademartiri. 

Looking to the future, he anticipates a trend towards the progressive widening of the chest 

CT examination performed for any indication in which the heart and coronary arteries 

can be assessed. 

“This translates into an inevitable screening for coronary artery disease. Radiologists are 

not ready yet for this, but they should prepare,” he warned. 

Finally, because newer CT technologies allow a comprehensive approach to acute chest 

pain, in the near future radiologists who work in emergency departments will have to 

confront the possibility of clinical requests to rule out all major causes of acute chest pain. 

Figure: 

A 73 year-old woman with 

multiple cardiovascular risk 

factors was admitted to the 

emergency department with 

chest pain radiated to the left 

arm and tachycardia after blunt 

trauma. ECG-gated CT of the 

entire thorax was performed for 

a triple rule-out. CT angiography 

excluded aortic dissection and 

pulmonary embolism, along 

with other collateral findings. CT 

showed a pattern of non-calcified, 

non-obstructive atherosclerosis 

along the left anterior descending 

coronary artery (LAD). 

A–D: volume-rendered images 

of thoracic aorta and the heart 

exclude aortic aneurysm and 

dissection. 

E: maximum intensity projection 

(MIP) coronal view of right and 

left pulmonary arteries without 

filling defects (normal finding). 

F: curved multiplanar 

reconstruction (MPR) of right 

coronary artery without significant 

stenoses. 

G, H: MPR of LAD with axial 

plane. (*): concentric soft plaque 

involves the bifurcation LAD – 

first diagonal branch with


Molecular imaging 

for radiologists 

By Mélisande Rouger 

Monday, March 7, 

08:30–10:00 

SF 15a 

Molecular imaging 

made easy 

Today, most of the research done in molecular imaging is performed not by radiologists 

but by scientists from other disciplines. As ultrasound, optics and MR are gaining weight 

in pre-clinical imaging, it is very probable that they will soon compete with PET and 

SPECT, currently the most widely used molecular imaging modalities in practices. With 

this whole range of tools about to make their way into the clinic, radiologists should seize 

the opportunity to be among the first to master these techniques. 

A dedicated ECR 2011 session will deliver key, simple tips about the current possibilities 

offered by various modalities, to spark radiologists’ interest in functional and molecular 

imaging. 

“Our aim is to give radiologists an introduction to molecular imaging. It should guide 

them through this field by giving them useful knowledge and explaining how they can 

become active in their institution,” said Fabian M.A. Kiessling, Professor of Experimental 

Molecular Imaging at Aachen University Hospital, who will chair the session. 

Except for a few brilliant specialists, most radiologists have limited involvement with 

molecular imaging, but interest is growing. A session on the topic during the last German 

Congress of Radiology attracted crowds of delegates, mainly young radiologists seemingly 

keeping an eye on these tools from the very beginning of their training. 

“Currently molecular imaging research is dominated by biologists, chemists and nuclear 

doctors. But now that we are moving towards clinics, there is more reason for radiologists 

to get closely involved. Most of them have a rough idea of what it is about. They may know 

FDG PET and other PET and SPECT applications but not consider that Gd-DTPA-EOB 

enhanced liver MRI, SPIO-enhanced lymph node and liver imaging, and MR-spectroscopy 

are also molecular imaging applications in principle,” Kiessling said. 

In particular optical imaging could be a great chance for radiologists to get started. In preclinical 

imaging, optics are the classical tool for examining small animals. 

Successful examples of work done with optics are many, from 2008 Nobel Prize chemist 

Roger Y. Tsien and his studies with GFP and RFP (fluorescent proteins) to the recent 

introduction of the fluorescence camera system Xiralite ® , which enables diagnostic 

imaging of rheumatoid arthritis in the joints of both hands. 

26

B1 

A 

B2 

Over the past few months, 300 to 400 cases have successfully been investigated with this 

tool. As well as being reliable and relatively cheap (400,000 euros) it is also small, which 

could facilitate its installation in hospitals or ambulances. 

“Optical imaging will be widely used in clinics, which is why I think it’s very important to 

talk about it now,” Kiessling said. 

Experts will also present their work with ultrasound (US) in the imaging of angiogenesis, 

cancer and plaque characterisation. 

“I did a lot of molecular MRI in the past, and I am very sceptical about whether it will 

broadly make its way into the clinics within the next years because it is less sensitive 

than PET or optics or even US,” Kiessling said. However, molecular agents may be used 

to identify healthy tissues like lymph nodes and thus delineate pathologies by their nonenhancement. 

In the long run, hyperpolarised agents may significantly broaden the 

capability of MRI in molecular imaging. 

Further developments in PET and SPECT should also encourage radiologists to acquire 

skills in nuclear imaging. Its current use in clinics seems to be just the tip of the iceberg 

and many more applications will be possible within a few years. Its refinement will trigger 

a redefinition of diagnostic imaging, Kiessling envisions. 

Figure A: 

Fusion image of fluorescence 

optical tomography and µCT of an 

atherosclerotic mouse. The colour 

coding shows the activation of a 

catepsin-sensitive optical probe 

in an atherosclerotic plaque in the 

aortic arc. 

Figure B: 

Accumulation of VEGFR2- 

targeted microbubbles in highly 

angiogenic (B1) and low angiogenic 

(B2) breast cancer xenografts. 

The high sensitivity of molecular 

ultrasound imaging to characterise 

angiogenesis in tumours at a 

molecular level is clearly shown. 

(Provided by 

Dr. Fabian M.A. Kiessling) 

“Molecular imaging is already here but there is still much more potential. It should be of 

big interest to the radiologist; it adds a tool to the specialisation of diagnostic radiologists. 

In my opinion, the diagnostic radiologist as we know him/her now will disappear, and I 

have the feeling that in the future radiologists will become universal diagnostic doctors. 

They will need profound knowledge of pathologies and molecular mechanisms in order to 

select how the diagnosis should be done,” he said. 

However, doubts remain as to whether molecular imaging will become strong in the clinic. 

Subspecialisation and training would certainly help to raise attention to the tremendous 

possibilities offered by reading cellular functions. The European Institute for Biomedical 

Imaging Research (EIBIR) already offers training workshops in cell imaging via its 

ENCITE project. But one major aim of the ECR session is to push for the creation of 

a master’s degree in molecular imaging, Kiessling underlined. “We all think that it will 

change the diagnostic procedure in the future, so it is very important that radiologists are 

going on with this,” he concluded. 

27


Special Focus 

Sessions 


SF 2 Child abuse: right images, 

right behaviour, right words 

 

 

 

 

 


M.I. Argyropoulou; Ioannina/GR 

• How to image and detect patterns of 

skeletal injury indicating child abuse 

P.K. Kleinman; Boston, MA/US 

• Imaging strategies to fully determine 

intracranial injury resulting from child abuse 

C. Adamsbaum; Paris/FR 

• What is the information required by any 

court and how the radiological reports 

should be phrased 

S. Chapman; Birmingham/UK 


The radiologist at the eye of the storm 

Friday, March 4, 08:30–10:00, Room F2 

SF 3a The BI-RADS 3 controversy 

 

 

 

 

 


M.G. Wallis; Cambridge/UK 

• Defining lesions to follow-up 

P. Skaane; Oslo/NO 

• Decreasing the number of BI-RADS 3 in 

clinical settings 

L.J. Pina Insausti; Pamplona/ES 

• Management of BI-RADS 3 lesions 

F. Sardanelli; Milan/IT 


BI-RADS 3: biopsy or watch 

Friday, March 4, 08:30–10:00, Room Q 

SF 3b The ABC of EVAR 

 

 

 

 

 


M. Szczerbo-Trojanowska; Lublin/PL 

• Endovascular treatment of 

thoracic aortic aneurysms 

J.-P. Beregi; Lille/FR 

• Endovascular treatment 

of abdominal aortic aneurysms 

R. Morgan; London/UK 

• The role of imaging in follow-up 

K.A. Hausegger; Klagenfurt/AT 


The key role of imaging in endovascular 

aortic aneurysm repair 

Friday, March 4, 08:30–10:00, Room L/M 

SF 3c Tumour response to treatment: 

RECIST, desist or insist 

 

 

 

 

 


R.H. Reznek; London/UK 

• Monitoring response to treatment in 

patients with cancer: why and how. 

The Oncologist’s view 

P. Johnson; Southampton/UK 

• Principles in the use of conventional/anatomic 

imaging for response assessment 

L. Schwartz; New York, NY/US 

• PET in monitoring response 

W. Weber; Freiburg/DE 


Why does the radiologist need to 

understand the importance of 

monitoring response and how it is done 

Friday, March 4, 08:30–10:00, Room D2 

SF 3d Head and neck oncology: the 

three musketeers (CT, MR, PET) 

 

 

 

 

 


A. Borges; Lisbon/PT 

• State-of-the-art CT/MR/PET as 

baseline modalities 

S. Bisdas; Tübingen/DE 

• State-of-the-art CT/MR/PET in 

the treated neck 

F.A. Pameijer; Utrecht/NL 

• New techniques and protocols: 

perfusion, diffusion, spectroscopy 

and new PET tracers 

V. Vandecaveye; Leuven/BE 


The three musketeers were actually FOUR 

28


Special Focus 

Sessions 


SF 6 Dynamic MR imaging of the 

pelvic floor: easy and useful 

 

 

 

 

 


D. Weishaupt; Zurich/CH 

• How I do it 

C.S. Reiner; Zurich/CH 

• Indications and spectrum of 

pathological findings 

F. Maccioni; Rome/IT 

• Dynamic imaging of the pelvic floor: 

MR imaging or conventional technique 



Does dynamic pelvic MR imaging replace 

conventional defecography 

Saturday, March 5, 08:30–10:00, Room A 

SF 7 My ‘most beautiful’ mistakes 

 

 

 

 

 


M. Zins; Paris/FR 

• Abdomen 

A.H. Freeman; Cambridge/UK 

• GU 

L.E. Derchi; Genoa/IT 

• Chest 

C. Schaefer-Prokop; Amersfoort/NL 


What have we learned from our mistakes 

Sunday, March 6, 08:30–10:00, Room G/H 

SF 11 Can we predict premature ageing 

 

 

 

 

 


G. Guglielmi; Foggia/IT 

• Brain ageing/dementia 

F. Barkhof; Amsterdam/NL 

• Bone and joint ageing 

A. Cotten; Lille/FR 

• Cardiovascular ageing 

T. Saam; Munich/DE 


What specific knowledge do you need to 

be able to interpret and understand the 

radiological scenarios in geriatric patients 

Sunday, March 6, 14:00–15:30, Room F1 

SF 13 Quantifying liver fat, 

inflammation and fibrosis: 

routine or research 

 

 

 

 

 

 


C.B. Sirlin; San Diego, CA/US 

• Quantification of liver fat 

S.B. Reeder; Madison, WI/US 

• Quantification of liver inflammation 

J.F.L. Cobbold; London/UK 

• Quantification of liver fibrosis 

B. Van Beers; Clichy/FR 

• Summary of presentations 

C.B. Sirlin; San Diego, CA/US 


Routine or research 

Sunday, March 6, 16:00–17:30, Room E2 

SF 14 Thoracic emergencies: 

triage with MDCT 

 

 

 

 

 


D.R. Kool; Nijmegen/NL 

• MDCT in acute chest pain 

F. Cademartiri; Parma/IT 

• MDCT in chest trauma: 

indications, technique and interpretation 

H. Mirka; Plzen/CZ 

• Radiation in emergency thoracic CT: 

can it be reduced 

S. Leschka; St. Gallen/CH 


Increasing use of MDCT in emergency 

radiology of the chest: is it appropriate 

Can we stop it Do we want to 

29


Special Focus 

Sessions


Special Focus 

Sessions 

Monday, March 7, 08:30–10:00, Room E1 

SF 15a Molecular imaging made easy 

 

 

 

 

 


F.M.A. Kiessling; Aachen/DE 

• Probes and targets in optical imaging 

C.W.G.M. Löwik; Leiden/NL 

• Ultrasound providing molecular imaging 

M. Palmowski; Aachen/DE 

• MR in molecular imaging 

E.A. Schellenberger; Berlin/DE 


Which role can radiologists easily 

play in molecular imaging 

A.K. Dixon; Cambridge/UK 


SF 15b CT of small airways: elementary 

images for disease classification 

 

 

 

 

 


J.A. Verschakelen; Leuven/BE 

• Basic signs in small airways disease 

D.M. Hansell; London/UK 

• From pattern to diagnosis 

C. Beigelman; Paris/FR 

• Beyond morphology 

H.-U. Kauczor; Heidelberg/DE 


Signs of small airways disease can 

be seen on CT but when and why 

do they really matter 

Monday, March 7, 16:00–17:30, Room D1 

SF 18a Transarterial treatment of liver 

tumours: major advances 

 

 

 

 

 

 


J. Lammer; Vienna/AT 

• Advances in chemoembolisation 

of liver metastases 

M.A. Funovics; Vienna/AT 

• Embolisation of HCC with drug 

eluting beads 

K. Malagari; Athens/GR 

• Selective internal radiotherapy 

J.I. Bilbao; Pamplona/ES 

• Combined therapies before and 

after ablation 

R. Lencioni; Pisa/IT 


Which treatment option is the best for 

the various stages of disease 

Monday, March 7, 16:00–17:30, Room F2 

SF 18b Brain perfusion made easy: 

CT/MR 

 

 

 

 

 


E.T. Tali; Ankara/TR 

• Techniques for CT and MR, 

post-processing, radiation 

R.A. Meuli; Lausanne/CH 

• Brain tumours 

A. Jackson; Manchester/UK 

• Stroke and vascular diseases 

J. Vymazal; Prague/CZ 


Guidelines, recommendations, hints and 

tips to get more from perfusion imaging 

in CNS pathologies 

31


New bridges could 

help improve cancer 

patient management 


Saturday, March 5, 

16:00–17:30 

Joint Session of the 

ESR and the EORTC 

(European Organisation 

for Research and 

Treatment of Cancer): 

PC 10 

Imaging as the 

number one tool for 

oncology trials 

The science of radiology is changing rapidly, and now offers better and more advanced tools for 

imaging patients with cancer, who represent an ever increasing population. Thanks to its ability 

to provide functional information on tumours, radiology has come to play a pivotal role in the 

management of oncology patients. As a consequence, the role of the radiologist has continued 

to expand and they have become more involved upstream in treatment. 

A joint session held by the ESR and the European Organisation for Research and Treatment of 

Cancer (EORTC) will present the current state of cancer imaging and explore potential areas of 

collaboration that could benefit patients. 

Clinicians rely more than ever on imaging studies to assess tumour response to various 

treatments. While in the past the role of radiologists was often limited to measuring the 

diameter and volume of tumours, nowadays multi-parametric imaging techniques allow 

accurate evaluation of functional changes. 

As an example, radiologists can monitor tumour blood flow through perfusion imaging 

techniques; they can provide an estimate of cell density and/or nucleus/cytoplasm ratio thanks 

to diffusion imaging; and they are even able to assess the ultrastructure of certain tumours 

using tensor imaging, and determine tumour necrosis by using MR spectroscopy, for instance 

in the brain. 

With new possibilities come new responsibilities. Radiologists must not only look at and report 

‘morphological’ imaging studies, but they should familiarise themselves with these new ‘multiparametric’ 

imaging methods. 

“Many of these techniques demand a lot of work and dedication. As it is today, many radiologists 

don’t have the time or the expertise in clinical trials to apply these new techniques. We will need 

to train them not only to perform these imaging studies but also to learn how to interpret 

functional imaging data,” said Professor Paul M. Parizel, from Antwerp University Hospital, 

who will chair the session together with Françoise Meunier, EORTC Director General. 

The session will provide examples of how best to assess cell density and tumour angiogenesis 

through MRI. Furthermore, radiologists who attend the session will learn about the existence 

of a dedicated platform for cancer research and treatment in Europe, and the role they could 

play within it. 

32

The EORTC is the biggest European organisation involved with clinical trials in oncology 

patients. With over 300 participating institutions involved in reviewing and evaluating tumour 

response, the potential it offers to radiologists is tremendous. 

Parizel, who met with the EORTC in 2009, is convinced of it. “I think it is highly relevant to 

work with the EORTC, and this session provides a unique opportunity for radiologists to get 

involved at an early stage in the design of trials,” he said. 

So far, radiologists have mainly been called upon to assess the imaging results of trials that were 

often designed without their input. But the clinicians and people involved in the trials might 

not have understood the full potential of radiology. 

Prof. Paul M. Parizel 

from Antwerp University 

Hospital will co-chair the 

Professional Challenges Session on 

the role of imaging in oncology trials. 

Dr. Françoise Meunier 

is Director General of the 

European Organisation for 

Research and Treatment of 

Cancer and will co-chair the 

Professional Challenges Session. 

“Radiologists are usually not directly involved in taking care of patients. The decision to 

enrol some patients in certain trials is mainly made by clinicians and oncologists. As a result, 

radiologists are often only involved at a later stage, when they are called upon to interpret 

imaging studies. A lot of the radiological work is hidden, and, unfortunately, the public has very 

little understanding of the role played by radiologists,” Parizel admitted. 

And yet, in order to answer clinically relevant questions, it is important to make the correct 

choices for imaging, and to tailor the imaging strategy specifically to the questions that need 

to be answered. 

The EORTC, which has worked a lot with nuclear medicine for PET studies for instance, lacked 

structured contact with radiology. Both are now willing to improve their cooperation. “The 

EORTC made the strategic decision to create an imaging group, which includes radiologists, 

supported by the appropriate infrastructure, the EORTC Imaging Platform, so that we can 

better face the challenge of attaining personalised medicine and targeted therapies,” explained 

Meunier. 

More could come out of the ECR professional challenges session. 

“I hope that this session will open a window to demonstrate to radiologists that there is another 

parallel universe, the one of the EORTC, and that we can build strong bridges between the two 

worlds. There is no doubt in my mind that improved collaboration between the ESR and the 

EORTC will open new horizons for better treatment and imaging, to the benefit of oncology 

patients ,” said Parizel. 

33


Professional Challenges 

Sessions 

Thursday, March 3, 16:00–17:30, Room L/M 

Joint Session of the ESR and the EANM 

(European Association of Nuclear Medicine): 

PC 2 Radiology and nuclear medicine: 

really a joint venture 

 

 

 

 

 

• Chairmen’s introduction 

P. Bourguet; Rennes/FR 

É. Breatnach; Dublin/IE 

• Evaluation of tumour response to therapy: 

the role of radiology 

M. O’Connell; Dublin/IE 

• Evaluation of tumour response to therapy: 

the role of nuclear medicine 

A. Chiti; Milan/IT 

• Alzheimer’s disease: 

the role of radiology 

J. Alvarez-Linera; Madrid/ES 

• Alzheimer’s disease: 

the role of nuclear medicine 

K. Tatsch; Karlsruhe/DE 


The advantages of working together 

for nuclear medicine and radiology 


PC 7 Professional issues in 

interventional radiology: 

education, training and standards 

 

 

 

 

 



J.H. Peregrin; Prague/CZ 

• Education and training in IR 

A.-M. Belli; London/UK 

• Turf battles facing IR 

J.A. Reekers; Amsterdam/NL 

• Future directions in IR 

M.J. Lee; Dublin/IE 


What does an interventional 

radiologist need to know 


Joint Session of the ESR and the EORTC 

(European Organisation for Research and 

Treatment of Cancer): 

PC 10 Imaging as the number one tool 

for oncology trials 

 

 

 

 

 

 


F. Meunier; Brussels/BE 

P.M. Parizel; Antwerp/BE 

• The EORTC Imaging Group: 

vision and strategy on cancer imaging 

S. Stroobants; Antwerp/BE 

• Can we assess cell density of tumours 

with imaging techniques 

D.-M. Koh; Sutton/UK 

• Which imaging techniques are useful to 

evaluate tumour angiogenesis 

D. Sahani; Boston, MA/US 

• Challenges for morphologic imaging in 

oncology trials: reproducibility and reading 

F.E. Lecouvet; Brussels/BE 


Can we use imaging parameters as 

biomarkers in multicentre trials and 

predict tumour response 

Monday, March 7, 08:30–10:00, Room L/M 

PC 15 Teleradiology: 

for better or for worse 

 

 

 

 

 


L. Donoso; Barcelona/ES 

• Are we safeguarding patients’ rights 

D. Caramella; Pisa/IT 

• Excellence in teleradiology: 

key issues in workflow management 

J. Schillebeeckx; Bonheiden/BE 

• Dedicated solutions for specific 

clinical scenarios 

H. Billing; Barcelona/ES 


To what extent has teleradiology 

demonstrated it can improve 

radiological services 

34


Professional Challenges 

Sessions 

35


Common clinical 

cases in a click 


Saturday, March 5, 

to Monday, March 7 

CC 18 

CLICK (Clinical 

Lessons for Imaging 

Core Knowledge): 


A number of clinical situations pose severe differential diagnostic challenges to both the 

radiologist and clinician. A perfect command of imaging modalities is mandatory to help 

radiologists find the origin of a headache or fever, but sufficient clinical knowledge is 

increasingly needed to suggest the appropriate examination, according to experts. 

With clinical skills, radiologists can act as consultants in the early steps of an investigation. 

They can suggest the best examination to be carried out in a patient and they must be aware 

of other non-radiological examinations. 

“There is an increasing need to bring about such an educational session, which combines 

clinical and diagnostic imaging knowledge,” said András Palkó, Professor of Radiology 

at Szeged Medical School in Hungary, who will chair a dedicated categorical course, 

appropriately named Clinical Lessons for Imaging Core Knowledge (CLICK), at ECR 2011. 

Six of the most common situations encountered in daily practice will be dealt with in six 

dedicated sessions, each featuring a speaker focusing on clinical considerations and another 

describing imaging techniques and typical findings. 

In all patients, the less ionising examination will usually be carried out first. In cases of 

dyspnoea, a chest x-ray is always followed by CT but there are nowadays numerous ways of 

examining a patient. Here, radiologists must know to which diseases this symptom may be 

linked and adapt the scanning protocol to provide the most appropriate radiation dose to 

provide a diagnostic benefit to the patient. 

Patient information is crucial and will influence the way the examination is carried out. 

An incidentally found focal liver lesion in a patient with a known liver disease or cancer 

somewhere else in his/her body will trigger a series of examinations which might prove 

unnecessary in a healthy person. 

36

A B C 

“A combined knowledge of imaging technologies and clinicians’ expectations are key 

elements for a fruitful collaboration with referring physicians, reinforcing the pivotal role 

of radiologists in patients’ management,“ said Martine Rémy-Jardin, Professor of Radiology 

at Hôpital Calmette in Lille, who will coordinate the session on dyspnoea 

Other renowned radiologists accepted the invitation to give presentations, responding to 

the challenging topic and the innovative structure. 

Another particular detail might have motivated them to take part in this course. At the 

end of each session, a third speaker will quiz the audience on typical cases. Equipped with 

keypads, participants will have to solve each case, putting in practice what they have just 

been taught. 

This exercise increases the level of consciousness of the audience, Palkó believes. “It is a 

kind of evaluation of the first two talks. It is a practical overview of what has been told 

before; first you have the theory, then the practice,” he explained. 

Interactive sessions are traditionally very popular at ECR and Palkó, who will also hold a 

talk on clinical considerations in the liver, hopes to receive a positive response from the 

audience. “It’s an experiment, so we’ll see. It may attract crowds of delegates but it may also 

not prove quite as successful,” he said cautiously. 

The ECR 2012 Programme Planning Committee, encouraged by the quality and originality 

of the course, has already decided to repeat it next year. 

Figure A: 

Transverse CT scan obtained at 

the level of the cardiac cavities 

in a 67 year-old male smoker 

presenting with progressive 

worsening of dyspnoea. Note the 

abnormal thinning and lipomatous 

metaplasia of the left ventricular 

wall (arrows), suggestive of 

sequellae of myocardial infarction. 

Figure B: 

Transverse CT scan obtained 

at the level of the upper lung 

zones showing mild ground glass 

attenuation, abnormal thickening 

of peribronchovascular bundles, 

thin septal lines and right-sided 

pleural effusion. These features 

are highly suggestive of interstitial 

edema, thus explaining the patient’s 

dyspnoea. 

Figure C: 

Transverse CT scan obtained below 

the tracheal bifurcation showing 

an endobronchial mass obstructing 

the right main bronchus, 

corresponding to a bronchial 

carcinoid tumour. 

(All images provided by 

Dr. Martine Rémy-Jardin) 

37


Categorical 

Courses 

KISS (Keep It Simple and Straightforward): Musculoskeletal MRI 

Thursday, March 3, 16:00–17:30, Room D1 

CC 216 The hand and wrist 

Moderator: R. Schmitt; Bad Neustadt a.d. Saale/DE 

A. How I do it 

J.-L. Drapé; Paris/FR 

B. Normal variants and pitfalls 

J. Hodler; Zurich/CH 

C. Identifying and reporting 

abnormal findings 

L. Cerezal; Santander/ES 


CC 316 The shoulder 

Moderator: A. Oktay; Izmir/TR 


J. Kramer; Linz/AT 


M. Reijnierse; Leiden/NL 



S. Waldt; Munich/DE 


CC 616 The knee 

Moderator: J. Labuscagne; Bunbury, WA/AU 


A. Barile; L’Aquila/IT 


S.J. Eustace; Dublin/IE 



M. Maas; Amsterdam/NL 

Saturday, March 5, 08:30–10:00, Room D1 

CC 716 The ankle and foot 

Moderator: M. Shahabpour; Brussels/BE 


M. Zanetti; Zurich/CH 


A.H. Karantanas; Iraklion/GR 



A. Cotten; Lille/FR 


CC 1016 The basics of MSK MRI at 3T 

Moderator: A. Baur-Melnyk; Munich/DE 

A. Optimising protocols 

C. Glaser; Munich/DE 

B. Pitfalls, strengths and weaknesses 

T.C. Mamisch; Berne/CH 

C. New techniques and applications 

S. Trattnig; Vienna/AT 

Sunday, March 6, 14:00–15:30, Room D1 

CC 1316 The lumbar spine 

Moderator: M. Epermane; Riga/LV 


P.J. Richards; Stoke-on-Trent/UK 


B. Tins; Oswestry/UK 



A. Stäbler; Munich/DE 


CC 1416 Soft tissue extremity masses 

Moderator: A.R. Mester; Budapest/HU 


J.C. Vilanova; Girona/ES 


F.M.H.M. Vanhoenacker; Antwerp/BE 



J.L.M.A. Gielen; Edegem/BE 


CC 1516 The hip 

Moderator: C.W.A. Pfirrmann; Zurich/CH 


A. Kassarjian; Majadahonda/ES 


U. Studler; Basle/CH 



P.M. Cunningham; Navan/IE 

38


Categorical 

Courses 

Radiology in Abdominal Emergencies 


CC 1017 Missing perfusion: 

abdominal ischaemic disease 

Moderator: O. Chan; London/UK 

A. Mesenteric angiography: diagnostic and 

therapeutic approach 


B. The black bowel 

P. Rogalla; Toronto, ON/CA 

C. Clinical management: 

what you need to know 

D.E. Malone; Dublin/IE 


CC 1117 The hole in the guts 

Moderator: S. Puri; New Delhi/IN 

A. Wasting time with plain radiography 

M. Laniado; Dresden/DE 

B. Defining the role of US 

J.B.C.M. Puylaert; The Hague/NL 

C. In search of the hole: CT 



CC 1417 Inflammation and oedema 

Moderator: N. Elmas; Izmir/TR 

A. The three musketeers: appendicitis, 

diverticulitis, colitis 

J. Stoker; Amsterdam/NL 

B. Liver and biliary tree 

J.A. Soto; Boston, MA/US 

C. Pancreatitis: common and critical 

P.R. Ros; Cleveland, OH/US 

Monday, March 7, 08:30–10:00, Room A 

CC 1517 The acute abdomen 

Moderator: J.-M. Bruel; Montpellier/FR 

A. Abdominal hernias 

G. Brancatelli; Palermo/IT 

B. The wrong twist: 

mesenteric and omental torsion 

S. Efremidis; Ioannina/GR 

C. Acute stages in neoplastic diseases 

J.A. Guthrie; Leeds/UK 

39


Categorical 

Courses 

CLICK (Clinical Lessons for Imaging Core Knowledge): Common Clinical Cases 

Saturday, March 5, 08:30–10:00, Room C 

CC 718 Dyspnoea 

Moderator: M. Rémy-Jardin; Lille/FR 

A. Clinical considerations 

J. Neuwirth; Prague/CZ 

B. Imaging techniques and typical findings 

H. Prosch; Vienna/AT 

C. Interactive case discussion 

J. Andreu; Barcelona/ES 


CC 1018 Palpable abdominal mass 

Moderator: F. Caseiro-Alves; Coimbra/PT 


D. Akata; Ankara/TR 


M. Prokop; Nijmegen/NL 


A.H. Freeman; Cambridge/UK 

Sunday, March 6, 08:30–10:00, Room C 

CC 1118 Surprise in the liver 

Moderator: C. Bartolozzi; Pisa/IT 


A. Palkó; Szeged/HU 


C.J. Zech; Munich/DE 




CC 1318 Fever of unknown origin 

Moderator: P.A. Grenier; Paris/FR 


C.P. Heussel; Heidelberg/DE 


G.R. Ferretti; Grenoble/FR 


G.H. Mostbeck; Vienna/AT 


CC 1418 Focal neurological disorders 

Moderator: M. Sasiadek; Wroclaw/PL 


D. Balériaux; Brussels/BE 


P. Barsi; Budapest/HU 


G. Krumina; Riga/LV 

Monday, March 7, 08:30–10:00, Room C 

CC 1518 Female pelvic pain 

Moderator: A.J.M. Maubon; Limoges/FR 


G. Restaino; Campobasso/IT 


B. Brkljačić; Zagreb/HR 


A.G. Rockall; London/UK 

40 

= Interactive session with electronic voting/self assessment


Categorical 

Courses 

41


Europe and USA 

combine expertise in 

oncologic imaging 


Sunday, March 6, 

08:30–17:30 

MC 25 

Joint Course of 

ESR and RSNA 

(Radiological Society 

of North America) 

Oncologic imaging is performed daily in virtually every radiology practice. Radiologists 

play an essential role in detecting, characterising, and staging tumours, as well as in 

assessing treatment response and monitoring for tumour recurrence. 

In order to make the most of the latest important developments in cancer patient 

management, radiologists need practical knowledge and up-to-date information. This is 

what the two leading radiological societies, the ESR and RSNA, have planned to provide 

by holding their first ever joint course at the upcoming ECR. 

“Cancer is a global disease and a global challenge,” said RSNA Immediate Past President 

Prof. Hedvig Hricak from New York. “This ECR/RSNA joint educational project will help 

to strengthen and unify our approaches to oncologic imaging.” 

Cross-sectional imaging, including CT, MRI (with its latest addition of whole body MRI) 

and PET-CT, has revolutionised the way cancers are diagnosed and treated. Imaging can 

now be used for many aspects of patient management, from assessment of the spread 

and resistance of a tumour to monitoring of the response to therapy. In addition to basic 

anatomic information, treatment monitoring now provides more and more functional 

imaging parameters to assess perfusion and metabolism. 

“Due to a change of paradigm regarding the treatment of oncologic patients, it has become 

necessary for physicians to address the issue of oncologic imaging and education in oncologic 

imaging in a worldwide vision,” said ESR Past President Prof. Christian J. Herold, from 

Vienna, one of the course coordinators. 

But it is also a change in the perception of oncologic imaging that prompted the idea for 

a common initiative. “Oncologic imaging has been very focused for a long time, but we 

feel that some sort of comprehensive approach is now necessary, because tumours are not 

located in only one organ or organ system. As soon as there is a metastatic spread, they 

may be distributed all across the body,” explained ESR President Prof. Maximilian F. Reiser 

from Munich. 

The course, which will also be held at RSNA this November, will be divided into lectures on 

different tumour entities and presented by some of the finest radiologists from both sides of 

the Atlantic, including Reiser and Hricak, and ECR 2011 President Prof. Yves Menu, from 

Paris, with a lecture on pancreatic cancer. 

= Interactive session with electronic voting/self assessment 

42

A B C 

D 

E 

These lectures will provide a practical, clinically-relevant summary of key imaging issues 

in common cancers (ovarian, kidney, lymphoma, colon, pancreas, prostate and liver) using 

an interactive, case-based approach. After an overview of principles of oncologic imaging 

and current cancer-related terminology, there will follow organ-specific lectures focusing 

on how imaging can optimise detection and characterisation of specific tumours and 

measure tumour treatment response, providing a value-added radiology report. 

Oncologic imaging is a wide field with a major bearing on patient health but there are 

currently few opportunities for subspecialisation. This can cause uneasiness among 

radiologists, experts observe. 

“A large proportion of radiological practice involves imaging of cancer patients. Yet many 

radiologists feel insecure when interpreting such examinations, due to a lack of specialised 

training in oncologic imaging, the complexity of the findings, and the high stakes involved 

for the patient,” said RSNA speaker Prof. David Panicek, from New York, who will discuss 

principles of oncologic imaging and reporting. 

Consequently, there are ongoing discussions regarding the introduction of oncologic 

imaging as a subspecialty and its integration into the radiology curriculum. 

“This joint initiative has many components: one is the course on oncologic imaging but 

the additional step would be to promote oncologic imaging as a subspecialty. That would 

have consequences for resident training in radiology and we are considering promoting 

fellowships in oncologic imaging,” Herold said. 

Could this joint course be a springboard for other common educational programmes 

“Perhaps as we work closer in education there will be opportunities in other areas 

of mutual interest such as quality and safety, and research,” suggested RSNA speaker 

Prof. Richard Baron, from Chicago, who will talk about liver cancers. 

Other themes such as obesity, which is becoming more and more important in Europe 

but already an urgent issue in the U.S., metabolic diseases such as diabetes, and radiation 

exposure could be dealt with in joint sessions, said Reiser. Common forces and common 

ideas would also make the societies more effective when negotiating with political decision 

makers for instance, he added. 

Figure A: 

Complication of chemotherapy: 

Chemotherapy-induced biliary 

sclerosis. Contrast-enhanced CT 

of a patient with biliary sclerosis 

caused by hepatic arterial infusion 

of fluorodeoxyuridine (FUDR) 

for colorectal hepatic metastases. 

Biliary sclerosis developed 

three months after initiation of 

treatment. 

Figure B: 

Prostate cancer in transition zone 

with extraprostatic extension, best 

shown on T2-weighted endorectal 

coronal MR image. Knowledge 

of tumour location facilitated a 

wider anterior and lateral resection 

margin than usual. 

Figure C: 

Preoperative CT in a patient with 

stage IIIC epithelial ovarian cancer, 

showing large, heterogeneous 

nodal deposit in right superior 

diaphragmatic region. Presence 

of supra-diaphragmatic 

lymphadenopathy signifies 

unresectable disease and the need 

for neoadjuvant chemotherapy. 

Figure D, E: 

Peritoneal carcinomatosis in 

ovarian cancer, more evident at 

T2-weighted fat-suppressed MRI 

than CT. Irregular rind of tumour 

is present along the posterior 

surface of right hepatic lobe, just 

caudal to bare area of liver. In 

absence of ascites, the rind is barely 

perceptible on CT. 

(All images courtesy of Dept. of 

Radiology, MSKCC, New York) 

43


Mini 

Courses 

Organs from A to Z: Pancreas 

Saturday, March 5, 08:30–10:00, Room B 

MC 719 Imaging inflammation 

and function 

Moderator: O. Akhan; Ankara/TR 

A. Acute pancreatitis 

P.R. Ros; Cleveland, OH/US 

B. Chronic pancreatitis 

G. Morana; Treviso/IT 

C. Management of complications 

of pancreatitis 

C.D. Becker; Geneva/CH 

• Discussion 

Saturday, March 5, 16:00–17:30, Room E2 

MC 1019 Cystic tumours, endocrine 

neoplasms and congenital 

anomalies 

Moderator: I.G. Lupescu; Bucharest/RO 

A. Cystic tumours 

R. Pozzi-Mucelli; Verona/IT 

B. Endocrine and other solid 

pancreatic tumours 


C. Congenital and developmental anomalies 

M. Karcaaltincaba; Ankara/TR 



MC 1119 Imaging adenocarcinoma 

Moderator: T.K. Helmberger; Munich/DE 

A. MDCT: 

how to diagnose, how to stage 

W. Schima; Vienna/AT 

B. MR imaging: 

a main course or just a side dish 


C. Detection and staging: 

multimodality comparison 

D.E. Malone; Dublin/IE 


44


Mini 

Courses 

The Beauty of Basic Knowledge: 


Thursday, March 3, 14:00–15:00, Room Z 

MC 21A Interpreting the chest 

radiograph: basic concepts 

J. Cáceres; Barcelona/ES 

Friday, March 4, 14:00–15:00, Room Z 

MC 21B Lobar collapse 

 


Saturday, March 5, 12:30–13:30, Room Z 

MC 21C Air-space disease 


Sunday, March 6, 12:30–13:30, Room Z 

MC 21D Rounded lesion(s) 


Monday, March 7, 12:30–13:30, Room Z 

MC 21E Decreased opacity of the lung(s) 


Registration: 

The number of participants for each session is restricted 

to 50. Participants need to register in advance as of October 1, 

2010 (www.myESR.org). 

45


Mini 

Courses 

Functional Imaging of Tumours: 

How to Do It 

Thursday, March 3, 16:00–17:30, Room F1 

MC 222 Basics you should know 

Moderator: J. Stoker; Amsterdam/NL 

A. Tumour angiogenesis and 

perfusion parameters 

D. Sahani; Boston, MA/US 

B. Diffusion imaging 

B.A. Taouli; New York, NY/US 

C. Metabolic imaging using PET/CT 

G. Antoch; Essen/DE 


MC 322 Functional and ultra 

structural MR 

Moderator: L. Martí-Bonmatí; Valencia/ES 

A. Diffusion imaging and whole body MRI 

A. Luciani; Creteil/FR 

B. Quality and quality control in DCE-MRI 

and DCE-CT 

V.J. Goh; Northwood/UK 

C. Synthesis: functional imaging 

for tumour management 

V. Vilgrain; Clichy/FR 


MC 622 Dynamic contrast-enhanced 

(DCE) imaging 

Moderator: A. Ba-Ssalamah; Vienna/AT 

A. DCE-CT 

J. Votrubová; Prague/CZ 

B. DCE-MR 

A.R. Padhani; Northwood/UK 

C. DCE-US 

L. Solbiati; Busto Arsizio/IT 

46


Mini 

Courses 

Joint Course of the ESR and RSNA 

(Radiological Society of North America) 

Sunday, March 6, 08:30–10:00, Room N/O 

MC 1125 Essentials in oncologic imaging: what 

radiologists need to know (part 1) 

Moderator: D.M. Panicek; New York, NY/US 

A. Principles of oncologic imaging 

and reporting 

D.M. Panicek; New York, NY/US 

B. Lung cancers (primary, metastases) 

C.J. Herold; Vienna/AT 

C. Colon cancer 

R.M. Gore; Highland Park, IL/US 

• Questions 




Moderator: D.M. Panicek; New York, NY/US 

A. Pancreatic cancer 

F. Caseiro-Alves; Coimbra/PT 

B. Kidney cancer 

E.K. Fishman; Baltimore, MD/US 

C. Ovarian cancer 

H. Hricak; New York, NY/US 

• Questions 




Moderator: H.-U. Kauczor; Heidelberg/DE 

A. Oncologic imaging: terminology, 

definitions and buzzwords 


B. Liver cancers (primary, metastases) 

R.L. Baron; Chicago, IL/US 

C. Prostate cancer 

J.O. Barentsz; Nijmegen/NL 

• Questions 




Moderator: H.-U. Kauczor; Heidelberg/DE 

A. Lymphoma 

M.P. Federle; Stanford, CA/US 

B. Musculoskeletal neoplasms 

M.F. Reiser; Munich/DE 

C. Chemo- and radiation 

therapy-induced toxicity 

H.-U. Kauczor; Heidelberg/DE 

• Questions 


47




Abdominal and Gastrointestinal 

Thursday, March 3, 14:00–15:30, Room A 

SS 101a Hepatocellular carcinoma: screening, 

diagnosis and management 

Moderators: L. Grazioli; Brescia/IT 

B. Guiu; Dijon/FR 

Thursday, March 3, 14:00–15:30, Room C 

SS 101b Imaging of the oesophagus 

and stomach 

Moderators: S.A. Jackson; Plymouth/UK 

A.M. Riddell; Sutton/UK 

Friday, March 4, 08:30–10:00, Room C 

RC 301 Abdominal lymphoma 

Moderator: A. Rahmouni; Creteil/FR 

A. Solid organs 

E. de Kerviler; Paris/FR 

B. Hollow abdominal viscera 

R.M. Mendelson; Perth, WA/AU 

C. Genitourinary tract involvement 



SS 401a Imaging the pancreas: 

challenges and controversies 

Moderators: R.F. Dondelinger; Liège/BE 

A.-S. Rangheard; 

Le Kremlin Bicêtre/FR 

Friday, March 4, 10:30–12:00, Room E1 

SS 401b MRI of rectal cancer 

Moderators: M. Bellomi; Milan/IT 

C. Hoeffel; Reims/FR 


SS 501a CT perfusion and dual energy CT 

in abdominal imaging 

Moderators: B. Marincek; Kilchberg/CH 

G. Petralia; Milan/IT 


SS 501b CT colonography: 17 years on 

Moderators: S. Gryspeerdt; Roeselare/BE 

M.M. Morrin; Dublin/IE 


RC 701 Tumour evaluation: 

beyond morphology 

 

 


O. Lucidarme; Paris/FR 

A. US and CEUS 

M. Claudon; Vandoeuvre-les-Nancy/FR 

B. CT and MRI perfusion 

F. Berger; Munich/DE 

C. MR diffusion and PET/CT 

C. Della Pina; Pisa/IT 


How can you easily implement some 

functional imaging into your practice 


SS 801a Imaging evaluation of liver fat, 

iron and fibrosis 

Moderators: J.M. Alústiza; San Sebastián/ES 

M.A. Bali; Brussels/BE 


SS 801b Imaging evaluation of abdominal 

tumours response to therapy 

Moderators: D.J. Breen; Southampton/UK 

A. Siemianowicz; Piekary Slaskie/PL 


SS 801c Small bowel: assessment of 

function and inflammation 

Moderators: D.D.T. Maglinte; Indianapolis, IN/US 

G. Masselli; Rome/IT 


RC 1101 Inflammatory bowel disease: 

which test and when 


Z. Tarján; Budapest/HU 

A. Role of US in diagnosis and follow-up 

V. Válek; Brno/CZ 

B. Role of CT in diagnosis and follow-up 

S. Romano; Naples/IT 

C. CT versus MRI, M.A. Patak; Zurich/CH 


Five good reasons for the radiologist 

to be at the forefront 

48





Sunday, March 6, 10:30–12:00, Room A 

SS 1201a Diffusion-weighted MRI: 

advances and applications 


RC 1501 Rectal cancer imaging: 

all you need to know 

Moderators: S. Gourtsoyianni; Iraklion/GR 

B.J. Op de Beeck; Antwerp/BE 


SS 1201b Colon and rectum: 

a multimodality perspective 

Moderators: E. Fraile Moreno; Madrid/ES 

F. Iafrate; Rome/IT 


RC 1301 Abdominal MRI: 

protocols that work 

 

 


G. Brown; Sutton/UK 

A. Staging with US and CT 

A. Maier; Vienna/AT 

B. Staging with MRI 

L.C.O. Blomqvist; Stockholm/SE 

C. Monitoring therapy and detection of 

local recurrence 

R.G.H. Beets-Tan; Maastricht/NL 


What are the clinicians really expecting 

from us: the main questions/answers 

Moderator: S.D. Yarmenitis; Iraklion/GR 

A. Liver 

W. Schima; Vienna/AT 

B. Small bowel and colon 

N. Papanikolaou; Iraklion/GR 

C. Pancreas and bile ducts 

C. Matos; Brussels/BE 


RC 1401 CT colonography: the big picture 

Moderator: S.A. Taylor; London/UK 

A. Optimised techniques for best results 

D. Regge; Turin/IT 

B. Guide to interpretation and 

generating a useful report 

T. Mang; Vienna/AT 

C. Dose, risk and relevance in 

a screening population 

A. Graser; Munich/DE 


SS 1601a Advances in MRI and US in 

abdominal imaging 

Moderators: S. Bohata; Brno/CZ 

E. Danse; Brussels/BE 


SS 1601b Imaging of non-neoplastic 

conditions of the GI tract 

Moderators: M.M. Maher; Cork/IE 

D.J.M. Tolan; Leeds/UK 

Monday, March 7, 14:00–15:30, Room N/O 

SS 1701 Liver MRI approaches 

function and structure 

Moderators: V. Maniatis; Athens/GR 

A. Mishra; Tripoli/LY 


RC 1801 Peritoneum and mesentery 

Moderator: F.-T. Fork: Malmö/SE 

A. Primary solid peritoneal and 

mesenteric tumours 


B. Imaging of cystic mesenteric or 

omental masses 

C. Stoupis; Maennedorf/CH 

C. Patterns of peritoneal carcinomatosis 

P.K. Prassopoulos; Alexandroupolis/GR 

49




Breast 


SS 102 Ultrasonography: new developments 

Moderators: G.I. Kirova; Sofia/BG 

F. Pediconi; Rome/IT 


RC 202 Breast US 

 

 

 

Moderator: E. Azavedo; Stockholm/SE 

A. The role of US in screening, diagnosis 

and staging of breast cancer 

J. Camps Herrero; Valencia/ES 

B. The role of US in premalignant and 

benign lesions 

I. Günhan-Bilgen; Izmir/TR 

C. New technologies in US 

R. Salvador; Barcelona/ES 


SS 402 Mammography: 

from screening to digital technology 

Moderators: F. Diekmann; Berlin/DE 

G. Forrai; Budapest/HU 


SS 502 Magnetic resonance imaging 

Moderators: C. de Bazelaire; Paris/FR 

A. Oktay; Izmir/TR 


RC 602 Breast MRI today 

 

 

 

 


W.A. Kaiser; Jena/DE 

A. How to perform and interpret 

high quality breast MRI 

C.S. Balleyguier; Villejuif/FR 

B. Evidence-based controversies 


C. How to improve the specificity of 

breast MRI 

J. Veltman; Nijmegen/NL 


Do we find too many cancers with MRI 


RC 1102 Interventional: 

from diagnosis to treatment 

 

 

 

Moderator: G. Acunas; Istanbul/TR 

A. Practical tips for a successful needle 

biopsy procedure 

M.T.G. Gaskarth; Cambridge/UK 

B. Underestimation of disease in needle biopsies 

I. Schreer; Kiel/DE 

C. New developments: 

therapeutic interventional procedures 

B.D. Fornage; Houston, TX/US 


SS 1202 Magnetic resonance imaging 

Moderators: U. Bick; Berlin/DE 

E. Taheri; Tehran/IR 


RC 1302 Update in BI-RADS 

 

 

 

Moderator: G. Forrai; Budapest/HU 

A. Mammography – E. Aribal; Istanbul/TR 

B. US – G. Rizzatto; Gorizia/IT 

C. MRI – C.K. Kuhl; Aachen/DE 


RC 1402 Evaluation of the treated breast 

and follow-up 

 

 

 

 

 


A. Tardivon; Paris/FR 

A. Evaluation of residual disease after 

excisional biopsy 

C. Boetes; Maastricht/NL 

B. Evaluation of response to neoadjuvant 

chemotherapy 

P.A.T. Baltzer; Jena/DE 

C. Surveillance for and detection of 

recurrent disease after therapy 

F.J. Gilbert; Aberdeen/UK 

• Panel discussion: The new challenge in 

breast cancer: evaluation of response 


SS 1602 Biomarkers in breast MRI 

Moderators: S.H. Heywang-Köbrunner; Munich/DE 

C.C. Riedl; Vienna/AT 


SS 1702 Current problems in breast imaging 

Moderators: E. Belloni; Piacenza/IT 

A. Kanakas; Nicosia/CY 

50




Cardiac 

Thursday, March 3, 14:00–15:30, Room I/K 

SS 103 MR imaging of coronary 

artery disease 

Moderators: M. Gardarsdottir; Reykjavik/IS 

A. Stadler; Vienna/AT 

Thursday, March 3, 16:00–17:30, Room I/K 

RC 203 Cardiac imaging: what’s up Doc 

Moderator: C. Peebles; Southampton/UK 

A. 3T cardiac imaging: twice as good 

M. Gutberlet; Leipzig/DE 

B. Cardiac CT: how low can dose go 

S. Leschka; St. Gallen/CH 

C. Cardiac post-processing: latest tricks 

B.J. Wintersperger; Toronto, ON/CA 

Friday, March 4, 08:30–10:00, Room I/K 

RC 303 Systematic approach to 

congenital heart disease (CHD) 

Moderator: A.P. Parkar; Bergen/NO 

A. Vascular rings and other congenital 

vascular things 

A.J.B.S Madureira; Porto/PT 

B. MRI: getting more specific 

A.M. Taylor; London/UK 

C. MDCT: the expanding role 

A. Küttner; Frankfurt a. Main/DE 


SS 403a Cardiac MR: 

myocardiopathies and more 

Moderators: A. Carneiro; Porto/PT 

L. Natale; Rome/IT 

Friday, March 4, 10:30–12:00, Room P 

SS 403b Coronary CT angiography 

Moderators: H. Alkadhi; Zurich/CH 

E. Konen; Tel Hashomer/IL 


SS 503 Coronary CT: 

economic impact and dose issues 

Moderators: D. Fleischmann; Stanford, CA/US 

D. Piotrowska-Kownacka; Warsaw/PL 


SS 1203 Atherosclerosis imaging 

Moderators: F. Knollmann; Pittsburgh, PA/US 

E. Mershina; Moscow/RU 

Sunday, March 6, 16:00–17:30, Room I/K 

RC 1403 MRI and CT before cardiac 

interventions or surgery 

 


G.P. Krestin; Rotterdam/NL 

A. Can CT predict the outcome of 

percutaneous intervention 

C. Loewe; Vienna/AT 

B. Can MRI predict the outcome of 

coronary revascularisation 

M. Francone; Rome/IT 

C. The value of CT before percutaneous 

aortic valve replacement 

R. Salgado; Antwerp/BE 


Improve your interaction with 

your colleagues 

Monday, March 7, 08:30–10:00, Room I/K 

RC 1503 Imaging advanced stages of 

ischaemic heart disease 

Moderator: J.-N. Dacher; Rouen/FR 

A. CT: angiography, function and perfusion 

G. Feuchtner; Innsbruck/AT 

B. MR perfusion imaging: 

how much quantification do we need 


C. Imaging patients after bypass surgery 

K.-F. Kreitner; Mainz/DE 


SS 1603 Emerging techniques and applications 

Moderators: G. Hadjidekov; Sofia/BG 

P.K. Vanhoenacker; Aalst/BE 


SS 1703 Valvular and congenital heart disease 

Moderators: G. Bastarrika; Pamplona/ES 

G.K. Schneider; Homburg a.d. 

Saar/DE 


SS 803 Cardiac stress imaging 

and functional analysis 

Moderators: S. Katsilouli; Athens/GR 

F. Pugliese; London/UK 

51




Chest 


SS 104 Lung cancer imaging 

Moderators: A. Devaraj; Cambridge/UK 

J.D. Dodd; Dublin/IE 


SS 404 Pulmonary nodules: 

detection and characterisation 

Moderators: E. Rizzo; Genolier/CH 

M. Scaglione; Castel Volturno/IT 


SS 504 Diffuse lung disease 

Moderators: D. Hahn; Würzburg/DE 

N. Sverzellati; Parma/IT 


RC 604 Bedside chest imaging 

Moderator: H. Prosch; Vienna/AT 

A. Bedside chest radiography: technical 

aspects and correct interpretation 

E. Eisenhuber; Vienna/AT 

B. Bedside thoracic ultrasonography: 

how far can it go 

K. Vidmar Kocijancic; Ljubljana/SI 

C. Radiologic-guided bedside interventions 

of the thorax 

F. Gleeson; Oxford/UK 

Saturday, March 5, 08:30–10:00, Room I/K 

RC 704 Non-small cell lung cancer 

Moderator: J. Vilar; Valencia/ES 

A. Update in TNM classification 

S. Diederich; Düsseldorf/DE 

B. PET/CT in lung cancer 

N. Howarth; Chêne-Bougeries/CH 

C. Radiofrequency ablation of NSCLC: 

current status 

F. Deschamps; Villejuif/FR 


SS 804 Pulmonary embolism and beyond 

Moderators: D. Musset; Clamart/FR 

G. Staskiewicz; Lublin/PL 


RC 1004 Diffuse lung diseases: 

what the radiologist should know 

 



A. The glossary of terms for thoracic 

imaging: old and new definitions 

J.A. Verschakelen; Leuven/BE 

B. From pattern recognition to disease 

diagnosis: a practical approach (part 1) 

M.-L. Storto; Chieti/IT 

C. From pattern recognition to disease 

diagnosis: a practical approach (part 2) 

T. Franquet; Barcelona/ES 


how do we report CT of the chest 


RC 1104 CT angiography of the chest 

beyond aorta 

Moderator: C. Engelke; Göttingen/DE 

A. CT angiography for PE diagnosis during 

pregnancy and post-partum 

M.-P. Revel; Paris/FR 

B. CT angiography of large vessel vasculitis 

A.A. Bankier; Boston, MA/US 

C. CT angiography for severe haemoptysis 

A.R. Larici; Rome/IT 


RC 1304 When CT sees both the heart and 

the lungs 


L. Bonomo; Rome/IT 

A. Anatomic cardiac details that every 

radiologist should know 

S.P.G. Padley; London/UK 

B. Incidental findings and their 

clinical relevance 

A. de Roos; Leiden/NL 

C. Pulmonary hypertension and 

right ventricle function 

M. Rémy-Jardin; Lille/FR 


Ready for routine reporting of cardiovascular 

findings on CT scans of the chest 

52




Chest 


SS 1604 Pulmonary infection 

and cystic fibrosis 

Moderators: I. Hartmann; Rotterdam/NL 

G.H. Mostbeck; Vienna/AT 


SS 1704 CT angiography of the chest: 

dual energy and beyond 

Moderators: N. Tacelli; Lille/FR 

E.J.R. van Beek; Edinburgh/UK 


RC 1804 The new faces of pulmonary 

infection 

Moderator: B. Feragalli; Chieti/IT 

A. Aspergillosis in the 

immunocompromised patient 

S.J. Copley; London/UK 

B. The changing patterns of 

pulmonary tuberculosis 

W.F.M. De Wever; Leuven/BE 

C. Emerging viral infections 


53




Computer Applications 

Thursday, March 3, 14:00–15:30, Room Q 

SS 105 CAD, image analysis 

Moderators: P. Badura; Gliwice/PL 

P. Mildenberger; Mainz/DE 

Thursday, March 3, 16:00–17:30, Room Q 

RC 205 Computer-aided detection/diagnosis 


E. Pietka; Gliwice/PL 

A. The role of CAD in modern-day imaging 

A. Todd-Pokropek; London/UK 

B. Emergence of open-source software 

O. Ratib; Geneva/CH 

C. CAD in oncology: from principles to 

clinical implementation 

E. Neri; Pisa/IT 


The take-home points 


SS 1605 Image analysis in oncology 

Moderators: M. Onu; Bucharest/RO 

J. Reponen; Raahe/FI 

Monday, March 7, 14:00–15:30, Room Q 

SS 1705 Managing patient dose, 

quality assurance 

Moderators: E. Bellon; Leuven/BE 

J. Fernandez-Bayó; Sabadell/ES 


RC 1805 Image sharing 

 



A. Image data beyond radiology: 

new techniques 

E.R. Ranschaert; ’s-Hertogenbosch/NL 

B. Intraoperative imaging for surgeons 

A. Pietrabissa; Pisa/IT 

C. Images and models for CAS 

H.U. Lemke; Berlin/DE 


The take-home points 

54




Molecular Imaging and Contrast Media 

Thursday, March 3, 14:00–15:30, Room N/O 

SS 106 PET CT as a tool for 

molecular imaging 

Moderators: A. Hauser; Bruderholz/CH 

M. Schwaiger; Munich/DE 


RC 306 Contrast media: 

always as safe as we wish 


S.K. Morcos; Sheffield/UK 

A. Iodinated CM: whether CIN is a SIN, 

and how to avoid it 

R.W.F. Geenen; Alkmaar/NL 

B. MR contrast agents: rumble in the jungle 

G. Heinz-Peer; Vienna/AT 

C. PET tracers: established tracers and 

those on the horizon 

F.C. Gärtner; Munich/DE 


What specific precautions are mandatory 

in order to guarantee contrast media safety 

to patients and healthcare professionals 

Friday, March 4, 10:30–12:00, Room N/O 

SS 406 Breaking news on MR contrast 

media: from cell specificity to 

clinical safety 

Moderators: T. Allkemper; Münster/DE 

A. Giovagnoni; Ancona/IT 


RC 606 Clinical potential of 

molecular imaging: 

between dream and reality 

Moderator: G. Frija; Paris/FR 

A. Molecular imaging from bench to bedside 

F.M.A. Kiessling; Aachen/DE 

B. Cardiovascular disease 

L. Hofstra; Utrecht/NL 

C. Oncology 

M.G. Pomper; Baltimore, MD/US 


SS 1206 MRI as a tool for 

molecular imaging 

Moderators: A. Rahmouni; Creteil/FR 

W. Semmler; Heidelberg/DE 


SS 1606 Contrast media: 

clinical evidence, news and facts 

Moderators: T. Leiner; Utrecht/NL 

B. Tombach; Osnabrück/DE 


SS 1706 Fancy new stuff in experimental 

and clinical molecular imaging 

Moderators: C.D. Claussen; Tübingen/DE 

M.G. Pomper; Baltimore, MD/US 

55




Genitourinary 


SS 107 Gynaecologic masses 

Moderators: C.D. Alt; Heidelberg/DE 

K. Kinkel; Chêne-Bougeries/CH 


RC 307 Gynaecologic emergency and 

its mimics 

Moderator: K. Kinkel; Chêne-Bougeries/CH 

A. Imaging of emergencies in pregnancy 

G. Masselli; Rome/IT 

B. Emergencies of gynaecologic origin 

A.G. Rockall; London/UK 

C. Emergencies of non-gynaecologic origin 



SS 507 Prostate cancer 

Moderators: U.G. Mueller-Lisse; Munich/DE 

M. Secil; Izmir/TR 


RC 707 CTU and MRU: 

urinary tract imaging 

Moderator: R. Manfredi; Verona/IT 

A. CTU/MRU in acute obstruction 

T. Meindl; Munich/DE 

B. Chronic/intermittent obstruction 

M.-F. Bellin; Le Kremlin-Bicêtre/FR 

C. Tumours: CTU/MRU 

N.C. Cowan; Oxford/UK 


RC 1007 Imaging of the scrotum and penis 

Moderator: S.S. Ozbek; Izmir/TR 

A. Acute scrotum 


B. Scrotal tumours 

L.E. Derchi; Genoa/IT 

C. Imaging of the penis 

M. Bertolotto; Trieste/IT 


SS 1207 Renal MRI 

Moderators: O. Buckley; Dublin/IE 

S. Moussa; Edinburgh/UK 


RC 1307 Kidney: imaging and intervention 

Moderator: M.N. Özmen; Ankara/TR 

A. Angiomyolipoma: a review 

N. Grenier; Bordeaux/FR 

B. The (not so) rare malignant tumours of 

the kidney 

P. Hallscheidt; Heidelberg/DE 

C. Radiofrequency and cryotherapy of 

renal tumours: techniques, results 

and complications 

J.-M. Correas; Paris/FR 


RC 1407 MRI in prostate cancer 

 

 


J. Venancio; Lisbon/PT 

A. MRI in detection of prostatic cancer 

F. Cornud; Paris/FR 

B. MRI in the post-treatment follow-up 

A.T. Turgut; Ankara/TR 

C. New frontiers in imaging of the prostate 

J.O. Barentsz; Nijmegen/NL 


What is the most appropriate 

radiological approach in patients 

with rising PSA levels, and when 


SS 1607 Male lower urinary tract 

Moderators: D. Beyersdorff; Berlin/DE 

O. Nikolic; Novi Sad/RS 


SS 1707 Recent advances in GU 

Moderators: G. Ivanac; Zagreb/HR 

R.H. Oyen; Leuven/BE 

56




Head and Neck 

Thursday, March 3, 14:00–15:30, Room G/H 

SS 108 Ear, eye and paranasal sinuses 

Moderators: N. Dfouni; Geneva/CH 

K. Zelenak; Martin/SK 

Thursday, March 3, 16:00–17:30, Room N/O 

RC 208 An insight into middle ear 

pathologies 

Moderator: T.J. Vogl; Frankfurt a. Main/DE 

A. Normal anatomy and congenital 

malformations of the middle ear 

C. Czerny; Vienna/AT 

B. Cholesteatoma and chronic infection 

F. Veillon; Strasbourg/FR 

C. Implants and postoperative findings in 

the middle ear 

B. Verbist; Leiden and Nijmegen/NL 


SS 408 Challenges in head and neck cancer 

Moderators: M.I. Furmanek; Warsaw/PL 

H.C. Thoeny; Berne/CH 


RC 1508 Common pains 

in the head and neck 

Moderator: K. Hrabák; Budapest/HU 

A. Salivary colic 

T. Beale; London/UK 

B. Trigeminal neuralgia 

B.F. Schuknecht; Zurich/CH 

C. Painful swallowing 

M. Becker; Geneva/CH 

Monday, March 7, 14:00–15:30, Room G/H 

SS 1708 Insights into thyroid and 

parathyroid pathologies 

Moderators: L. Grzycka-Kowalczyk; Lublin/PL 

J. Olliff; Birmingham/UK 


RC 1808 Management of the 

post-treatment head and neck: 

a diagnostic dilemma 

Saturday, March 5, 08:30–10:00, Room N/O 

RC 708 Suprahyoid neck 

Moderator: D. Pereira Coutinho; Lisbon/PT 

A. Anatomy-guided differential diagnoses 

C.R. Habermann; Hamburg/DE 

B. Suprahyoid neck lesions in daily clinical 

practice 

V. Chong; Singapore/SG 

C. Tips and tricks for suprahyoid neck lesions 

A. Trojanowska; Lublin/PL 


RC 1008 Runny and stuffy noses: 

paranasal sinus imaging 

 

 


R. Maroldi; Brescia/IT 

A. Expected changes after treatment 

R. Hermans; Leuven/BE 

B. Surveillance imaging, tumour recurrence 

and treatment complications 

A.D. King; Hong Kong/CN 

C. Predicting outcome after radiation 

therapy in head and neck cancer: 

what is evidence-based 

R. Maroldi; Brescia/IT 


Recurrence, inflammation, necrosis or 

scar: is imaging useful 


M.G. Mack; Frankfurt a. Main/DE 

A. Functional anatomy and 

anatomic variants 

S. Robinson; Vienna/AT 

B. Sinusitis: imaging findings before 

and after treatment 

D. Farina; Brescia/IT 

C. Sinonasal tumours 

H.B. Eggesbø; Oslo/NO 


Diagnostic considerations in runny 

and stuffy noses 

57




Interventional Radiology 


SS 109 Interventional oncology 

Moderators: L. Crocetti; Pisa/IT 

S.K. Venkatesh; Singapore/SG 


RC 209 The trauma patient 

 

 

 

 

 


A. Nicholson; Leeds/UK 

A. Imaging modalities and logistics 

J. Ferda; Plzen/CZ 

B. Management of arterial trauma 

M. Katoh; Homburg/DE 

C. Solid organ trauma 

J. Cazejust; Paris/FR 


Do we need IR in the ER 


SS 409 Chemoembolisation of 

liver tumours 

Moderators: N. Fotiadis; London/UK 

J. Tacke; Passau/DE 


SS 509 US, MR and CT guided 

interventions 

Moderators: G. Goh; London/UK 

R.W. Günther; Aachen/DE 


RC 609 RF ablation beyond the liver 

 

 

 

Moderator: A. Adam; London/UK 

A. RF ablation in bone 

A.D. Kelekis; Athens/GR 

B. RF ablation in the kidney 

M.A. Farrell; Waterford/IE 

C. RF ablation in the chest 

I. Bargellini; Pisa/IT 


RC 1109 Venous intervention 

 

 

 

Moderator: L. Lonn; Copenhagen/DK 

A. DVT and prevention of 

pulmonary emboli 

C. Binkert; Winterthur/CH 

B. Endovascular treatment of varicose veins 

D.J. West; Stoke-on-Trent/UK 

C. Central venous occlusions 

C. Hohl; Siegburg/DE 


SS 1209 Musculoskeletal intervention 

Moderators: X. Buy; Strasbourg/FR 

T. Sikdar; Harlow/UK 


RC 1309 Infection and percutaneous 

drainage 

 

 

 

Moderator: M. Bezzi; Rome/IT 

A. Empyema 

A. Keeling; Dublin/IE 

B. Abdominal abscess 

V. Válek; Brno/CZ 

C. Pelvic abscess 

M.A. Funovics; Vienna/AT 


RC 1409 Oncologic interventions 

in the liver 

 

 

 

Moderator: M. Glynos; Athens/GR 

A. RF ablation 


B. Portal embolisation 

O.M. van Delden; Amsterdam/NL 

C. Future directions 

J. Kettenbach; Berne/CH 


SS 809 Peripheral vascular intervention 

Moderators: M. Cerna; Olomouc/CZ 

G.N. Papageorgiou; Athens/GR 

58






RC 1509 Musculoskeletal interventions 

 

 


A. Gangi; Strasbourg/FR 

A. Guidelines for spinal infiltrations and 

nerve blocks 

S. Masala; Rome/IT 

B. Vertebroplasty and kyphoplasty 

T. Sabharwal; London/UK 

C. Interventional management of painful 

osseous metastases 

A.G. Ryan; Waterford City/IE 


Experience-based vs evidence-based 

practice in spinal intervention 


SS 1609 Aorta, vein and lymphatic 

interventions 

Moderators: S. Müller-Hülsbeck; Flensburg/DE 

J. Raupach; Hradec Kralove/CZ 


SS 1709 Genitourinary and 

gastrointestinal interventions 

Moderators: S.A. Thurnher; Vienna/AT 

M.A.A.J. van den Bosch; Utrecht/NL 

59




Musculoskeletal 


SS 110 Tumours, bone marrow and 

whole body 

Moderators: M. Adriaensen; Heerlen/NL 

J.F.M. Meaney; Dublin/IE 


SS 410 Cartilage and bone imaging 

Moderators: G. Andreisek; Zurich/CH 

A. Blum; Nancy/FR 

Friday, March 4, 14:00–15:30, Room B 

SS 510 Spine 

Moderators: M.P. Aparisi Gomez; Valencia/ES 

V.N. Cassar-Pullicino; Oswestry/UK 


RC 610 Metabolic bone diseases 

Moderator: J. Freyschmidt; Bremen/DE 

A. Metabolic bone disease for the 

practicing radiologist 

M. Sundaram; Cleveland, OH/US 

B. Latest advance in osteoporosis 

C.R. Krestan; Vienna/AT 

C. Rickets, osteomalacia, hyperparathyroidism 

and renal osteodystrophy 

J.E. Adams; Manchester/UK 


RC 710 Bone marrow oedema and bone 

marrow oedema-like lesions 

 


B. Vande Berg; Brussels/BE 

A. BME and osteoarthritis 

F.W. Roemer; Augsburg/DE 

B. BME and early inflammatory disease 

A.J. Grainger; Leeds/UK 

C. BME and trauma 

O. Hauger; Bordeaux/FR 


Can we still use the term BME 

or should we be more specific 


SS 810 Hip and ankle 

Moderators: A. Feydy; Paris/FR 

V. Zubler; Zurich/CH 


RC 1010 Hip through the ages 

Moderator: E.C. Kavanagh; Dublin/IE 

A. The paediatric hip 

D.J. Wilson; Oxford/UK 

B. The hip in the young athlete 

C.W.A. Pfirrmann; Zurich/CH 

C. The ageing hip 

A.H. Karantanas; Iraklion/GR 


RC 1110 Sports injuries: US or MRI 

 

 


G.M. Allen; Oxford/UK 

A. Muscle and US 

C. Martinoli; Genoa/IT 

B. Tendon and US 

A. Klauser; Innsbruck/AT 

C. Muscle and tendon by MRI 

U. Aydingoz; Ankara/TR 

• Panel Discussion: 

What is the best imaging modality for 

diagnosing sports injuries 


SS 1210 Shoulder and wrist 

Moderators: I.W. McCall; Oswestry/UK 

S.P. Morozov; Moscow/RU 


RC 1310 Postoperative imaging of the 

lower extremity 

Moderator: F. Aparisi; Valencia/ES 

A. Hip 

S.J. Eustace; Dublin/IE 

B. Knee 

K. Verstraete; Gent/BE 

C. Ankle 

C. Masciocchi; L’Aquila/IT 

60






SS 1610 Inflammation and infection 

Moderators: G. Mantzikopoulos; Athens/GR 

M.C. Wick; Innsbruck/AT 


SS 1710a Musculoskeletal intervention 

Moderators: J. Martel; Alcorcón/ES 

C. van Rijswijk; Leiden/NL 


SS 1710b Imaging the knee 

Moderators: A. Platkajis; Riga/LV 

R.M. Rodrigo; Bilbao/ES 


RC 1810 Bone tumours 

 

 


J.L. Bloem; Leiden/NL 

A. Diagnosis: from radiographs to MRI 

K. Wörtler; Munich/DE 

B. Staging and intervention 

S. James; Birmingham/UK 

C. New techniques (including DWI) 

S. Pans; Leuven/BE 


What is the clinical impact of advanced 

imaging, and when should what kind of 

advanced/sophisticated imaging be used 

61

Insights into Imaging 

Education and strategies in European radiology 

Learn to see things differently 

The ESR’s new bi-monthly journal offers a whole new perspective on European 

radiology, uncovering trends, revealing policy statements and taking a deeper look 

into the issues that surround radiological practice. For a real insight into the world 

of imaging, visit www.i3-journal.org




Neuro 

Thursday, March 3, 14:00–15:30, Room L/M 

SS 111 Brain tumours: 

grading, treatment and follow-up 

Moderators: D. Goldsher; Haifa/IL 

A. Levinsson; Malmö/SE 

Thursday, March 3, 16:00–17:30, Room G/H 

RC 211 Introduction to the brain 

 

 

 

Moderator: T. Stosic-Opincal; Belgrade/RS 

A. Brain anatomy made easy 

T.A. Yousry; London/UK 

B. Pattern recognition and normal 

variants to know 

M.M. Thurnher; Vienna/AT 

C. Clinical symptoms correlated 

to brain anatomy 

M. Smits; Rotterdam/NL 


SS 411 Brain tumours: 

detection and characterisation 

Moderators: P. Demaerel; Leuven/BE 

P. Zamecnik; Heidelberg/DE 


SS 511a Imaging in stroke 

Moderators: J. Fiehler; Hamburg/DE 

J. Frühwald-Pallamar; Vienna/AT 


SS 511b Neurovascular diseases 

Moderators: I.Q. Grunwald; Oxford/UK 

A. van der Lugt; Rotterdam/NL 


SS 811 Neurovascular intervention 

planning and follow-up 

Moderators: S.J. Bakke; Oslo/NO 

S. Puchner; Vienna/AT 

Saturday, March 5, 16:00–17:30, Room G/H 

RC 1011 Common disorders of the 

paediatric brain 

 

 

Moderator: O. Flodmark; Stockholm/SE 

A. Foetal MR imaging: more than just 

T2-weighted images 

C. Hoffmann; Tel Hashomer/IL 

B. Normal findings and pitfalls in 

paediatric neuroimaging 

A. Rossi; Genoa/IT 

 

C. Neuroimaging in the acutely ill child 

E. Vázquez; Barcelona/ES 


RC 1111 Imaging stroke 

 

 

 

 

 


R. Siemund; Lund/SE 

A. Etiology and pathophysiology of stroke 

R. von Kummer; Dresden/DE 

B. Stroke imaging in the acute phase or in 

critically ill patients 


C. Intervention in stroke 

M. Leonardi; Bologna/IT 


Where do we stand in stroke therapy 

today 


SS 1211 Added value of DTI and fMRI 

in brain and spine 

Moderators: A. Bizzi; Milan/IT 

D. Seixas; Vila Nova de Gaia/PT 


RC 1311 Focal brain lesions 

 

 

 

Moderator: M. Golebiowski; Warsaw/PL 

A. Differential diagnosis of T2 

hyperintense lesions 

A. Rovira-Cañellas; Barcelona/ES 

B. Neoplasm or non-neoplasm 

Z. Rumboldt; Charleston, SC/US 

C. Adult glioma: advanced neuroimaging 

for treatment planning 

C. Calli; Izmir/TR 

63




Neuro 


RC 1411 Update on brain aneurysms 

 

• Chairman’s introduction to brain aneurysms 

S. Bracard; Nancy/FR 

 

A. Subarachnoid haemorrhage 

L. van den Hauwe; Brasschaat/BE 

 

B. CTA/MRA in aneurysm diagnosis 

Z. Merhemic; Sarajevo/BA 

C. Treatment of aneurysms 2011 

P. Vilela; Almada/PT 

 


Where do we stand in brain aneurysm 

treatment today 


RC 1511 Epilepsy 

 

 

 

 

 


B. Gómez-Ansón; Barcelona/ES 

A. Tumour as a cause of epilepsy 

M. Stajgis; Poznan/PL 

B. Non-neoplastic causes of epilepsy 

M.A. Papathanasiou; Athens/GR 

C. Multimodality epilepsy protocol 

L. Stenberg; Lund/SE 

• Panel discussion: Imaging epilepsy 


SS 1611 Imaging applications, software 

and post-processing 

Moderators: N. Bargalló; Barcelona/ES 

A. Löve; Lund/SE 


SS 1711 Paediatric neuroimaging: 

from fetus to child 

Moderators: I.M. Björkman-Burtscher; Lund/SE 

G. Morana; Genoa/IT 


RC 1811 Spinal cord 

 

 

 

Moderator: M. Muto; Naples/IT 

A. Myelitis vs myelopathy 

M. Gallucci; L’Aquila/IT 

B. Spinal intradural tumours 

J.W.M. Van Goethem; Antwerp/BE 

C. Vascular disorders of the spinal cord 

R. Nijenhuis; Maastricht/NL




Paediatric 

Saturday, March 5, 08:30–10:00, Room Q 

RC 712 Advanced brain imaging 

 

 

 

Moderator: C. Venstermans; Antwerp/BE 

A. Diffusion tensor MRI 

A. Righini; Milan/IT 

B. MR spectroscopy 

L. Astrakas; Ioannina/GR 

C. Vascular diseases: 

the role of CTA, MRA, angiography (DSA) 

N. Girard; Marseille/FR 


SS 812 Neuroradiology: pre- and 

postnatal studies 

Moderators: C. Roche; Galway/IE 

L. Tzarouchi; Ioannina/GR 

Sunday, March 6, 08:30–10:00, Room Q 

RC 1112 Abdominal emergencies in children 

 

 

 

Moderator: M. Haliloglu; Ankara/TR 

A. Non-traumatic acute abdomen 

C. Veyrac; Montpellier/FR 

B. GU emergencies in children: 

kidney, ovary, testis 

M. Riccabona; Graz/AT 

C. Abdominal trauma in children 

M.P. García-Peña; Barcelona/ES 


SS 1212 Cardiothoracic imaging 


RC 1412 Children’s bones and joints 

 

 

 

Moderator: M. Rasero; Madrid/ES 

A. Imaging findings in childhood 

osteomyelitis 

R.R. van Rijn; Amsterdam/NL 

B. Hip dysplasia: 

US techniques and recommendations 

K. Rosendahl; Bergen/NO 

C. Whole body imaging: PET/CT vs MRI 

P.D. Humphries; London/UK 


RC 1512 Chest imaging: 

what to use and when to use it 

 

 

 

Moderator: M. Raissaki; Iraklion/GR 

A. Thoracic trauma and 

foreign body inhalation 

M.L. Lobo; Lisbon/PT 

B. Infiltrative diseases of the chest 

G. Staatz; Mainz/DE 

C. MRI of the chest in children 

M.U. Puderbach; Heidelberg/DE 


SS 1612 Abdominal and malignant diseases 

Moderators: C. Balassy; Vienna/AT 

L.-S. Ording-Müller; Tromsø/NO 

Moderators: A.D. Calder; London/UK 

M.A. Lucic; Sremska Kamenica/RS 


RC 1312 Safety first 

 

 

 

Moderator: R. Fotter; Graz/AT 

A. Security and dose with conventional 

radiology 

J.-F. Chateil; Bordeaux/FR 

B. CT in children: dose reduction strategies 

R.A.J. Nievelstein; Utrecht/NL 

C. Ensuring safety for infants undergoing MRI 

T.G. Maris; Iraklion/GR 

65




Physics in Radiology 


SS 513 New CT reconstruction and 

post processing techniques 

Moderators: J. Damilakis; Iraklion/GR 

C. Leidecker; Forchheim/DE 

Saturday, March 5, 16:00–17:30, Room P 

RC 1013 Diagnostic radiology 

and pregnancy 

 

 

 

Moderators: R. Padovani; Udine/IT 

H. Ringertz; Linköping/SE 

A. Conceptus doses and risks from maternal 

diagnostic x-ray examinations 

J. Damilakis; Iraklion/GR 

B. X-ray imaging and pregnancy: 

justification and optimisation 

of exposure 

P. Vock; Berne/CH 

C. Pregnancy and MRI: 

risks to the unborn child 

J. De Wilde; Edinburgh/UK 

Sunday, March 6, 08:30–10:00, Room P 

RC 1113 High field MRI: beyond 3T 

 

 

 

Moderators: M. Tosetti; Pisa/IT 

A.J. van der Molen; Leiden/NL 

A. Challenges of high field MR 

M. Bock; Heidelberg/DE 

B. A complicated solution to a complicated 

problem: transmit array 

K.P. Pruessmann; Zurich/CH 

C. Is 7T ready for clinical use 

R.W. Bowtell; Nottingham/UK 


SS 1213 Novel techniques and 

new technologies 

Moderators: L. Struelens; Mol/BE 

A. Todd-Pokropek; London/UK 


RC 1313 Clinical audit, accreditation and 

the role of the medical physicist 

 

 

 

Moderators: W.J.M. van der Putten; Galway/IE 

M. Wucherer; Nürnberg/DE 

A. European-wide perspective on 

clinical audit 

H. Jarvinen; Helsinki/FI 

B. National perspective: 

clinical audit inspections 

S. Ebdon-Jackson; Didcot/UK 

C. Hospital perspective on clinical audit 

P. Gilligan; Dublin/IE 


RC 1413 Visualisation, perception and 

image processing 

 

 

 

Moderators: A.A. Lammertsma; Amsterdam/NL 

B.B. Wein; Aachen/DE 

A. Visualisation and perception 

A.G. Gale; Loughborough/UK 

B. Image processing and perception 

B.M. ter Haar Romeny; Eindhoven/NL 

C. Clinical application of image processing 

A. Persson; Linköping/SE 

Monday, March 7, 08:30–10:00, Room P 

RC 1513 Simulations make us understand 

x-ray imaging 

 

 

 

Moderators: K. Bacher; Gent/BE 

S. Barter; Cambridge/UK 

A. Monte Carlo simulations of x-ray tubes 

and x-ray spectra 

M. Koutalonis; London/UK 

B. Monte Carlo simulations of virtual 

patients (anthropomorphic phantoms) 

P.R. Bakic; Philadelphia, PA/US 

C. Monte Carlo simulations of x-ray 

detectors and x-ray images 

K. Smans; Leuven/BE 


SS 1613 X-ray technologies: 

assessment, QA and dosimetry 

Moderators: R. Grimmer; Erlangen/DE 

U. Zdesar; Ljubljana/SI 


SS 1713 Technical validation of the new 

opportunities in CT imaging 

66 

Moderators: J. Geleijns; Leiden/NL 

W. Stiller; Heidelberg/DE




Radiographers 

Saturday, March 5, 08:30–10:00, Room L/M 

RC 714 Radiography as a profession 

and a science 

 

 

Moderators: N. Kinsman; Poole/UK 

C. van Kuijk; Amsterdam/NL 

A. Cultural competence in the practice of 

radiography: international implications 

N.N. 

B. Basic technique for image interpretation 

C. Patrick; Poole/UK 


SS 814 Improving productivity and quality: 

the radiographer‘s area of responsibility 

Moderators: B. Bjorkman; Huskvarna/SE 

D. Tscholakoff; Vienna/AT 


RC 1014 Radiography as an 

ethical practice 

 

 

 

Moderators: B.T. Andersson; Lund/SE 

A.L. Baert; Kessel-Lo/BE 

A. The relationship between man and 

technology in radiographic practice: 

a narrative approach 

B.R. Mussmann; Odense/DK 

B. Ethical codes across Europe 

D.S. Oreti; Monfalcone/IT 

C. Ethical problems in diagnostic radiology 

in terms of radiation protection 

K. Paalimäki-Paakki; Oulu/FI 

Sunday, March 6, 08:30–10:00, Room L/M 

RC 1114 Radiation protection and optimisation 

of radiological procedures 


SS 1214 The radiographer‘s role in 

optimising radiation exposure 

Moderators: M. Maas; Amsterdam/NL 

G. Paulo; Coimbra/PT 


RC 1314 Radiotherapy and integration with 

a diagnostic-therapeutic path 

 

 

 

Moderators: S. Geers-van Gemeren; Utrecht/NL 

C. Hohl; Siegburg/DE 

A. Electronic portal imaging used for 

development and improvements in 

radiation therapy for prostate cancer 

A. Thorolfsdottir; Reykjavik/IS 

B. Image-guided radiation therapy: 

when imaging meets therapy 

A. Sarchosoglou; Athens/GR 

C. Bridges between radiotherapy and radiography 

from a European perspective 

K. Sjövall; Lund/SE 


RC 1414 Radiography in the 

operating theatre 

 

 

Moderators: R. Passariello; Rome/IT 

A. Yule; Cardiff/UK 

A. Cone-beam CT imaging in the operating 

room during endovascular aortic repair 

(EVAR) 

K.R. Eide; Trondheim/NO 

B. Key radiographic skills in the 

operating theatre 

K.G. Holmes; Lancaster/UK 

 

 

 

Moderators: K. Åhlström Riklund; Umea/SE 

D. Katsifarakis; Athens/GR 

A. Diagnostic quality and patient dose 

management in digital radiography systems 

L.J.O.C. Lanca; Lisbon/PT 

B. The radiographer’s position in the initial 

optimisation procedure 

D. Pekarovic; Ljubljana/SI 

C. Radiation dose optimisation and the 

radiographer’s role 

A. Henner; Oulu/FI 

67




Vascular 


SS 115 Aorta 

Moderators: E. Bruguiere; Paris/FR 

T. Pfammatter; Zurich/CH 

Thursday, March 3, 16:00–17:30, Room P 

RC 215 Extracranial vascular 

malformations: imaging strategies 

prior to endovascular therapy 

 

 

 

 

 


J.E. Jackson; London/UK 

A. Pathology, correct anatomical 

classification and clinical work-up 

H. Kubiena; Vienna/AT 

B. Imaging of capillary, venous, 

lymphovenous and arteriovenous 

malformations 

L. Schultze Kool; Nijmegen/NL 

C. Technical aspects of endovascular 

treatment 

P.C. Rowlands; Liverpool/UK 


Who should decide management 


SS 415 Neurovascular disorders 

Moderators: G. Markose; London/UK 

L.N. Tanenbaum; New York, NY/US 


SS 515 Peripheral arteries 

Moderators: F. Fanelli; Rome/IT 

V. Sarajlic; Sarajevo/BA 


RC 615 Non-traumatic acute aortic dissection 

and malperfusion syndromes 


RC 715 Vascular imaging: diabetes and 

vascular occlusive disease 

 

 

 

Moderator: M. Sapoval; Paris/FR 

A. Metabolic syndrome, diabetes and 

vascular disease: what do we need 

to know 

E. Minar; Vienna/AT 

B. Imaging strategies in the diabetic 

foot syndrome 

R. Iezzi; Rome/IT 

C. Imaging prior to revascularisation: 

CTA, MRA or DSA 

S.O. Schönberg; Mannheim/DE 


SS 815 Vessel wall, plaque, diabetes 

Moderators: I.E. Chemelli-Steingruber; 

Innsbruck/AT 

A. Cieszanowski; Warsaw/PL 


SS 1615 Special applications, 

functional imaging 

Moderators: W.P.T.M. Mali; Utrecht/NL 

M. Sadick; Mannheim/DE 


RC 1815 Advances in vascular imaging 

 

 

 

Moderator: P.M.T. Pattynama; Gouda/NL 

A. Vascular imaging at 3T 

H. Hoppe; Berne/CH 

B. Dual energy CT and time resolved CT 

K. Nikolaou; Munich/DE 

C. Flat panel CT (C-arm CT) 

H. Rousseau; Toulouse/FR 

 

 

 

 

 



A. Predisposing factors for developing 

non-traumatic acute aortic dissections 

V. Bérczi; Budapest/HU 

B. Acute aortic dissections: 

detection and classification 


C. Acute aortic dissections: 

imaging of complications 

M.H.K. Hoffmann; Ulm/DE 


Which imaging modality is best for 

endovascular management 

68


EFOMP 

Workshop 

New Technology in Diagnostic Radiology: 

Advances in Breast Imaging 

Organising Committee: 

Chairman: 

Members: 

H. Bosmans; Leuven/BE 

S. Christofides; Nicosia/CY 

A. Del Guerra; Pisa/IT 

K. Faulkner; Wallsend/UK 

A. Torresin; Milan/IT 


EF 1 Advances in technology 

for breast imaging 

Moderators: S. Christofides; Nicosia/CY 


• Welcome address 

S. Christofides; Nicosia/CY 


• Breast tomosynthesis 

P.R. Bakic; Philadelphia, PA/US 

• Breast CT 

W.A. Kalender: Erlangen/DE 

• X-ray colour in breast imaging 

C. Ullberg; Danderyd/SE 


EF 2 Screening and diagnostic 

breast imaging 

Moderators: K. Faulkner; Wallsend/UK 

J.N. Vassileva; Sofia/BG 

• QA, image quality and dose in screening 

with digital mammography 


• MRI diagnostic breast imaging 

K. Gilhuijs; Utrecht/NL 

• Is there a future for radioisotope 

breast imaging 

S. Ziegler; Munich/DE 

69


E 3 – European 

Excellence in Education 

Foundation Course: Paediatric Radiology 


E³ 320b Genitourinary problems: 

common daily practice 

 

 

 

Moderator: V. Donoghue; Dublin/IE 

A. Imaging strategy in urinary infections 


B. Urinary tract dilatation: what should be 

done, to whom and when 

F.E. Avni; Brussels/BE 

C. Renal and pararenal masses: basic rules 

P. Tomà; Rome/IT 


E³ 420 Common digestive 

problems in children: 

the radiologist as a key player 

 

 

 

Moderator: A. Paterson; Belfast/UK 

A. Abdominal and pelvic pain: 

a practical approach 

S.G.F. Robben; Maastricht/NL 

B. Jaundice in children: 

common causes and imaging strategy 

D. Pariente; Le Kremlin-Bicêtre/FR 

C. Neonatal bowel obstruction: 

the role of the radiologist 

S. Ryan; Dublin/IE 


E³ 520 Thoracic diseases: 

common, important and 

potentially devastating 

 

 

 

Moderator: C.E. de Lange; Oslo/NO 

A. Investigating a child with a ‘cough’: 

a pragmatic approach 

C. Owens; London/UK 

B. Unresolving pneumonia: when and how 

to image, and clinical consequences 

K. Foster; Birmingham/UK 

C. Common cardiac disorders in children: 

the basic role of imaging 

C.J. Kellenberger; Zurich/CH 


E³ 620b Common musculoskeletal 

disorders: how to avoid the traps! 

 

 

 

Moderator: A.C. Offiah; Sheffield/UK 

A. Imaging a child with a limp 

A. Sprigg; Sheffield/UK 

B. Non-accidental injury: 

a radiologist’s nightmare 

P.K. Kleinman; Boston, MA/US 

C. Bone and joint infection and inflammation: 

pearls and pitfalls 

G.-H. Sebag; Paris/FR 


E³ 720 Paediatric neuroimaging: 

let’s make it simple! 

 

 

 

Moderator: J.F. Schneider; Basle/CH 

A. Neurosonography in the neonate: 

rules of thumb 

G. Enriquez; Barcelona/ES 

B. Common congenital cerebral abnormalities 

A. Rossi; Genoa/IT 

C. CNS infection and inflammation: 

signs you should not miss 



E³ 820 What should we know about 

antenatal imaging 

 

 

 

Moderator: C. Adamsbaum; Paris/FR 

A. Foetal imaging: current practice and 

evidence base 

C. Garel; Paris/FR 

B. Ventricular enlargement and beyond 

E.H. Whitby; Sheffield/UK 

C. Common chest and abdominal problems 

A. Darnell; Barcelona/ES 

Saturday, March 5, 12:15–13:15, 

EPOS 

Self assessment test 

 

Moderator: V. Donoghue; Dublin/IE 

Interactive computer evaluation of course 

learning 

70




Interactive Teaching Sessions 

Thursday, March 3, 14:00–15:30, Room B 

E³ 120 Commonly missed diagnosis in 

musculoskeletal conditions 

F. Kainberger; Vienna/AT 

K. Bohndorf; Augsburg/DE 

Thursday, March 3, 16:00–17:30, Room B 

E³ 220a Common radiological problems: 

incidental abdominal masses 

 

 

A. The incidental adrenal mass 

R.H. Reznek; London/UK 

B. Renal mass 

M. Prokop; Nijmegen/NL 

Thursday, March 3, 16:00–17:30, Room C 

E³ 220b Lung cancer: 

what the radiologist must report 

 

 

A. Staging 

A.R. Larici; Rome/IT 

B. Follow-up 

N. Howarth; Chêne-Bougeries/CH 


E³ 320a Thoracic infections: 


 

 

A. Pulmonary infections 

T. Franquet; Barcelona/ES 

B. Non-pulmonary chest infections 



E³ 620a Cancer of the uterus and cervix: 


B. Hamm; Berlin/DE 



E³ 1020 Infections of the central 

nervous system: 


 

 

A. ‘Dangerous’ viral and prion infections 

G. Wilms; Leuven/BE 

B. Bacterial and parasitic infections 

E.T. Tali; Ankara/TR 

Sunday, March 6, 08:30–10:00, Room B 

E³ 1120 Common radiological problems: 

palpable lower neck mass – 

thyroid or not 

 

 

A. Thyroid nodule 

H. van Overhagen; The Hague/NL 

B. Outside the thyroid 

N.J.M. Freling; Amsterdam/NL 


E³ 1220 Breast cancer: 


A. Tardivon; Paris/FR 


Sunday, March 6, 14:00–15:30, Room B 


cardiovascular 

 

 

A. Looking at the heart in chest x-rays 

J. Andreu; Barcelona/ES 

B. Looking at the heart in chest CT 

F. Laurent; Pessac/FR 

Monday, March 7, 08:30–10:00, Room B 

E³ 1520 Prostate cancer: 


A.R. Padhani; Northwood/UK 

H.-P. Schlemmer; Heidelberg/DE 


71







cognitive decline and dementia 

B. Gómez-Ansón; Barcelona/ES 

F. Barkhof; Amsterdam/NL 


E³ 1720a Common radiological problems: 

incidental chest lesions 

 

 

A. Solitary pulmonary nodule 

E. Castañer; Sabadell/ES 

B. Mediastinal mass 

J. Vilar; Valencia/ES 


E³ 1720b Colorectal cancer: 



C. Hoeffel; Reims/FR 


E³ 1820 Female pelvic infections: 




72 

= Interactive session with electronic voting/self assessment




Titel 

73


Accompanying 

Sessions 

1 st ESR/EANM Joint Pre-Congress 

Workshop on PET/CT 

Wednesday, March 2, 09:00–17:30, 

Room C 

Organisers: 

Co-Organiser: 

Welcome on behalf of the ESR 

09:00–09:15 

É. Breatnach; Dublin/IE 

É. Breatnach (ESR); Dublin/IE 

W. Langsteger (EANM); Linz/AT 

M. Beheshti (EANM); Linz/AT 

Welcome on behalf of the EANM 

09:00–09:15 

P. Bourguet; Rennes/FR 

Instrumentation and technique 

09:15–09:45 

• Radiology perspective 

T. Johnson; Munich/DE 

• Nuclear medicine perspective 

T. Beyer; Zurich/CH 

Radiation exposure 

09:45–10:15 


H.-C. Becker; Munich/DE 


S. Mueller; Essen/DE 

FDG PET 

10:15–10:30 

Head and neck including 

Cancer of Unknown Primary (CUP) 

11:00–11:45 




R. Hustinx; Liege/BE 

Lung cancer 

11:45–12:30 


F. Gleeson; Oxford/UK 


H. Steinert; Zurich/CH 

12:30–13:30 Lunch 

GI tumours 

13:30–14:15 


A. Ba-Ssalamah; Vienna/AT 


T. Hany; Zurich/CH 

Urogenital tumours 

14:15–15:00 


C. Nicolau; Barcelona/ES 


B. Krause; Munich/DE 

15:00–15:30 Break 2 

• Physiology, normal distribution and pitfalls 

A. Hertel; Fulda/DE 

10:30–11:00 Break 1 


74


Accompanying 

Sessions 

Lymphoma 

15:30–16:15 


M. O’Connell; Dublin/IE 


A. Buck; Munich/DE 

Future aspects 

16:15–16:45 

• Overview of future developments in CT 

T. Johnson; Munich/DE 

• Tracers beyond FDG in daily routine 

M. Beheshti; Linz/AT 

Concluding remarks from 

the ESR and the EANM 

16:45–17:00 

Chairs: É. Breatnach; Dublin/IE 

W. Langsteger; Linz/AT 

Test and quiz with evaluation 

17:00–17:30 

Chairs: É. Breatnach; Dublin/IE 

W. Langsteger; Linz/AT 

Registration for the workshop at 

www.myESR.org/Pre-congress_Workshop_on_PET-CT 

(fee: €100) 

75


Accompanying 

Sessions 

4 th Post Processing Face-Off Session 


Coordinators: 



After the great success in the last three years, ECR 2011 

will, for the fourth time, feature a ‘Workstation Face-Off ’ 

session. 

Continuous rapid technical advances in CT require state-ofthe-art 

post processing tools and workstations. Increasingly, 

these solutions are based on a thin client-server architecture 

which significantly speeds up loading times and workflow. 

In the 21 st century, radiologists have to be able to interpret 

3D datasets and to handle large data volumes. For numerous 

applications, dedicated post processing applications are 

available. All major vendors offer an ample variety of 

hardware and software, and it is often difficult to recognize 

the individual strengths and weaknesses of different systems. 

Our 4 th annual Post Processing Face-Off Session will allow 

you to get an impression of the 3D capabilities and large 

data volume handling provided by the latest workstation 

technology. 

Several workstations from different vendors will be set up 

on stage next to each other, and a selection of two cases 

provided by the ESR will be demonstrated by expert users. 

This year, the cases will focus on interpretation of CT 

angiographic datasets and complex oncological follow-up 

using RECIST 1.1 criteria and a volumetric approach. 

The aim of this session is to simulate a realistic ‘reading 

room’ atmosphere and to give an impression of how different 

workstations perform in a clinical scenario. We would like 

to cordially invite you to attend this exciting ‘tournament’ 

of post-processing! 

ESOR Session 


Experiencing variety in education 

Moderators: 

N. Gourtsoyiannis; Iraklion/GR 


During this session, the European School of Radiology 

(ESOR), will give an insight into the variety of its educational 

programmes and opportunities foreducation in radiology. 



• ESOR in action 


• Teach the teachers 

H. Cameron; Edinburgh/UK 

• Widening the vision of teaching in radiology 

S. Golding; Oxford/UK 

• Tutoring in radiology 


Awards 

On the occasion of the session, scholars and fellows will 

be awarded certificates for successfully completing the 

2010 Visiting Scholarship Programmes and Exchange 

Programmes for Fellowships. 

Radiology Trainees Forum 

RTF Highlighted Lectures 


Moderators: 

D. Bulja; Sarajevo/BA 

P.R. Kornaat; Leiden/NL 

• Musculoskeletal trauma in children 

I. Boric; Zagreb/HR 

• Basic principles in the interpretation of signal 

intensities on T1- and T2-weighted images 

G. Wilms; Leuven/BE 

• Plain film criteria: quality of the x-rays 



76


Accompanying 

Sessions 

EIBIR presents: IMAGINE Workshop 

Friday, March 4 to 

Sunday, March 6, Room U 

EIBIR presents this year’s IMAGINE Workshop – a new 

concept for ECR visitors. The sessions will feature research 

institutes, university groups and research departments of 

industrial companies who want to present novel and exciting 

technological developments in the field of diagnostic and 

interventional radiology. 

Focus areas of the IMAGINE Workshop are the development 

of quantitative imaging biomarkers, computeraided 

detection and diagnosis, integrated and interactive 

visualisation, therapy planning, image-guided interventions 

and robotics, and computer-assisted training. The workshop 

will feature novel technological developments in diagnosis, 

therapy planning and therapy guidance, among others. 

Learning objectives: 

1. To learn about the latest developments in quantitative 

image analysis, computer-aided diagnosis, and 

visualisation in the fields of cardiovascular imaging, 

neuro imaging, and oncology. 

2. To learn about sophisticated modelling in pre-operative 

planning and intra-operative guidance. 

Standards and Audit 

How to write better reports 

Saturday, March 5, 10:30–12:00, Room Z 

Moderator: E.J. Adam; London/UK 

• How to write a good radiological report 

L.P. Lawler; Dublin/IE 

• Structured reporting: European perspective 

R. Silverio; Grosseto/IT 

• Structured reporting: 

improving the quality of radiology reports 

C.E. Kahn; Milwaukee, WI/US 



Moderator: D. Vanel; Bologna/IT 



organised in cooperation with European Hospital 

Oral presentations 

There will be special sessions in the workshop area, giving 

applicants the opportunity to present their work. These 

sessions are also open to the public. 


08:30–10:00 

10:30–12:00 


14:00–15:30 

Workshop (guided tour) 


08:30–10:00 

10:30–12:00 


14:00–15:30 

Walk-In Session 

Saturday, March 5, 12:00-14:00, Room U 

Places will be allocated on a first-come, first-served basis. 

Submission Categories 

• Cardiovascular image analysis 

• Neuro image analysis 

• Image analysis in oncology 

• Image guided intervention 

More information and abstract submission 

(until December 31) at myESR.org/IMAGINE2011 

77

European Diploma 

in Radiology (EDiR) 

Prove your excellence! Take the ESR Diploma. 

The ESR is proud to announce the launch of the European Diploma 

in Radiology (EDiR); a brand new qualification that will provide 

General Radiologists with an objective, ESR-endorsed test of their ability. 

All parts of the examination will be held in English but non-native 

language skills will be taken into consideration by the oral examiners. 

The first examination will take place at ECR 2011, on 

Monday, March 7, in Vienna. 

Apply now at www.myESR.org/diploma!


Accompanying 

Sessions 

ENCITE Session 


Visualisation of cell therapy meets clinical application 

Moderator: G. Krestin; Rotterdam/NL 

The European Network of Cell Imaging and Tracking Expertise 

(ENCITE) is pleased to present cutting-edge developments of 

novel cell therapies pointing to clinical applications. Within 

the European community of cell imaging, this advance is of 

specific interest as, according to the recent developments, novel 

imaging tools are absolutely vital for the understanding of 

therapeutic effects to patients. Three examples of visualisation 

show promising results. 

• ENCITE – A translational approach 

for novel cell therapy applications 

S. Aime; Torino/IT 

• Visualising transplanted neural stem 

cells and tissue regeneration by MRI 

M. Modo; London/UK 

• Imaging dendritic cell vaccinations in melanoma patients 

M. Srinivas; Nijmegen/NL 

• Monitoring of SPIO labelled pancreatic 

islets in human liver by MRI 

M. Hajek; Prague/CZ 

• Discussion and exchange 

Details: www.encite.org 

EuroAIM Session 


Evidence-Based Radiology: 

Why is evidence-based radiology crucial 

Moderators: 

G. Krestin; Rotterdam/NL 


The experts from the European Network for Assessment of 

Imaging in Medicine (EuroAIM) will reply to this question. 

A special highlight will be the presentation of results of 

preliminary analysis focusing on the radiologist’s role in the 

production of secondary evidence, which is the best way to 

make impact on the whole medical world. 

• Applying EBM to radiology – The EuroAIM project 


• Secondary evidence for diagnostic imaging 

L.M. Sconfienza; Milan/IT 

• Secondary evidence for interventional radiology 

D. Vorwerk; Ingolstadt/DE 

• The ACRIN experience 

B.J. Hillmann; Charlottesville, VA/US 

Details: www.eibir.org 



Moderator: M.M. Thurnher; Vienna/AT 


79

Bracco. The Contrast Imaging Specialists. 

Solutions for Your Practice 

and Your Patients 

Don’t miss the Bracco symposia at ECR: 

Stay tuned…more to come! 

Portfolio 

Science 

Services 

www.braccoimaging.com



Practical Courses 

Image-Guided Breast Biopsy: 

How to do it 

Coordinator: 

M.H. Fuchsjäger; Vienna/AT 

Speakers: 




Instructors: 


B. Boyer; Paris/FR 

C. Dromain; Villejuif/FR 

F. Gras, Barcelona/ES 

R. Gruber; Vienna/AT 

G. Heinz-Peer; Vienna/AT 

L. Levy; Paris/FR 

M. Locatelli; Gorizia/IT 

A. Malich; Nordhausen/DE 

I. Miranda; Barcelona/ES 

L. Rotenberg; Neuilly-sur-Seine/FR 

B. Szabo; Szeged/HU 

C.F. Weismann; Salzburg/AT 

Percutaneous image-guided needle core biopsy is faster, less 

invasive and less expensive than surgical biopsy and has 

thus become the alternative for histopathology assessment 

of breast lesions. The choice of the respective image 

guidance method depends on lesion type (mass lesion, 

microcalcifications) as well as the visualisation through 

the various diagnostic imaging modalities. This practical 

course reviews indications, advantages, limitations and 

controversial issues in percutaneous image-guided biopsy 

of breast lesions under stereotactic, ultrasound and MR 

imaging guidance. 

Participants will work on phantoms not only to learn the 

device-related technical aspects of the performance but 

also how to choose the adequate guidance method, how 

to prepare the patient and percutaneous biopsy device, 

and how to adequately approach the lesion. Oncological 

as well as quality assurance aspects will be emphasised. 

The practical training courses are organised to allow time 

for each participant to perform interventions under expert 

supervision. 


1. To comprehend the indications and limitations 

of percutaneous image-guided breast biopsy. 

2. To understand how to ensure quality standards of 

breast biopsy under stereotactic, ultrasound and 

MR imaging guidance. 

3. To learn how to chose the adequate imaging 

guidance modality and prepare the patient accordingly. 

4. To be able to select the appropriate percutaneous 

biopsy device (automated large core or directional 

vacuum-assisted biopsy probe). 

5. To be able to perform breast biopsies under 

stereotactic, ultrasound and MR imaging guidance 

in accordance to international standards. 

Introductory lectures: 

• Indications, limitations and controversies 

for ultrasound-guided breast biopsy 



for stereotactic-guided breast biopsy 



for MR imaging-guided breast biopsy 


Registration: 

The number of participants for each course is restricted. 

Participants need to register in advance for the practical 

training courses (www.myESR.org) as of October 1, 2010, 

and must pay a fee of €50. Important details, including the 

schedule for the subscribed courses, are indicated on the 

confirmation/invoice. 

Attendance at the lecture session on Thursday afternoon 

is mandatory to participate in the pre-registered practical 

training courses. 

Schedule: 

Thursday, March 3 

SK 123 14:00–15:30 Introductory Lectures (Room P) 


SK 323 08:30–10:00 US guidance 

SK 423 10:30–12:00 Stereotactic guidance 

SK 523 14:00–15:30 MR imaging guidance 



SK 723 08:30–10:00 US guidance 



SK 1023 16:00–17:30 US guidance 



SK 1223 10:30–12:00 US guidance 



81

1 Tombach B, Bohndorf K, Brodtrager W, Claussen CD, Duber C, Galanski M, Grabbe E, Gortenuti G, Kuhn M, Gross-Fengels W, Hammerstingl R, Happel B, Heinz-Peer G, Jung G, Kittner T, Lagalla R, Lengsfeld P, Loose R, Oyen RH, Pavlica P, Pering C, Pozzi-Mucelli R, Persigehl T, Reimer P, Renken NS, Richter GM, Rummeny EJ, Schafer F, Szczerbo-Trojanowska M, Urbanik A, Vogl TJ, Hajek P. 

Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial. Eur Radiol 2008. 

2 Frenzel T, Lengsfeld P, Schirmer H, Hutter J, Weinmann HJ. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Invest Radiol 2008; 43(12):817-828. 

Gadovist® 1.0 mmol/mL solution for injection. Composition: 1 mL solution for injection contains 604.72 mg gadobutrol (equiv. 1.0 mmol) as active ingredient. Excipients: calcobutrol sodium, tromethamol, hydrochloric acid, water for injections. Indications: This medicinal product is for diagnostic use only. Gadovist® 1.0 is indicated in adults, adolescents, and children aged 7 years and older for: 

Contrast enhancement in cranial and spinal magnetic resonance imaging (MRI), contrast enhanced MRI of liver or kidneys in patients with high suspicion or evidence of having focal lesions to classify these lesions as benign or malignant, contrast enhancement in magnetic resonance angiography (CE-MRA). Contraindications: Hypersensitivity to the active substance or any of the excipients. 

Special warnings and precautions for use: Gadovist® 1.0 should not be used in patients with uncorrected hypokalemia. In patients with severe cardiovascular disease Gadovist® 1.0 should only be administered after careful risk benefit assessment because only limited data are available so far. Gadovist® 1.0 should be used with special care in patients with known congenital long QT syndrome or 

a family history of congenital long QT syndrome; with known previous arrhythmias after taking medicinal products that prolong cardiac repolarisation; who are currently taking a medicinal product that is known to prolong cardiac repolarisation e.g. a Class III antiarrhythmic (e.g. amiodarone, sotalol). The possibility that Gadovist® 1.0 may cause torsade de pointes arrhythmias in an individual 

patient cannot be excluded (see SPC). Since contrast medium elimination is delayed in patients with severely impaired renal function, the benefits must be weighed very carefully against the risks in such cases. In particularly severe cases, it is advisable to remove Gadovist® 1.0 from the body by extracorporeal haemodialysis: For removal of the agent from the body, at least 3 dialysis sessions within 

5 days of the injection should be performed. No impairment of renal functions has been observed during clinical trials performed on a limited number of patients. Data are too limited to exclude the possibility of renal toxicity or aggravation of renal impairment. There have been reports of nephrogenic systemic fibrosis (NSF) associated with use of some gadolinium-containing contrast agents in 

patients with severe renal impairment (GFR < 30ml/min/1.73m 2 ). As there is a possibility that NSF may occur with Gadovist® 1.0, it should only be used in these patients after careful consideration. Haemodialysis shortly after Gadovist® 1.0 administration in patients currently receiving haemodialysis may be useful at removing Gadovist® 1.0 from the body, but its potential to prevent NSF is unknown 

and should not be used as a preventative measure in other patient groups. Hypersensitivity reactions, as have been reported for other contrast media containing gadolinium, have also been observed after administration of Gadovist® 1.0. In patients with an allergic disposition the decision to use Gadovist® 1.0 must be made after particularly careful evaluation of the risk-benefit ratio. In rare cases 

delayed anaphylactoid reactions (after hours to days) have been observed. Like with other gadolinium containing contrast agents special precaution is necessary in patients with a low threshold for seizures. Undesirable effects: Following adverse reactions have been observed in clinical trials. Uncommon (≥ 1/1,000 to < 1/100): Headache, Dizziness, Paresthesia, Dysgeusia, Nausea, Vasodilatation, 

Injection site pain, Injection site reaction. Rare (≥ 1/10,000 to < 1/1,000): Parosmia, Dyspnoea, Vomiting, Urticaria, Rash, Hypotension, Anaphylactoid reaction. Following additional adverse reactions have been reported from postmarketing spontaneous reporting: Rare (≥ 1/10,000 to < 1/1,000): Cardiac arrest, Tachycardia, Loss of consciousness, Convulsion, Conjunctivitis, Eyelid oedema, Respiratory 

arrest, Bronchospasm, Cyanosis, Oropharyngeal swelling, Cough, Sneezing, Face edema, Hyperhidrosis, Pruritus, Erythema, Circulatory collapse, Flushing, Feeling hot, Malaise, Anaphylactoid shock. Additional safety information: Short-lasting mild to moderate feelings of coldness, warmth or pain at the injection site have been uncommonly observed in association with the venous puncture or 

contrast medium injection. On paravascular injection Gadovist® 1.0 may cause tissue pain lasting up to several minutes. Hypersensitivity reactions (e.g. urticaria, rash, vasodilatation) have been uncommonly reported and were mostly of mild to moderate intensity. In rare cases anaphylactoid reactions ranging to shock may occur. Delayed anaphylactoid reactions (after hours to days) have been 

observed rarely. Patients with an allergic disposition suffer more frequently than others from hypersensitivity reactions. Date of revision of text: September 2009 Please note: for current prescribing information refer to the package insert and/or contact your local Bayer Schering Pharma organisation. Bayer Schering Pharma AG, 13342 Berlin, Germany. Adverse reactions can be reported to 

GPV.CaseProcessing@bayerhealthcare.com 

EU.DI.05.2009.0093 October 2010 

Please visit our 

Lunch Symposium 


12:30 – 13:30 

Room D 1 

Chairman: 

Prof. Meng Law (US) 

The Power of Contrast 

Q Delivering high diagnostic efficacy 1 

Q Macrocyclic compound – 

class with highest stability 2



Practical Courses 

Musculoskeletal US: 

Shoulder and elbow 

Coordinator: 

E.G. McNally; Oxford/UK 

Speakers: 




P. Peetrons; Brussels/BE 

Instructors: 

N. Boutry; Lille/FR 

M. Court-Payen; Copenhagen/DK 

J. De Rooij; Nijmegen/NL 

A.J. Grainger; Leeds/UK 



P.J. O’Connor; Leeds/UK 



E. Silvestri; Genoa/IT 

J. Teh; Oxford/UK 

This programme will be in two parts. The first part will 

be a live demonstration of US anatomy and examination 

techniques for the shoulder and the elbow, coupled with a 

review of the common pathological findings in these areas. 

The demonstrators will emphasise the important anatomical 

features and provide participants with useful tips to get the 

most from US examinations in these challenging areas. This 

will be followed by small group ‘meet the experts’ practical 

training courses where participants can refine their own 

examination skills under expert guidance. 


1. To understand the applications of 

US in these two areas. 

2. To see an expert examination performed live. 

3. To see examples of common pathology. 

4. To have the opportunity for group and 

expert appraisal of the delegates’ own techniques. 

Introductory lectures: 

US of the supraspinatus tendon 

• Anatomy and demonstration 


• Pathology 


US of the elbow 

• Anatomy and demonstration 


• Pathology 


Registration: 

The number of participants for each course is restricted. 

Participants need to register in advance for the practical 

training courses (www.myESR.org) as of October 1, 2010, 

and must pay a fee of €50. Important details, including the 

schedule for the subscribed courses, are indicated on the 

confirmation/invoice. 

It is recommended that non-experienced users follow the 

introductory lectures before entering the practical training 

courses. 

Schedule: 


SK 324 08:30–10:00 Introductory Lectures 

(Room N/O) 

SK 424 10:30–12:30 Practical training course 




83


Siemens Breast Care Day 

Program ECR 2011 

Thursday, March 3, 2011 

12.30 – 13.30 

Siemens Lunch Symposium 

Breast Care goes 3D 

Room F2, Entrance Level 

14.00 - 15.00 

Panel Discussion 

Breast cancer screening – 

The conflicts between medical and business priorities 

Room OES250, Entrance Level 

14.00 – 15.30 

Hands-on-Workshop MR Breast Reading and Reporting 

Siemens Experience Lounge in the Austria Vienna Center, 

Entrance Level 

15.30 – 17.00 

Student Workshop 

One step from theory to practice – A workshop for students 

on digital imaging in breast cancer screening 

Room OES250, Entrance Level 

16.00 – 17.30 

Hands-on-Workshop CT Oncology 

Siemens Experience Lounge in the Austria Vienna Center, 

Entrance Level 

Siemens 

Breast Care 

Day 

Thursday is Siemens Breast Care Day 

Siemens Healthcare invites you to this program which covers the topic of breast care. 

The program on March 3, 2011 is part of the European Congress of Radiology in Vienna. 

www.siemens.com/ecr-BreastCareDay


Satellite 

Symposia 


SY 1 Satellite Symposium organised by 

Siemens 

Breast care goes 3D 

Moderator: D. Uhlenbrock; Dortmund/DE 


D. Uhlenbrock; Dortmund/DE 

• Automated 3D US breast volume scanning 

M. Rutten; ‘s-Hertogenbosch/NL 

• Digital 3D breast tomosynthesis and its 

emerging role in breast cancer diagnosis 

J. Barkhausen; Lübeck/DE 

• More than MR-mammography 

W.A. Kaiser; Jena/DE 




GE Healthcare 

 

Widening clinical capabilities in 

MRI: latest advances 

• Contributions to patient centric MR 

J. Coumans; Waukesha, WI/US 

• New 1.5T MR technology in clinical practice 

B. Wirth; Lons-le-Saunier/FR 

• In search for molecular imaging: 

the tri-modality imaging approach 

G.K. von Schulthess; Zurich/CH 



Bayer Schering Pharma 

Advances in contrast enhanced MRI: 

efficacy, safety and applications 

Moderator: M. Law; Los Angeles, CA/US 

• An overview of safety and efficacy for the 

gadolinium chelates 

V. Runge; Temple, TX/US 

• Contrast-enhanced MRI in multiple sclerosis: 

applications and strategies 

A. Rovira-Cañellas; Barcelona/ES 

• VALUE-trial-results from interim analysis 




Philips Healthcare 

 

Philips Sonalleve MR-HIFU: innovations 

in focused ultrasound therapy solutions 

Moderator: T. Andreae; Helsinki/FI 



SuperSonic Imagine 

Aixploring the breakthroughs against 

cancer and fibrosis 

Moderator: C. Cohen Bacrie; Aix-en-Provence/FR 

• Presentation of clinical benefits of 

ShearWave elastography worldwide breast 

trial: model and final results 

C. Cohen Bacrie; Aix-en-Provence/FR 

• Validation of ShearWave elastography worldwide 

breast trial model with European cases 

F.K.W. Schäfer; Kiel/DE 

• Preliminary experience with ShearWave 

elastography in the management of prostate cancer 


• ShearWave elastography for the 

evaluation of liver fibrosis 

G. Ferraioli; Pavia/IT 




Ingenuity TF PET/MR – 

seeing what’s never been seen before 

Moderator: T. Havens; Cleveland, OH/US 

• Ingenuity TF PET/MR: technical overview 

P. Maniawski; Cleveland, OH/US 

• Ingenuity TF PET/MR: clinical overview 




Bracco 

 

Programme to be announced 


SY 8 Satellite Symposium jointly 

organised by Siemens and 

Bayer Schering Pharma 

Synergies in CT: for better patient care 

Moderator: J.E. Wildberger; Maastricht/NL 

• Contrast induced nephropathy: 

does it matter for CT applications 

U.J. Schoepf; Charleston, SC/US 

• CT dose optimisation in paediatrics 

M. Siegel; St. Louis, MO/US 

• Optimising contrast media application 

for modern imaging 

A.H. Mahnken; Aachen/DE 

• Second generation iterative reconstruction: 

initial results 

M. Lell; Erlangen/DE 

85

Guerbet offers unique contrast media 

for medical imaging 

Dotarem ® 0.5 mmol/mL, solution for injection in vials and pre-filled syringes – Qualitative and 

quantitative composition per 100 mL: Gadoteric acid* (27.932 g) corresponding to DOTA (20.246 g) 

– Gadolinium oxide (9.062 g) (*: Gadoteric acid: gadolinium complex of 1,4,7,10 tetraazacyclododedane-N,N’,N’’,N’’’ 

tetraacetic acid). CLINICAL PARTICULARS: Therapeutic indications: Magnetic 

Resonance Imaging for cerebral and spinal disease, diseases of the vertebral column, and the other 

whole-body pathologies (including angiography). Indications and approvals may vary in different countries. 

Please refer to the local SPC before prescribing. Posology and method of administration: The 

recommended dose is 0.1 mmol/kg, i.e. 0.2 mL/kg in adults, children and infants. In angiography, 

depending on the results of the examination being performed, a second injection may be administered 

during the same session if necessary. In some exceptional cases, as the confirmation of isolated metastasis 

or the detection of leptomeningaeal tumors, a second injection of 0.2 mmol/kg can be administered. 

Contraindications: History of hypersensitivity to gadolinium salts. Contraindications related to MRI: 

subjects with a pacemaker, subjects with a vascular clip. Special warnings and precautions for use: 

Administer only by strict intravenous injection. Dotarem ® must not be administred by subarachnoid 

(or epidural) injection. Caution is recommended for anaphylactic-like reactions, renal insuffiency and 

CNS disorders. There have been reports of Nephrogenic Systemic Fibrosis (NSF) associated with use 

of some gadolinium-containing contrast agents in patients with severe renal impairment (GFR


Satellite 

Symposia 



GE Healthcare 

X-ray advanced applications: clinical 

progress and benefits in routine practice 

Moderator: L. Katz; Buc/FR 

• Imaging metal implants: benefits of digital 

radiography advanced applications 

A. Blum; Nancy/FR 

• Digital breast tomosynthesis: 

clinical performance and vision 

G. Gennaro; Padua/IT 

• Routine use of digital tomosynthesis for lung 

nodule detection: clinical, workflow and 

economic impacts 

S. Kheddache; Gothenburg/SE 

• Contrast-enhanced spectral mammography: 

clinical benefits in diagnostic workflow 

C. Dromain; Villejuif/FR 



Guerbet 

Patient management in oncology: 

screening, diagnosis and staging 

of colorectal cancer 

Moderator: D.-M. Koh; Sutton/UK 

• How to improve the patient management in 

oncology with complementary techniques 


• Patient acceptance improvement with 

minimal bowel preparation in screening 

CT colonography 

J. Stoker; Amsterdam/NL 

• Water-coloCT: an alternative imaging 

technique for colon cancer diagnosis 

P.-J. Valette; Lyon/FR 

• Dynamic MR imaging in liver staging 

after colon cancer 

T.J. Vogl; Frankfurt a. Main/DE 

• Whole-body staging with contrast-enhanced 

PET-CT 

G. Antoch; Essen/DE 

• Questions and conclusion 




Hitachi 

Hitachi real-time tissue elastography 

(HI-RTE): from the experts 

Moderator: D. Musset; Clamart/FR 

• Welcome and introduction 

D. Musset; Clamart/FR 

• State of the art Hitachi real-time tissue 

elastography: characterisation of focal breast 

lesions 

A. Thomas; Berlin/DE 

• New aspects in tendon imaging 


• Hitachi real-time tissue elastography 

in radiology 

P.S. Sidhu; London/UK 

• Non-invasive evaluation of liver fibrosis 

using Hitachi real-time tissue elastography 

K. Fujimoto; Tanabe/JP 




Ingenia 1.5T and 3.0T: the first-ever 

digital broadband MRI systems 

Moderator: J. van den Bremer; Eindhoven/NL 


C. Smits; Latham, NY/US 

• Clinical experiences with Ingenia 1.5T 

T. Leiner; Utrecht/NL 

• Clinical experiences with Ingenia 3.0T 

V. Vandecaveye; Leuven/BE 




Advances in radiology ultrasound using 

iU22 xMATRIX technology 

Moderator: E. Danse; Brussels/BE 

• Liver and renal 3D conventional and 

contrast-enhanced US using the iU22 

xMatrix system: technical innovation or 

clinical revolution 


• xMatrix ultrasound: the power of CT/MR in 

your hand 

S.T. Elliott; Newcastle upon Tyne/UK 

87

Satellite 

Symposia 


SY 14 Satellite Symposium jointly 

organised by Bracco and Toshiba 

Contrast enhanced ultrasound (CEUS): 

the effective imaging solution 

Moderator: M. Claudon; Vandoeuvre-les-Nancy/FR 

• New clinical data to support DCE-US as the 

imaging modality for the monitoring of antiangiogenesis 

therapies efficacy 

N. Lassau; Villejuif/FR 

• Evaluation of the clinical impact of CEUS in 

the treatment of abdominal aneurysm 

V. Cantisani; Rome/IT 

• The role of CEUS in the assessment of renal graft: 

immediate and long term transplant follow-up 

T. Fischer; Berlin/DE 



Hologic 

The use of breast tomosynthesis 

in clinical practice 

Moderator: A. Smith; Bedford, MA/US 



Siemens 

Shaping the future of molecular and 

magnetic resonance imaging 

Moderator: M. Schwaiger; Munich/DE 

• Reducing CT dose in myocardial 

perfusion SPECT/CT 

E. O’Shaughnessy; Poole/UK 

• Whole-body MR-PET: first experiences 

M. Schwaiger; Munich/DE 

• Clinical relevance and potential of 3 Tesla 

for musculoskeletal imaging: first experiences 

using MAGNETOM Skyra 

T.C. Mamisch; Berne/CH 



GE Healthcare 

Promise of advanced oncology imaging 

Moderator: R.C. Sigal; Velizy/FR 

• Latest guidance technologies for 

interventional oncology 


• Advanced 3T MRI of gastrointestinal oncology 


• MR guided focused ultrasound (MRgFUS) 

for treating oncology patients 

C. Catalano; Rome/IT, A. Napoli; Rome/IT 

• The role of fusion imaging in complex 

biopsy and ablative procedures 




Sectra 

How new technology can improve cancer 

detection and lower radiation dose in 

mammography 

Moderator: M. Danielsson; Solna/SE 

H. Ringertz; Linköping/SE 

• Risk of radiation-induced breast cancer in 

mammographic screening 

M.J. Yaffe; Toronto, ON/CA 

• 10 years of breast screening in Ireland: clinical 

review and impact of digital imaging 

F. Flanagan; Dublin/IE 

• Breast tomosynthesis: an overview and 

results from the first prospective clinical 

study comparing tomosynthesis to 2 view 

and 1 view 2D mammography 

M.G. Wallis; Cambridge/UK 

• First clinical results of single shot spectral 

imaging in mammography 

M. Danielsson; Solna/SE


Satellite 

Symposia 



GE Healthcare 

Redefining the rules of CT imaging: new 

frontiers for patient care and image quality 

Moderator: A. Laghi; Latina/IT 

• New insights from contrast media research 

J.A. Jakobsen; Oslo/NO 

• Gemstone spectral imaging (GSI): 

a significant advance in the diagnostic 

performance of CT for emergency imaging 

J. de Mey; Brussels/BE 

• Ultra low dose abdominal CT with iterative 

reconstruction technologies: how low can you go 

M.M. Maher; Cork/IE 




Innovative approaches with CT 

Moderator: L. De Vries; Amsterdam/NL 

• Liver anatomical segmentation: an innovative 

approach and software application 

P.-J. Valette; Lyon/FR 

• First experiences with iDOSE - dose 

reduction and better image quality 

M. Dobritz; Munich/DE 



Bracco 

Programme to be announced 



Siemens 

Pioneering innovations in ultrasound 

• Acoustic radiation force imaging (ARFI): 

repeatability of measurements and 

assessment in relation to immediate 

targeted liver biopsy 

P.S. Sidhu; London/UK 

• Strain imaging and automated ultrasound 

in the breast 


• Automated image fusion: a new processing 

approach in clinical use 

D.-A. Clevert; Munich/DE 

89

s I m p ly b e T T e r . 

The brilliant combination of safety, 

efficiency and flexibility. 

u l r i c h m e d i c a l ® C T C o n T r a s T a g e n T I n j e C T o r 

NEW 

For more than 25 years contrast 

agent injectors of ulrich medical 

help radiologists in precise 

diagnostic imaging. 

The technical question still driving 

us after all these years: How can 

we even better combine the 

highest levels of safety, efficiency 

and flexibility 

Our answer is the CT motion. 

Not available in U.S., pending 510k clearance. 

ECR 2011 Expo C Booth 326 

ulrich GmbH & Co. KG l Buchbrunnenweg 12 l 89081 Ulm l Germany 

Phone: +49 (0)731 9654-0 l Fax: +49 (0)731 9654-2805 

injector@ulrichmedical.com l www.ulrichmedical.com 

90


Industry 

Hands-On Workshops 

Thursday, March 3 to 

Sunday, March 6, Siemens 

Experience Lounge, OE – entrance level 

Industry Hands-On Workshop 

organised by Siemens Healthcare 

Clinical experts will demonstrate to you how to better 

use and further benefit from our solutions for advanced 

multimodality reading. A special focus will be placed 

on the new imaging software syngo.via. Benefit from 

experts’ experience and receive an update on state-of-theart 

techniques in CT, MR and Molecular Imaging. As a 

registered attendee for ECR 2011 these workshops are free 

of charge. Programme to be announced. 

Friday, March 4 to Monday, March 7, 

Osirix Hands-On Workshop Room, 

01 – 1 st level 


organised by aycan 

About OsiriX PRO 

Medical images present a steadily growing challenge. In 

these Hands-On Workshops, we introduce you to the 

latest state of medical image postprocessing. Attendees can 

follow the session’s contents on provided Apple Macintosh 

workstations. 

• Agenda Basic Course: 

OsiriX PRO Basics, Import/Export, 2D-Viewer, 

Reviewing, Thickslab/MPR/MIP, Teleradiology with iPad. 

• Agenda Advanced Course I: 

Volumetric Analysis, 3D Volume Rendering, 

Segmentation, Bone Removal. 

• Agenda Advanced Course II: 

Fusion, 3 point based registration, 4D analysis. 

• Agenda Advanced Course III: 

Sizing of AAA Stentgrafts. 

Saturday, March 5 and 

Sunday, March 6, 09:00–18:00, 

Carestream Health Industry Hands-On 

Workshop Room, 01 – 1 st level 


organised by Carestream Health 

Digital Mammography Self-assessment Workshop 

Goals and Objectives: 

Following completion of this programme, the participants 

should be more familiar with reading and manipulating 

digital mammography screening cases and will have 

assessed their reading skills to detect cancers in their early 

stage and to maintain a good balance between recall rate 

and detection rate. 

This workshop gives participants the opportunity for 

hands-on experience. Participants may register for up 

to seven one-hour sessions. Each session starts with an 

introduction that includes the learning objectives of the 

workshop, the method of reading and self-assessment and 

instruction on how to use the system. 

Participants will have 45 minutes to read the cases, 

and then assess their own number of false positives 

and false negatives, and discuss the cases with medical 

experts. Participants will be able to choose between a 

total of seven different modules, each one containing 

30 selected mammography screening cases with a mix 

of biopsy-proven positives and negatives. Each module 

is independent of the others; they do not need to be 

completed sequentially. 

Instructors: 

R. Holland; Nijmegen/NL 

U. Bick; Berlin/DE 


Industry Hands-On Workshop Room, 

01 – 1 st level 


organised by Philips Healthcare 

Programme to be announced. 

No pre-registration required, registration at room entrance 

/ first come first served basis. 

Registration for the Industry Hands-On Workshops 

is possible via the MyUserArea on www.myESR.org 

91


Dignitaries 

ECR 2011 

Borut Marincek 

Kilchberg/CH 

Gold Medallist 

Borut Marincek is Professor emeritus 

of Radiology at the University of Zurich, 

Switzerland, where he has served since 1997. 

He is the author or co-author of more than 290 

peer-reviewed articles, more than 50 books 

and book chapters and has given more than 

220 lectures, orations and invited lectures in 

Europe and overseas. Although well known 

for his work in gastrointestinal and abdominal 

radiology, Professor Marincek has maintained a 

broad focus throughout his career, and includes 

genitourinary, oncologic, cardiovascular and 

emergency radiology among his scientific 

interests. He sits on the editorial boards of 

several journals, including the Advisory 

Editorial Board of European Radiology, has 

received honours from many national and 

international radiological societies and is a 

recent past president of the European Society 

of Gastrointestinal and Abdominal Radiology 

and the European Congress of Radiology (both 

2009). At ECR 2011 he will be awarded the 

Gold Medal of the ESR. 

Martine Rémy-Jardin 

Lille/FR 


Martine Rémy-Jardin is Professor of Radiology 

and Head of the Department of Cardio- 

Thoracic Imaging at the University Centre of 

Lille. Her fields of interest include HRCT of 

diffuse infiltrative lung diseases, pulmonary 

vascular diseases, and cardiac and pulmonary 

functional imaging, but the major focus of 

her research has been spiral CT imaging. Her 

published works comprise 220 peer-reviewed 

publications, 75 postgraduate publications, 

377 scientific papers, and 39 books and 

chapters. She has been a regular reviewer for 

several journals, currently including European 

Radiology, and is a member of numerous 

professional and scientific societies, including 

the American Thoracic Society, the Society of 

Thoracic Radiology, the European Society of 

Thoracic Imaging, the European Respiratory 

Society, the French Society of Thoracic 

Imaging, and the French Society of Radiology, 

for which she served as President of the 

Scientific Committee from 1995 to 2006. At 

ECR 2011 she will be presented with the Gold 

Medal of the ESR. 

Ralph Weissleder 

Charlestown, MA/US 


Ralph Weissleder is Professor of Radiology and 

Professor of Systems Biology at Harvard Medical 

School, and Director of the Massachusetts General 

Hospital (MGH) Center for Systems Biology. He is 

also Attending Clinician (Interventional Radiology) 

at MGH as well as a member of the Dana-Farber/ 

Harvard Cancer Center, the Broad Institute and the 

Harvard Stem Cell Institute (HSCI). Dr. Weissleder’s 

research interests include the development of 

novel molecular imaging techniques, tools for 

early disease detection, nanomaterials for sensing, 

and systems analysis. He has published over 500 

original publications in peer-reviewed journals 

and has authored several textbooks. His work has 

been honoured with numerous awards including 

the J. Taylor International Prize in Medicine, the 

Millennium Pharmaceuticals Innovator Award, and 

the 2008 RSNA Outstanding Researcher Award. In 

2009, he was also elected as a member of the US 

National Academies Institute of Medicine. At ECR 

2011 he will be awarded the Gold Medal of the ESR. 

Denis Le Bihan 

Gif-sur-Yvette/FR 

Opening Lecturer 

Denis Le Bihan is the Founding Director of 

NeuroSpin, a new Institute aimed at developing 

and using ultra-high-field magnetic resonance 

to understand the brain. He has authored or coauthored 

over 250 articles, book chapters and review 

articles in the fields of MRI, imaging, neuroscience 

and radiology. His work has achieved international 

recognition for his outstanding contributions to the 

development of new imaging methods, including 

the Gold Medal of the International Society for 

Magnetic Resonance in Medicine, the Lounsbery 

Award from the National Academy of Sciences 

(USA) and French Academy of Sciences, and the 

Louis D. Award of the Institut de France. Dr. Le 

Bihan is a full member of the French Academy of 

Sciences, an Honorary Member of the American 

Society of Neuroradiology and a Knight of the 

French National Order of Merit. At ECR 2011 he 

will give the Opening Lecture ‘Water: radiologists’ 

best friend’ 

92


Byung Ihn Choi 

Seoul/KR 

Honorary Membership 

Byung Ihn Choi is Professor at the 

Department of Radiology of Seoul National 

University, College of Medicine in Korea and 

is an internationally recognised abdominal 

radiologist, particularly in the field of 

hepatobiliary imaging. Having worked at a 

variety of institutions across the USA and in 

Tokyo between 1985 and 1994, Dr. Choi has 

greatly contributed to the international profile 

of Korean radiology. Throughout his career he 

has published more than 600 scientific papers, 

while also serving on the editorial boards of 

numerous national and international journals. 

He is currently president of the Asian Oceanian 

Society of Radiology (AOSR), and the Korean 

Association for the Study of the Liver (KASL), 

and president-elect of the Asian Society 

of Abdominal Radiology (ASAR), and his 

contributions to international radiology have 

led to honorary membership of many regional 

and international radiological societies. He 

will be awarded Honorary Membership of the 

European Society of Radiology at ECR 2011. 

Jian-Ping Dai 

Beijing/CN 


Jian-Ping Dai is a professor at the Radiology 

Department of the Beijing Neurosurgical 

Institute and Beijing Tiantan Hospital, 

Capital Medical University, where he is also 

chairman of his department. He is a tireless 

educator and tutor and is well known as 

one of the most influential characters in the 

development of radiology in China. Dr. Dai 

has focused his research on interventional 

therapy for cerebrovascular disease and 

functional neuroimaging and has received 

several awards from the Chinese government 

for his outstanding contribution to his country. 

During his presidency of the Chinese Society 

of Radiology from 1996 to 2005, radiology 

in China accelerated its development and 

communication with other radiological 

societies such as the European Society of 

Radiology, the Radiological Society of North 

America, and the Asian Oceanian Society of 

Radiology. At ECR 2011 Dr. Dai will receive 

Honorary Membership of the European 

Society of Radiology.. 

Hedvig Hricak 

New York, NY/US 


Hedvig Hricak is Chairman of the Department 

of Radiology at Memorial Sloan-Kettering 

Cancer Center (MSKCC) and Professor of 

Radiology at the Weill Medical College of 

Cornell University. She was previously a 

professor of radiology, radiation oncology, 

urology and gynaecology at the University of 

California at San Francisco. She has authored 

or co-authored 343 peer-reviewed original 

research articles, 159 review/editorial articles, 

132 book chapters and 18 books, and given 

more than 135 named or keynote lectures. 

She is a member of the Institute of Medicine, 

National Academy of Science. She is a fellow 

of the American College of Radiology, the 

International Society for Magnetic Resonance 

in Medicine, and the Society of Uroradiology 

and her many awards include the gold medals 

of the International Society for Magnetic 

Resonance in Medicine and the Association 

of University Radiologists, the Béclère Medal 

from the International Society of Radiology, the 

Moroccan Merit Medal from the International 

Society of Radiology and the Order of the 

Croatian Morning Star of Katarina Zrinska, 

Presidential Award from Croatia. Dr. Hricak 

is the current Immediate Past President of 

the Radiological Society of North America. 

At ECR 2011 she will be awarded Honorary 

Membership of the European Society of 

Radiology. 

93


Dignitaries 

ECR 2011 

Richard L. Baron 

Chicago, IL/US 

Honorary Lecturer 

Richard L. Baron is currently chairman of the 

Department of Radiology at the University 

of Chicago, where he has served since 2002. 

He was the founding President and CEO of 

the University of Pittsburgh Physicians, an 

academic healthcare enterprise of over 1,400 

physicians, and served in that role from 1997 

to 2002. Dr. Baron has over 135 published 

articles and 26 book chapters, predominately in 

liver and biliary tract imaging and has been the 

recipient of numerous awards for his research, 

including the Hounsfield Award from the 

Society of Computed Body Tomography and 

Magnetic Resonance and The Roscoe E. Miller 

Award from the Society of Gastrointestinal 

Radiologists. At ECR 2011 he will present the 

Wilhelm Conrad Röntgen Honorary Lecture 

‘Detecting liver tumours: the search for the 

Holy Grail’. 

José Cáceres 

Barcelona/ES 


José Cáceres is Professor and Chief of 

Diagnostic Radiology at H.G.U. Vall d’Hebron 

Universidad Autónoma, Barcelona. An 

outstanding radiologist with a focus on 

thoracic imaging, Professor Cáceres is well 

recognised as an exceptional educator in his 

field and has received numerous honours for 

his contributions to the discipline, including 

the Gold Medal of the Spanish Society of 

Radiology. He has shared his expertise in chest 

radiology by serving as the chest imaging 

section editor for European Radiology and 

by chairing the chest subcommittee of the 

European Congress of Radiology three times. 

He is also a past president of the European 

Society of Chest Radiology and the Spanish 

Society of Thoracic Imaging, receiving 

honorary membership of both societies. At 

ECR 2011 he will present the Josef Lissner 

Honorary Lecture ‘The chest radiograph: 

a perfect design’. 

Majda M. Thurnher 

Vienna/AT 


Majda M. Thurnher is Associate Professor of 

Radiology at the Medical University of Vienna, a 

position she has held since 2001. Her primary focus 

is on neuroradiology, especially spinal imaging, 

and she has shared her experience throughout 

Europe and the USA as a visiting professor. Her 

published work includes 49 peer-reviewed articles, 

21 book chapters and 86 scientific papers, and she 

has contributed as a reviewer and editorial board 

member to numerous national and international 

journals, including guest editorship of special 

issues of European Radiology and Neuroimaging 

Clinics of North America. She has delivered more 

than 130 invited lectures at international meetings 

and has been a regular member of the Programme 

Planning Committee for the European Congress of 

Radiology (ECR). She is a member of the executive 

boards of several scientific societies, including the 

European Society of Neuroradiology (ESNR) and 

the American Society of Spine Radiology (ASSR). 

At ECR 2011 she will give the Pierre et Marie Curie 

Honorary Lecture „Beyond morphology and into 

physiology: newer spine imaging techniques“. 

Marc Ghysels 

Brussels/BE 

Guest Lecturer 

Marc Ghysels is a 50-year-old Belgian radiologist 

who has acquired an international reputation among 

art collectors, dealers, curators and experts working 

in auction rooms for his radiological analysis of art 

works. After specialising in interventional radiology 

at Erasme Hospital in Brussels, Thomas Jefferson 

Hospital in Philadelphia and Hammersmith 

Hospital in London, he worked in hospitals for 

fifteen years before establishing a private radiology 

practice in Brussels, analysing antiquities and art 

works from a wide range of cultures. Art specialists 

worldwide have called on his radiological skills and 

knowledge to detect the methods used to make 

art works, what damage they have suffered, how 

much restoration has been done, and to expose the 

tricks used by forgers to deceive other methods of 

scientific analysis. At ECR 2011 he will present the 

Guest Lecture ‘Slicing through Antiques & Works 

of Art’. 

94

Invited Lectures 

ECR 2011 

Opening Lecture 

Thursday, March 3, 18:55–19:15, Room A 

Water: radiologists’ best friend 

Denis Le Bihan; Gif-sur-Yvette/FR 

Guest Lecture 


Slicing through Antiques & Works of Art 

Marc Ghysels; Brussels/BE 

Honorary Lectures 

Josef Lissner Honorary Lecture 


The chest radiograph: a perfect design 

José Cáceres; Barcelona/ES 

Pierre et Marie Curie 



Beyond morphology and into physiology: 

newer spine imaging techniques 

Majda M. Thurnher; Vienna/AT 

Wilhelm Conrad Röntgen 



Detecting liver tumours: 

the search for the Holy Grail 

Richard L. Baron; Chicago, IL/US 

95

Concerts 

kammerorchesterbasel, conductor Kristjan Järvi 

Angelika Kirchschlager, mezzo-soprano 

J. Sibelius, R. Wagner, E. Grieg 

Artemis Quartett, string quartet 

L. van Beethoven 

Wiener Symphoniker, 

conductor Adam Fischer 

Denis Matsuev, piano 

Z. Kodály, F. Liszt, J. Brahms 

Concentus Musicus Wien, 

conductor Nikolaus Harnoncourt 

Arnold Schönberg Chor 

G.F. Händel 

Latvian National Symphony Orchestra, 

conductor Karel Mark Chichon 

Elina Garanca, mezzo-soprano 

G. Verdi, G. Donizetti, N. Rimski-Korsakow, G. Bizet

in Vienna 

Tonkünstler-Orchester Niederösterreich, 

conductor Michail Jurowski 

Lars Vogt, piano 

C.M. von Weber, L. van Beethoven, 

D. Shostakovich 

Rolando Villazón, tenor 

Gerold Huber, piano 

Songs by R. Schumann 

Klangforum Wien, conductor 

Emilio Pomárico 

Marisol Montalvo, soprano 

I. Yun, N. Obuchow, A. Jolivet, K. Szymanowski 

Tonkünstler-Orchester Niederösterreich, 

conductor Andrés Orozco-Estrada 

Flamenco 

ORF Radio Symphonie Orchester Wien, 

conductor Peter Eötvös 

Natalia Zagorinskaya, soprano 

Carolin Widmann, violin 

Z. Kodály, P. Eötvös, G. Kurtág, B. Bartók 

Thomas Quasthoff, baritone 

András Schiff, piano 

Songs by H. Wolf, G. Mahler

Antigone 

By Sophokles 

Theatre 

Die Pappenheimer oder Das O der Anna O. 

By Franzobel 

Was ihr wollt 

By William Shakespeare 

Das weite Land 

By Arthur Schnitzler 

Der Parasit 

By Friedrich Schiller 

Die Beteiligten 

By Kathrin Röggla 

Rausch 

By August Strindberg 

Das blinde Geschehen 

By Botho Strauß 

Phaedra 

By Jean Racine

in Vienna 

lieber schön 

By Neil LaBute 

Heldenplatz 

By Thomas Bernhard 

Die heilige Johanna der Schlachthöfe 

By Bertolt Brecht 

Drei Schwestern 

By Anton Tschechow 

Die Ratten 

By Gerhard Hauptmann 

Ein Monat auf dem Lande 

By Iwan Turgenjew 

Lulu 

By Frank Wedekind


ESR 

Executive Council 

(March 2010 – March 2011) 

Maximilian F. Reiser; Munich/DE 

President 

András Palkó; Szeged/HU 

1 st Vice-President 

Gabriel P. Krestin; Rotterdam/NL 

2 nd Vice-President 

Christian J. Herold; Vienna/AT 

Past-President 

Yves Menu; Paris/FR 

Congress Committee Chairman 

Lorenzo Bonomo; Rome/IT 

1 st Vice-Chairman of the Congress Committee 

José I. Bilbao; Pamplona/ES 

2 nd Vice-Chairman of the Congress Committee 

Adrian K. Dixon; Cambridge/UK 

Publications Committee Chairman 

Luis Martí-Bonmatí; Valencia/ES 

Research Committee Chairman 

Éamann Breatnach; Dublin/IE 

Education Committee Chairman 

Luís Donoso; Barcelona/ES 

Professional Organisation Committee Chairman 

Fred E. Avni; Brussels/BE 

Subspecialties Committee Chairman 

Guy Frija; Paris/FR 

National Societies Committee Chairman 

Luigi Solbiati; Busto Arsizio/IT 

Communication & International Relations 

Committee Chairman 

Katrine Åhlström Riklund; Umea/SE 

Finance Committee Chairperson 

Peter Baierl; Vienna/AT 

Executive Director 


ESOR Scientific/Educational Director 

100


ECR 2011 

Committees 

CONGRESS COMMITTEE 

Chairperson (Congress President) 


1 st Vice-Chairperson 

(1 st Congress Vice-President) 

L. Bonomo; Rome/IT 

2 nd Vice-Chairperson 

(2 nd Congress Vice-President) 


Ordinary Members 

V.E. Sinitsyn; Moscow/RU 



ESR President 


ESR Executive Director 

P. Baierl; Vienna/AT 

Ex-officio Members: 

Chairperson of the 

Finance Committee 

K. Åhlström Riklund; Umea/SE 

Chairperson of the 

Publications Committee 


PROGRAMME PLANNING COMMITTEE 

Postgraduate Educational 

Programme 

Chairman: 


Members: 




M. Maas; Amsterdam/NL 

M.G. Mack; Frankfurt a. Main/DE 

K. Nikolaou; Munich/DE 

R. Salvador; Barcelona/ES 

J. Votrubová; Prague/CZ 

M. Zanetti; Zurich/CH 

Scientific Papers 

Chairman: 

V.E. Sinitsyn; Moscow/RU 

Members: 

E. de Kerviler; Paris/FR 


A. Trojanowska; Lublin/PL 

Scientific Exhibition (EPOS) 

Chairman: 


Members: 

I. Björkman-Burtscher; Lund/SE 

I. Lupescu; Bucharest/RO 



A.M. Davies; Birmingham/UK 


E³ – European Excellence in 

Education: 



Foundation Course 

V. Donoghue; Dublin/IE 

e-Learning 


P. Pokieser; Vienna/AT 

Cases of the Day 

R. Hermans; Leuven/BE 

Physics Programme 



D. Vanel; Bologna/IT 


M.M. Thurnher; Vienna/AT 

Evaluation 

G.A. Krombach; Aachen/DE 

Publications Committee Chairman 


101


ECR 2011 

Committees 

SCIENTIFIC SUBCOMMITTEES 


The ESR would like to thank ESGAR for 

their cooperation on this subcommittee 

Chairmen: 

H. Fenlon; Dublin/IE 

C. Triantopoulou; Athens/GR 

Members: 

C. Ayuso; Barcelona/ES 

M.A. Bali; Brussels/BE 

A. Ba-Ssalamah; Vienna/AT 


R. Bouzas; Vigo/ES 


D.J. Breen; Southampton/UK 

L. Curvo-Semedo; Coimbra/PT 

J.B. Dormagen; Oslo/NO 

S. Gourtsoyianni; Iraklion/GR 


U. Korman; Istanbul/TR 

P. Leander; Malmö/SE 

T. Mang; Vienna/AT 

M.A. Patak; Zurich/CH 

F. Pilleul; Lyon/FR 

S. Rafaelsen; Vejle/DK 

S. Romano; Naples/IT 

S. Stojanovic; Novi Sad/RS 

C. Stoupis; Maennedorf/CH 

Z. Tarján; Budapest/HU 

S.A. Taylor; London/UK 



Breast 

The ESR would like to thank EUSOBI for 


Chairman: 

G. Esen; Istanbul/TR 

Members: 


H. Dobson; Glasgow/UK 


G. Kirova; Sofia/BG 

A. Malich; Nordhausen/DE 


F. Thibault; Paris/FR 

J. Veltman; Nijmegen/NL 

Cardiac 

The ESR would like to thank ESCR for 


Chairman: 

A.J.B.S. Madureira; Porto/PT 

Members: 

H. Alkadhi; Zurich/CH 

G. Feuchtner; Innsbruck/AT 

M. Gardarsdottir; Reykjavik/IS 

S. Katsilouli; Athens/GR 

K.-F. Kreitner; Mainz/DE 

E. Mershina; Moscow/RU 


A.P. Parkar; Bergen/NO 

J.-F. Paul; Le Plessis Robinson/FR 

C. Peebles; Southampton/UK 

D. Piotrowska-Kownacka; Warsaw/PL 

P.K. Vanhoenacker; Aalst/BE 

Chest 

The ESR would like to thank ESTI for 


Chairman: 

M.-L. Storto; Chieti/IT 

Members: 

E. Castañer; Sabadell/ ES 

W.F.M. De Wever; Leuven/BE 

S.R. Desai; London/UK 

B. Feragalli; Chieti/IT 

I. Hartmann; Rotterdam/NL 

K. Marten; Göttingen/DE 

J. Neuwirth; Prague/CZ 

A. Oikonomou; Alexandroupolis/GR 

H. Prosch; Vienna/AT 

M.-P. Revel; Paris/FR 

E. Rizzo; Lausanne/CH 

K. Vidmar Kocijancic; Ljubljana/SI 

Computer Applications 

The ESR would like to thank EuroPACS 

for their cooperation on this subcommittee 

Chairman: 

E. Pietka; Gliwice/PL 

Members: 

J. Fernandez-Bayó; Sabadell/ES 

T.G. Maris; Iraklion/GR 

E. Neri; Pisa/IT 

M. Onu; Bucharest/RO 


L.N. Sutton; Halifax/UK 

Molecular Imaging and 

Contrast Media 

Chairman: 

P. Reimer; Karlsruhe/DE 

Members: 

S. Chatziioannou; Athens/GR 

A. Cuocolo; Naples/IT 

B. Elmståhl; Malmö/SE 

L.S. Fournier; Paris/FR 

A.M. Herneth; Vienna/AT 

G.G. Karmazanovsky; Moscow/RU 

A.J. van der Molen; Leiden/NL 

M. Wozniak; Lublin/PL 

Genitourinary 

The ESR would like to thank ESUR for 


Chairman: 


Members: 

D. Beyersdorff; Berlin/DE 

F. Cornud; Paris/FR 

F.M. Danza; Rome/IT 


P. Liss; Uppsala/SE 

H.J. Michaely; Mannheim/DE 

S. Moussa; Edinburgh/UK 

D. Negru; Iasi/RO 

F. Papadopoulou; Ioannina/GR 


A.T. Turgut; Ankara/TR 

A. Vargha; Hidegség/HU 

Head and Neck 

The ESR would like to thank ESHNR for 


Chairman: 

H.C. Thoeny; Berne/CH 

Members: 

E. Arana; Valencia/ES 


D. Cuzino; Bucharest/RO 

N. Gritzmann; Vienna/AT 

P.-Y. Marcy; Nice/FR 

J. Olliff; Birmingham/UK 

L. Preda; Milan/IT 

B. Verbist; Leiden/NL 

102


ECR 2011 

Committees 


The ESR would like to thank CIRSE for 


Chairman: 

P.E. Andersen; Odense/DK 

Members: 

A. Basile; Catania/IT 

C. Binkert; Winterthur/CH 

E. Boullosa; Vigo/ES 

M. Glynos; Athens/GR 

P. Haage; Wuppertal/DE 

M. Januszewicz; Warsaw/PL 

J. Kettenbach; Berne/CH 

A. Krajina; Hradec Králové/CZ 

A.G. Ryan; Waterford City/IE 

T. Sabharwal; London/UK 

C. Tziakouri-Shiakalli; Nicosia/CY 

O.M. van Delden; Amsterdam/NL 


The ESR would like to thank ESSR for 


Chairman: 

E. Llopis; Valencia/ES 

Members: 

G.M. Allen; Oxford/UK 

F. Birsasteanu; Timisoara/RO 

P.M. Cunningham; Navan/IE 

J.-L. Drapé; Paris/FR 

M. Epermane; Valmiera/LV 

G. Guglielmi; Foggia/IT 


G. Mantzikopoulos; Athens/GR 

A. Oktay; Izmir/TR 

C.W.A. Pfirrmann; Zurich/CH 


S. Weckbach; Munich/DE 

Neuro 

The ESR would like to thank ESNR for 


Chairman: 

P.C. Maly Sundgren; Malmö/SE 

Members: 

N. Bargalló; Barcelona/ES 

V. Dousset; Bordeaux/FR 

J. Fiehler; Hamburg/DE 

Z. Merhemic; Sarajevo/BA 

M. Muto; Naples/IT 

L. Østergaard; Århus/DK 

I. Saatci; Ankara/TR 

M. Sasiadek; Wroclaw/PL 

T. Stosic-Opincal; Belgrade/RS 

J.W.M. van Goethem; Antwerp/BE 

P. Vilela; Almada/PT 

T.A. Yousry; London/UK 

Paediatric 

The ESR would like to thank ESPR for 


Chairman: 

J.-F. Chateil; Bordeaux/FR 

Members: 

A. Borthne; Lørenskog/NO 

M.P. García-Peña; Barcelona/ES 

M. Haliloglu; Ankara/TR 

C.J. Kellenberger; Zurich/CH 

O.E. Olsen; London/UK 


S. Ryan; Dublin/IE 

R.R. van Rijn; Amsterdam/NL 

Physics in Radiology 

The ESR would like to thank EFOMP for 


Chairman: 


Members: 

O. Ciraj-Bjelac; Belgrade/RS 

E. Guibelalde; Madrid/ES 

H. Jarvinen; Helsinki/ FI 

R. Padovani; Udine/IT 

O. Speck; Magdeburg/DE 

D.G. Sutton; Dundee/UK 

J.N. Vassileva; Sofia/BG 

Radiographers 

The ESR would like to thank ISRRT for 


Chairmen: 

B.T. Andersson; Lund/SE 

S.J. Golding; Oxford/UK 

Members: 

S. Braico; Rome/IT 

P. Gerson; Paris/FR 

A. Henner; Oulu/FI 

D. Pekarovic; Ljubljana/SI 

K. Sigurdardottir; Mosfellbaer/IS 

C. Vandulek; Kaposvár/HU 

Vascular 

The ESR would like to thank CIRSE for 


Chairman: 

W.R. Jaschke; Innsbruck/AT 

Members: 

E. Brountzos; Athens/GR 

A. Cieszanowski; Warsaw/PL 

M.W. de Haan; Maastricht/NL 

F. Fanelli; Rome/IT 

J.E. Jackson; London/UK 

T.J. Kroencke; Berlin/DE 

L.P. Lawler; Dublin/IE 

F. Thony; Grenoble/FR 

103

What if you could improve 

diagnostic and treatment 

efficiency in a new way 

Visit us at 

ECR 2011 

Hall Extension 

Expo A, 

Austria Center 

Vienna 

Morphological and functional information in one image, 

on one screen. For profound diagnosis and treatment. 

With Siemens, you can easily see the complete clinical picture and compare current results with what you have 

diagnosed before. Acquire morphological, functional, and metabolic images simultaneously as you have never 

done before. Bring together PET∙CT, MR, CT, Angiography, and X-ray on one screen, in one layout with syngo.via*. 

Compare current and previous results in an instant – allowing you to increase treatment precision and efficiency 

in a new way. Images, my way. www.siemens.com/ecr 

Answers for life. 

A91IM-9128-A1-ECR 

* syngo.via can be used as a stand-alone device or together with a variety of syngo.via-based software options, which are medical devices in their own rights.


ECR 2011 

Topic Coordinators 


KISS (Keep it simple and straightforward): 

Musculoskeletal MRI 

A.M. Davies; Birmingham/UK 

Radiology in Abdominal Emergencies 


P. Rogalla; Berlin/DE 

CLICK (Clinical lessons for imaging core knowledge): 



Mini Courses 

Organs from A to Z: Pancreas 


The Beauty of Basic Knowledge: 



E³ – European Excellence in Education 

Foundation Course: Paediatric Radiology 

V. Donoghue; Dublin/IE 



Update Your Skills (Practical Courses) 

Image-Guided Breast Biopsy: How to do it 


Musculoskeletal US: Shoulder and elbow 


4 th Post Processing Face-Off Session 



Functional Imaging of Tumours: How to do it 

C.A. Cuénod; Paris/FR 

Joint Course of ESR and RSNA 

(Radiological Society of North America): 

Essentials in oncologic imaging: 

what radiologists need to know 

R.L. Baron; Chicago, IL/US 




D.M. Panicek; New York, NY/US 


105

Register online now at 

www.myESR.org/registration2011

Scientific - myESR.org

Transform your PDFs into Flipbooks and boost your revenue!

Delete template?

Save as template ?